ML081930802: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
Line 1: Line 1:
{{Adams
#REDIRECT [[RA-08-060, Oyster Creek - Transmittal of Supplemental Response - Amergen Application to Revise Technical Specifications Secondary Containment Operability Requirements During Refueling]]
| number = ML081930802
| issue date = 07/03/2008
| title = Oyster Creek - Transmittal of Supplemental Response - Amergen Application to Revise Technical Specifications Secondary Containment Operability Requirements During Refueling
| author name = Cowan P B
| author affiliation = AmerGen Energy Co, LLC
| addressee name =
| addressee affiliation = NRC/Document Control Desk, NRC/NRR
| docket = 05000219
| license number = DPR-016
| contact person =
| case reference number = RA-08-060
| document type = Letter, Technical Specification, Amendment
| page count = 166
| project =
| stage = Supplement
}}
 
=Text=
{{#Wiki_filter:AmerG3 SM ArnerGen Energy Company, LLC www.exeloncorp.com An Exelon Company 200 Exelon Way Kennett Square, PA 19348 10 CFR 50.90 RA-08-060 July 3, 2008 U. S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555-0001 Oyster Creek Nuclear Generating Station Facility Operating License No. DPR-16 Docket No. 50-219
 
==Subject:==
Supplemental Response -AmerGen Application to Revise Technical Specifications Regarding Secondary Containment Operability Requirements During Refueling
 
==Reference:==
: 1) Letter from Pamela B. Cowan to U.S. Nuclear Regulatory Commission Technical Specification Change Request 338 -Secondary Containment Operability Requirements During Refueling, dated November 2, 2007 2) Letter from Pamela B. Cowan to U.S. Nuclear Regulatory Commission Response to Draft Request for Additional Information
-AmerGen Application to Revise Technical Specifications Regarding Secondary Containment Operability Requirements During Refueling, dated May 5, 2008 By letter dated November 2, 2007 (Reference 1), AmerGen Energy Company, LLC (AmerGen)submitted a request to revise the Oyster Creek Nuclear Generating Station (Oyster Creek)Technical Specifications (TS) to eliminate the requirement for secondary containment to be operable during handling of irradiated fuel with sufficient decay.By letter dated May 5, 2008 (Reference 2), AmerGen provided additional information in response to a U.S. Nuclear Regulatory Commission (NRC) request for additional information received via NRC facsimile dated March 25, 2008, regarding the referenced TS change request.Subsequently, the NRC notified AmerGen of discrepancies with information provided in support of the TS change request. The discrepancies were discussed during a follow-up telephone conversation on June 16, 2008, between representatives of the NRC and AmerGen. In particular, the NRC discussed concerns with RADTRAD data used in the Alternative Source Term (AST) Fuel Handling Accident (FHA) calculation, and other inconsistencies with information and data provided in the TS change request. As a result, AmerGen agreed to submit supplemental information to address the identified discrepancies by July 3, 2008.Accordingly, the attachments to this letter include the following information:
* A change to the dose conversion factor file. A blank line was inadvertently inserted, which impacted the dose conversion factors.
Technical Specification Change No. 338 Secondary Containment Operability Supplemental Response Docket No. 50-219 July 3, 2008 Page 2* Three tables, one in the License Amendment Request (LAR) and two in the FHA Calculation, have been revised for consistency with the calculation.
* Table 6.1.3 in the FHA Calculation indicates that the 0-2 hour X/Q values were used. An explanation is provided indicating why these values were used and why the values are considered conservative.
* There was a statement that 4,000 cfm in the Control Room (CR) produces the highest dose. AmerGen has determined the maximum CR dose plateau occurs for flow rates of 2,000 cfm or greater for the FHA (a short-term accident).
A sensitivity study was performed for the FHA, demonstrating the CR dose plateau first observed at a CR ventilation flow rate of 2,000 cfm. The RADTRAD output pages have been updated." The FHA Calculation previously used 14,000 cfm of CR intake flow with only 2,000 cfm exhaust flow. This produced a conservative result, but is unrealistic and has been corrected in the calculation." The calculated lower release rate from the refuel floor air space has been incorporated in the FHA Calculation to better reflect a more realistic two-hour release.If any additional information is needed, please contact Mr. Richard Gropp at 610-765-5557.
I declare under penalty of perjury that the foregoing is true and correct. Executed on the 3 rd day of July 2008.Respectfully, Pamela B. Cowan Director, Licensing and Regulatory Affairs AmerGen Energy Company, LLC Attachment 1: Revised FHA Calculation C-1302-822-E310-082, Revision 1 Attachment 2: Proposed Changes to License Amendment Request -Excerpts cc: Regional Administrator
-NRC Region I NRC Senior Resident Inspector
-OCNGS NRC Project Manager, NRR -OCNGS Director, Bureau of Nuclear Engineering, New Jersey Department of Environmental Protection ATTACHMENT 1 Oyster Creek Nuclear Generating Station Technical Specifications Change Request 338 -Supplemental Response Secondary Containment Operability Requirements During Refueling Revised Calculation C-1302-822-E310-082, Revision 1"Oyster Creek Analysis of Fuel Handling Accident (FHA) Using Alternative Source Terms (AST)"
ALEULA'ON NU. C-1302-822-E310-082 A RE. NOi PAGE NO. 1 ATTACHMENT 1 Deslan Analysis Major Revision Cover Sheet Design Analysis (Major Revision)
Last Page No.' 5 1 Analysis No.:' C-1302-822-E310-082 Revision:
1 Title: Oyster Creek Analysis of Fuel Handling Accident (FHA) Using Alternative Source Terms (AST)EC/ECR No.: 07-00790 Revision: 5  0 Station(s):'
Oyster Creek Component(s):
".....Unit No.:' N/A Discipline:
M Descrip. Code/Keyword:
,0 Dose Safety/QA Class:" S System Code: " 822 Structure:3 N/A CONTROLLED DOCUMENT REFERENCES" Document No.: From/To Document No.: From/To C-1302-826-E310-018, Rev. 0 From _ From C-1302-226-E620-369, Rev. 0 From From C- 1302-826-E540-017, Rev. 0 From is this Design Analysis Safeguards Information?
Yea C No [ If yes, see SY-AA-101-106 Does this Design Analysis contain Unverified Yes [ No Z It yes, ATl/AR#: Assumptions?
This Design Analysis C-1302-822-E310-062, Revisions 0 and OA In its entirety.SUPERCEDES:
"1 Description of Revision (list affected pages for partials):
This revision incorporates Revision OA, responses to various NRC RAI questions, as well as other issues and concerns indicated by the NRC. An error in the dose conversion factor file was corrected, a sensitivity study regarding CA flow rates was performed, and many editorial changes were made.Preparer:
" Method of Review:I Method of Review: zi Reviewer:
2 Review Notes: 23 I P", N d"e In depe.pdent review [All ,AU,. r ,-I (FO' in~ A~u~.se* O~y)(Far Edefnaf Anyses. ,WAy)External Approver-.
'Exelon Reviewer:
11 N/A pmNan*N/A PrimW Nama SIgn Nwm SUn Nwn.Date 076. --- ----Independent 3"d Party Review Reqd? aO Yes Z No C3 Gopal Patel, NUCO ~ 06/8) (1 Exelon Approver:"&#xfd; John Rommel H ck-e,- Va's.<apV 9&#xfd; 7 7-p'~jn Na."e sianNanez
--r LI CALCULATION NO. C-1302-822-E310-082 1 REV. NO. 1 1 PAGE NO. 2 General Review Questions Page 1 of 1 DESIGN ANALYSIS NO. C-1302-822-E310-082 REV: 1 1. Does the Design Analysis conform to design requirements?
: 2. Does the Design Analysis conform to applicable codes, standards, and regulatory requirements?
: 3. Have applicable design and safety limits been identified?
: 4. Is the analysis method appropriate?
: 5. Are the methods used and recommendations given conservative relative to the design and safety limits?6. Are assumptions/Engineering Judgments explained and appropriate?
: 7. Have appropriately verified Computer Program and versions been identified, when applicable?
: 8. Does the Computer Program conform with the NRC SER or similar document when applicable?
: 9. Has the input been correctly incorporated into the Design Analysis?10. Has the input been reviewed by all cognizant design authorities?
: 11. Are the analysis outputs and conclusions reasonable compared to the* inputs and assumptions?
: 12. Are the recommendations/results/conclusions reasonable based on previous experience?
: 13. Has a verification of the Design Analysis been performed by alternate methods?14. Has all input data been used correctly and is it traceable?
: 15. Has the effect on plant drawings, procedures, databases, and/or plant simulator been addressed?
: 16. Has the effect on other systems been addressed?
: 17. Have any changes in other controlled documents (e.g. UFSAR, Technical Specifications, COLR, etc.) been identified and tracked?18. When applicable, are the analysis results consistent with the proposed license amendment?
: 19. Have other documents that have used the calculation as input been reviewed and revised as appropriate?
: 20. Have all affected design analyses been documented on the Affected Documents List (ADL) for the associated Configuration Change?21. Do the sources of inputs and analysis methodology used meet current technical requirements and regulatory commitments? (If the input sources or analysis methodology are based on an out-of-date methodology or code, additional reconciliation may be required if the site has since committed to a more recent code)22. Have supporting technical documents and references been reviewed when necessary?
Yes[][]ED No El El LI N/A El 1:1 El MI MI El.LI El FI El LI E LI EI LI EI 1 ElI El LI LI LI D]LI El LI LI1 LI LI LI LI I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 3 1 Table of Contents DESIGN ANALYSIS COVER SHEET ..........................................................................................
..........
I GENERAL REVIEW CHECKLIST FOR DESIGN ANALYSIS ....................................................................
2 T A B L E O F C O N T E N T S ...................................
............................................................................................................
3 1. P U R P O S E /O B JE C T IV E .................................................................................................................................
4 2. METHOD OF ANALYSIS AND ACCEPTANCE CRITERIA ............................................................
5 2 .1. F u el S o u rce T erm M o d e l .............................................................................................................................
5 2 .2 .G ap A c tiv ity ............................................................................................................
........................
..........
6 2.3. Pool D econtam in ation Factor (D F) .......................................................................................................
6 2 .4 .R elea se M o d e l ...............................................................................................................................................
8 2 .5 .C o n tro l R o o m M o d e l ...................................................................................................................................
8 2 .6 .D o se M o d e lin g .............
.................................................................................................................................
9 2 .6 .1 .E A B an d L P Z ...........................................................................................................................................
9 2 .6 .2 .C o n tro l R o o m ................................................................................................................................
I .........
9 2 .7 .A ccep tan ce C riteria ....................................................................................................................................
10 3 .A S S U M P T IO N S .............................................................
.....................................................................
Ii..........
I 4 .D E S IG N IN P U T ........................
......................................................................................................................
12 5 .R E F E R E N C E S ................................................................................................................................................
15 6. C A L C U L A T IO N S ...............................
.........................
........ ............
....... ...............................................
16 6.1. RADTRAD Run Compartment Information
.............................................................................................
17 6.2. RADTRAD Run Transfer Pathway Information
...........................................................................................
17 6.3. RADTRAD Run Dose Location Information
...........................................................................................
18 6.4. RADTRAD Run Source Term & Dose Conversion Factor Information
...................................................
18 7. RESULTS AND CONCLUSIONS
...................
.................
...... ...... 20 Attachments A. RADTRAD Dose Conversion Factor Input File (Starts on Page 21)B. RADTRAD Output (Starts on Page 32)C. FHA RADTRAD Nuclide Information File (Starts on Page 44)D. FHA RADTRAD Release Fraction and Timing File (Page 53)E. Control Room vs. HVAC Flow Sensitivity Study and associated RADTRAD output (Starts on Page 54)* 50 cfm Case (Starts on page 56)a 200 cfm Case (Starts on page 68)* 1,000 cfm Case (Starts on page 80)* 5,000 cfm Case (Starts on page 92)* 10,000 cfm Case (Starts on page 104)* 14,000 cfm Case (Starts on page 116)* 20,000 cfm Case (Starts on page 128)* 28,000 cfm Case (Starts on page 140)F. Email from Gopal Patel, NUCORE, documenting independent third party review (Starts on page 152)
CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 4 1. PURPOSE/OBJECTIVE The purpose of this calculation is to apply Alternative Source Term (AST) methodology to the analysis of the design basis Fuel Handling Accident (FHA) for Oyster Creek Nuclear Generating Station (OCNGS). Dose consequences are calculated at the Exclusion Area Boundary (EAB), the Low Population Zone (LPZ) and the Control Room (CR). This calculation determines the safety features required to assure that regulatory limits in 10CFR50.67 are met, and is performed in conformance with guidance for analysis of this event provided in Regulatory Guide (RG) 1.183, Appendix B.This accident analysis evaluates the movement of fuel that has decayed a minimum of 24 hours since it last occupied part of a critical reactor core.Guidance in Technical Specification Task Force (TSTF) Traveler 51 suggests that a "recently irradiated fuel" parameter be developed to identify when secondary containment integrity features are required for spent fuel movement.
In this calculation, recently irradiated fuel would be that which requires one or more of the following safety features: 1. Secondary Containment Integrity to assure that releases are through the plant ventilation stack.2. The Standby Gas Treatment System (SGTS) for secondary containment release treatment.
This calculation supports changes to the OCNGS Technical Specifications that consider maintenance and operability of the secondary containment and emergency filtration systems and subsystems previously required to mitigate the radiological consequences of fuel handling accidents may not be necessary.
Not having to consider secondary containment and control room integrity and filtration requirements in support of refueling activities has the potential to improve the flexibility and duration of scheduled plant outage activities.
RG 1.183 (Ref. 2) is the basis for these evaluations.
Concerning the FHA, this AST guidance has the advantage of smaller gap fractions, a larger spent fuel pool decontamination factor [DF], and dose criteria that replace both the whole body and thyroid dose limits with a limit on Total Effective Dose Equivalent
[TEDE].The other changes from the current UFSAR analysis are listed below.* An offsite dose limit of 6.3 rem TEDE (RG 1.183 & 10 CFR 50.67(b)(2)(i))
is applied instead of the Standard Review Plan (SRP) 15.7.4 values of 25% of the 1 OCFR1 00 limits.* A control room dose limit of 5 rem TEDE (RG 1.183 & 10 CFR 50.67(b)(2)(iii))
is applied instead of the 5 rem whole body, or its equivalent (110CFR 50, Appendix A, GDC-1 9).* Design Basis analysis is based on NRC RG 1.183.* The Control Room I/Q's were recalculated for release from various potential release points with the new limiting x/o'S applied to this analysis.
A ground level release model is used.* No credit is taken for Secondary Containment automatic isolation and filtration
* Dose Conversion Factors (DCFs) for Immersion and Inhalation are taken from Federal Guidance Reports (FGRs) 12 (Ref. 5) and 11 (Ref. 4), respectively.
RG 1.183 cites these DCFs as acceptable current estimates for evaluating the radiological impact of nuclear plant accidents.
I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE No. 5 1 2. METHOD OF ANALYSIS AND ACCEPTANCE CRITERIA Analyses of radiological consequences resulting from a design basis Fuel Handling Accident (FHA)are performed using the guidance for application of Alternative Source Terms to this event in RG 1.183, Appendix B.Analyses of radiation transport and dose assessment are performed using RADTRAD v. 3.03 (Exelon DTSQA EX0004754
). RADTRAD is a simplified model of RADionuclide Transport and Removal And Dose Estimation developed for the NRC and endorsed by the NRC as an acceptable methodology for reanalysis of the radiological consequences of design basis accidents.
The technical basis for the RADTRAD code is documented in section 2 NUREG/CR-6604 (Ref. 3). The methodologies significant to this analysis are the dose consequence analysis (NUREG Section 2.3) and the Radioactive Decay Calculations (NUREG Section 2.4).2.1. Fuel Source Term Model The source term nuclide inventory (Ref 10) used for the Fuel Handling Accident (FHA) is the same as that previously used in the LOCA AST analysis (Ref 11). This inventory is considered to be bounding with respect to expected fuel .types in use or expected to be used at OCNGS.Regulatory Guidance for DBA fuel handling accidents is such that the fission product inventory of each of the damaged fuel rods is determined by dividing the total core inventory by the number of fuel rods in the core. To account for differences in power level across the core, radial peaking factors are applied in determining the inventory of the worst-case damaged rods.For OCNGS, the fraction of the core fuel damaged is based on the GESTAR II limiting case of damaging 140 fuel pins (based on a "Heavy Mast" design; i.e., the "NF500 mast") from GEl 1 or GE13 9x9 fuel bundle arrays with the analyzed equivalent of 74 pins per bundle, and with all of the damaged fuel assumed to have a limiting Radial Peaking Factor (PF) of 1.7.This analysis is for an assembly and mast drop from the maximum height allowed by the refueling platform over the reactor well onto fuel in the reactor, and bounds all locations in terms of fuel damage potential.
OCNGS core loads consist of all GEl 1 9x9 fuel assemblies, and therefore, the results of the GESTAR II limiting case are consistent with OCNGS core loading. The table below shows a comparison of various fuel bundle types with their associated fuel array. Although the OCNGS core reloads consists only of 9x9 fuel array bundle types, the spent fuel pool still holds some 8x8 assemblies.
The table demonstrates the analysis considering 9x9 fuel assemblies is bounding to an analysis considering 8x8 assemblies.
The 7x7 fuel array damaged core fraction with associated peaking factor is shown for comparative historical purposes only. The 7x7 fuel stored within the spent fuel pool at OCNGS has had sufficient decay such that the majority of the iodines have decayed. Fuel in the spent fuel pool has sufficient water coverage (>23 feet) over top of active fuel. (Ref. 1, FSAR section 9.1.2.2.1)
CALCULATION NO. C-1302-822-E310-082 REV. No. 1 I PAGE NO. 6 A B C......D E Damaged. Core Fractionl Assuming.Core is All Radial Damaged Core Fraction Fuel Pins in Failed Specified Bundle Type Peak'ing withPF.Bundle Type. .,Array Bundle Pins .IC-B/(560*A)I
.' Factor (PFj EC*D GEl 1, GE13 9x9 74 140 0.003378 1.7 0.005743 Various 8x8 62 124 0.003571 1.5 0.005356 Various 7x7 49 111 0.004045 1.5 0.006068 With a 1.7 radial peaking factor, the associated power of the damaged fuel = 1969 MWth *0.003378
* 1.7 = 11.31 MWth.Because of radioactivity decay, the worst-case fuel handling accident is that associated with handling fuel that has recently been part of a critical core operating at full power immediately prior to the accident.
Movement of irradiated fuel will not occur less than 24 hours after the associated reactor shutdown in accordance with station procedures, and therefore, 24 hours is the minimum decay period assumed. This value continues to be a very conservative assumption for BWRs, given the extensive operations necessary associated with reactor disassembly before commencing fuel movement.
Radioactive decay from the time of shutdown is modeled for 24 hours to support the opening of the most restrictive secondary containment potential release point.2.2. Gap Activity This calculation is applicable to fuel whose burnup and power limits are bounded by those specified in RG 1.183, footnote 11. This allows application of the gap activity fractions for non-LOCA events per RG 1.183, Table 3, which are as follows: 5% of the noble gases (excluding Kr-85)10% of the Kr-85 5% of the iodine inventory (excluding 1-131)8% of the 1-131 12% of the Alkali metal inventory Because RADTRAD does not allow for application of isotope specific release fractions, the"ocfhaikr.nif" file is modified to accommodate the differential gap activities among the halogen (I-131) and noble gas (Kr-85) gap fractions dictated by RG 1.183 (Ref. 2) shown above. Therefore, the initial activity of isotope 1-131 and Kr-85 are multiplied by 1.6 and 2.0, respectively, within the file "ocfhaikr.nik" in order to accommodate the respective 8% and 10% release fractions directed by regulatory guidance (Ref. 2).2.3. Pool Decontamination Factor (DF)An assessment of water coverage and effective DFs considering FHAs over the reactor well and in the spent fuel pool was performed.
It identified that the drop over the reactor well is more limiting.This is due to the number of rods failed in an accident over the reactor well being greater, as the number of failed fuel rods is determined by balancing the energy of the dropped assembly against the energy required to fail a rod. The entire amount of potential energy, including the energy of the entire assembly falling to its side from a vertical position (referenced to the top of the reactor core),
I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 7 is available for application to the fuel assemblies involved in the accident.
The drop distance assumed is 34 feet. (Ref 13) Water coverage over the reactor well is -30 feet as estimated from plant drawings.
A decontamination factor of 200 is assumed, per RG 1.183 and reference 8, associated with water coverage of 23 feet. However, no additional decontamination factor credit is taken for water depth greater than 23 feet in order to maintain conservatism and consistency with regulatory guidance.When a fuel handling accident occurs in the spent fuel pool, it is assumed that the dropped bundle will rest on the tops of the bail handles of the fuel in the storage racks. This puts the highest point of the (now horizontal) dropped assembly at 22.27 feet below the surface of the water. Therefore, for a drop over the spent fuel pool, coverage over the dropped assemblies is slightly less than 23 feet, assuming that the dropped bundle is laying across the tops of fuel bundles within the spent fuel racks. There is always greater than 23 feet of water above top of active fuel for bundles within the racks. However, the slight reduction in DF due to slightly less than 23 feet water coverage is offset by the reduction in fuel damage due to a much shorter drop (i.e., less than approximately 4 feet) over fuel in the spent fuel pool.OCNGS UFSAR Section 15.7.4.4 describes the number of fuel rods that are damaged during a design basis fuel handling accident.
Dropping a fuel assembly onto the reactor core from the maximum height allowed by the refueling equipment (less than 30 feet) results in an impact velocity of 40 ft/sec. The kinetic energy acquired by the falling assembly is less than 17,000 ft-lb and is dissipated in one or more impacts. The first impact is expected to dissipate most (80%) of the energy and cause the largest number of cladding failures.
This first impact is calculated to cause 105 fuel rods to fail. The second impact is calculated to cause 19 rods to fail. No rods are expected to fail during the third impact.For a fuel assembly drop onto the spent fuel storage racks within the spent fuel pool, the number of cladding failures due to the initial impact is expected to be much less than the 105 calculated for the 30-foot drop. This is due to the fact that the kinetic energy due to a drop of 4 feet (a conservatively large height) is less than that for a drop of about 30 feet. Using the standard kinematics equation, s = v 2/2a Where s = distance v =velocity a = acceleration due to gravity (32 ft/sec 2 in air, for conservatism), Solving for v;v = sqrt (2as) = sqrt (2
* 32 ft/sec 2
* 4ft) = 16 ft/sec This is the velocity achieved for a 4-foot drop (16 ft/sec). Since the velocity at the bottom of the fall in the spent fuel pool is 40% of that for a drop in the vessel, the number of rods damaged in the first impact would be 105
* 04 = 42. Since the second and third impacts are when the assembly falls from the vertical (to the horizontal position), this damage amount (19 fuel rods) remains unchanged.
Therefore, the total fuel rods damaged would be 42 + 19 = 61. This amounts to 49.2% of the fuel rods damaged during a drop in the fuel pool.
CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.:8 Using the equations from the Burley Paper (Ref. 8), as submitted and approved for Limerick, a DF for 22.5 feet water coverage is determined to be 183.2. This is an 8.4% decrease in overall DF.When this slight decrease in DF is compared to the (approximately) 50% decrease in fuel rods damaged in the spent fuel pool, the drop in the reactor vessel produces the higher dose and is therefore bounding.2.4. Release Model Release modeling uses the RADTRAD computer program. The compartments are the Refuel Floor Air Space (in the Reactor Building), the Environment (EAB and LPZ), and the Control Room.The refuel floor exhaust rate is set artificially high resulting.in 99.99% of the contained radioactivity being exhausted within two hours.The RFT files for this event provides for a rapid release (1.0E;04 hours) of gap activity to the fuel pool. The nominal gap fraction for noble gas is.5%, and for iodine is also 5%. The iodine release is further reduced to reflect the pool DF of 200. As discussed above, the normal Nuclide Inventory File (NIF) representing a OCNGS core is artificially adjusted to account for the higher than average gap fractions for 1-131 and Kr-85 provided by RG 1.183.The compartments are the Refuel Floor Air Space, the Environment, and the Control Room. Since the release of activity from the Refuel Floor Air Space is a time-dependent function only (all activity is assumed to be released over a two hour period), the actual volume is independent of the release. Therefore, an artificial volume of 100 ft 3 was chosen for simplicity.
The activity in the volume after a period of time can be expressed using the standard activity decay equation A=A 0 eAt, where, in this case, A 0 = initial activity, A = final activity, A = the fractional release rate, and t = 2 hours release duration.
Assuming that the fraction of activity remaining in the Refuel Floor Air Space after 2 hours (A/A 0) is sufficiently small (e.g., 0.0001), solving the equation for A yields a value of 4.605/hr (7.675 ft 3/min based on an assumed volume of 100 ft 3). Therefore, setting the Reactor Building exhaust rate to an artificially high value (i.e., >7.675 ft 3/min) will assure essentially complete release within 2 hours.This accident analysis evaluates the movement of fuel that has decayed a minimum of 24 hours since it occupied part of a critical reactor core. Since release through the plant vent stack is not assumed, the release is treated as a ground level (rather than elevated) release. No SGTS filtration is credited.2.5. Control Room Model The Oyster Creek Control Room HVAC system contains no HEPA or Charcoal filters. There is also no Control Room recirculation.
All intake air into the control room is unfiltered.
As a result, the radionuclide concentration inside the control room reaches equilibrium with the concentration of the plume at the Control Room HVAC System air intake within a short period of time after the postulated release. The dose to control room operators is Calculated over a total duration of 720 hours. Oyster Creek LAR No. 315, "Application of Alternative Source Term, submitted to NRC on March 28, 2005 (21 30-05-20040), reanalyzed the design basis LOCA radiological dose consequences for Oyster Creek using Alternative Source Term methodology.
The control room operator dose consequences were conservatively analyzed for the LOCA analysis using the full Control Room HVAC System flow seen during the purge mode of operation.
It should be noted that the purge mode (14,000 cfm intake) is not expected to be in operation during a radiological event. Therefore, the assumption that the Control Room HVAC system is operating in the purge mode for the duration of the LOCA results in a conservative radiological dose to control room CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 9 operators for the LOCA analysis.
However, the Control Room would be in the partial recirculation mode (2,000 cfm), which produces a slightly lower dose. In both modes of operation (purge and partial recirculation) the radiation exposure to personnel in the control room remains within the regulatory limits. The LOCA analysis contains a sensitivity study that bounds the range of flow between the 2,000 cfm flow in the partial recirculation mode, and the maximum flow of 28,000 cfm for the unlikely event both fans are operating in the full purge mode. Therefore, since any increase in flow beyond 4,000 cfm does not cause an increase in dose, the amount of unfiltered inleakage does not affect the total calculated control room operator dose for the LOCA analysis (calculated at 14,000 cfm). Note that this has previously been approved for TS Amendment No. 262 dated April 26, 2007.A new sensitivity study was performed (Attachment E) to determine the most limiting control room HVAC system flow rate for the fuel handling accident.
The different release fractions and timing of the radiological source term for the fuel handling accident versus the LOCA results in a different dose profile for the control room than that for the LOCA. The sensitivity study developed for the FHA bounds the normal, full recirculation, partial recirculation, and purge modes of operation with a maximum flow of approximately 28,000 cfm for the unlikely event that both fans are operating in the full purge mode. The sensitivity study performed bounds the range of flow between the 2,000 cfm flow in the partial recirculation mode, and the maximum flow of 28,000 cfm for the unlikely event both fans are operating in the full purge mode. The sensitivity study shows that any increase in flow beyond 2,000 cfm does not cause an increase in total calculated Control Room operator dose for this Fuel Handling Accident analysis (calculated at 2,000 cfm).2.6. Dose Modeling Dose models for both onsite and offsite are simplified and meet RG 1.183 requirements.
Dose conversion factors are based on Federal Guidance Reports 11 and 12 (Ref. 4, 5). RADTRAD uses the following formulations, integrated numerically over the accident duration: 2.6.1. EAB and LPZ Doses at the Exclusion Area Boundary (EAB) and Low Population Zone (LPZ) for the FHA are based on the following formulas: DosecEDE (rem) = Release (Curies) *-(sec/m3)
* Breathing Rate (m 3/sec)* Inhalation DCF (remCEDE/Ci inhaled)Q and DoseEDE (rem) = Release (Curies)*
X (sec/m 3)
* Submersion DCF (rem EDE m 3/Cisec)Q and finally, DOseEE (rem) DosecEDE (rem) + DoseE.E (rem)2.6.2. Control Room The formulas used by RADTRAD, by time increment, are: Dose cEDE (rem) = Time Dependent CR Air Concentration (Ci/mr 3)
* Time Increment Duration (sec) *Breathing Rate (mi /sec)
* Inhalation DCF (remCEDE/Ci inhaled)
* Occupancy Factor of I I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 PAGE NO. 10-1 and Dose EDE (rem) = Time Dependent CR Air Concentration (Ci/m 3)
* Time Increment Duration (sec) *Submersion DCF (rem EDE -m 3 / Ci -sec)
* Occupancy Factor of I* CR Geometry Factor and finally, Dose TEDE (rem)= DoseCEDE (rem) + Dose EDE (rem)2.7. Acceptance Criteria Dose acceptance criteria are per 10CFR50.67 and RG 1.183 guidance.Table 1 lists the regulatory limits for accidental dose to 1) a control room operator, 2) a person at the EAB, and 3) a person at the LPZ boundary.Table 1.Regulatory Dose Limits (Rem TEDE)*CR EAB LPZ (30 days) (2 hours) (30 days 5 6.3 6.3 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 J PAGE No. I I I 3. ASSUMPTIONS Assumptions and bounding analyzed conditions regarding the fuel handling accident scenarios are provided below.1. Movement of recently irradiated fuel will not occur less than 24 hours after the fuel has occupied a critical reactor core. This establishes the basis for a definition of "recently irradiated fuel". This value continues to be a very conservative assumption for BWRs, given the extensive operations necessary associated with reactor disassembly before commencing fuel movement.2. Fuel bundle peak burnup will not exceed the limits of RG 1.183 footnotelO.
Exelon procedure NF-AB-1 10-2210, Core Loading Pattern Development, requires that the core loading be developed in accordance with NRC Regulatory Guide 1.183. There is a procedural step to ensure that 1) peak rod-average burnup of the fuel is less than 62 GWD/Mt, 2) that the maximum linear heat generation rate does not exceed 6.3 kilo-watt/ft for any bundle exceeding a peak rod burnup of 54 GWD/MT, 3) that the cycle length not exceed 711 EFPD and 4) that the maximum radial peaking factor does not exceed 1.7.3. For fuel exceeding a 54 GWD/MTU burnup, the maximum linear heat generation rate will not exceed the RG 1.183 footnote 11 limit of 6.3 kW/ft rod average power. Exelon has processes in place that require checks to be performed on peak rod-average exposures for all fuel types.The Oyster Creek core design engineer utilizes the 3D simulator code, PANACEA,.
to confirm compliance with NRC Regulatory Guide 1.183. For any fuel rod that exceeds 54 GWD/Mt rod average exposure, the kW/ft value is checked to confirm that the linear hear generation rate is less than 6.3 kW/ft. For Oyster Creek's current operating cycle (Cycle 21), maximum rod average exposure at end-of-cycle is 55.1 GWd/Mt. The maximum linear heat generation rate for fuel rods projected to exceed 54 GWd/Mt is 5.1 kW/ft.4. The design basis GESTAR II (Ref. 13) bounding fuel damage assessment scenario associated with a drop over the reactor core is used. For this event the RG 1.183 DF value of 200 is conservative.
: 5. Spent fuel source terms are based on reactor core source terms as used in the AST LOCA analysis previously reviewed and approved by the NRC in TS Amendment No. 262 (Ref. 16).6. The damaged fuel-is assumed to have operated at a radial peaking factor of 1.7 (Ref. 13).7. Activity reaching the refuel floor airspace will essentially all be exhausted within 2 hours by using an artificially high exhaust rate per RG 1.183, Appendix B.8. Since the SGTS exhaust through the main stack is not credited, the release pathway is conservatively considered as unfiltered at ground level to the Control Room intake(s).
I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 ] PAGE NO. 12I 4. DESIGN INPUT The design inputs used for this calculation are summarized in the following table: Table 4.1-1 Design Input Parameters and Methods Parameter or Method AST Value Reference and. Comments Reactor Power 1969 MWth Includes 2 % margin for instrument uncertainty relative to the rated thermal power of 1930 MWt (Ref. 17).Fuel Assembly Configuration 9 x 9 with 140 rods damaged Bounding assumptions for and properties current Oyster Creek licensing basis FHA (FSAR 4.2, Ref. 1).Movement of irradiated fuel will conservatively not occur less than 24 hours after the associated reactor shutdown.Radial Peaking Factor 1.7 Conservative bounding assumption per Ref. 13.Allowable Fuel Burnup and RG 1.183, Table 3. The GE 11 fuel burnup is 55.1 non-LOCA gap fractions Fuel bundle peak burnup will GWD/MTU. There is a not exceed 62 GWD/MTU. For procedural step to ensure that fuel exceeding 54 GWD/MTU, 1) peak rod-average burnup of the maximum linear heat the fuel is less than 62 generation rate will not exceed GWD/Mt. For Oyster Creek's 6.3 kW/ft. current operating cycle (Cycle 21), maximum rod average exposure at end-of-cycle is 55.1 GWd/Mt. The maximum linear heat generation rate for fuel rods projected to exceed 54 GWd/Mt is 5.1 kW/ft.FHA Radionuclide Inventory From the 60 isotopes forming Spent fuel source terms are the RADTRAD library used in based on the same bounding the LOCA analysis, with decay reactor core source terms as to 24 hours. Gap activities are was used for the LOCA per R.G. 1.183. analysis previously reviewed and approved by the NRC in TS Amendment No. 262 dated April 26, 2007.Underwater Decontamination Noble Gases: 1 For conservatism, the effective Factor minimum depth of 23 feet (Ref.Particulate (cesiums and 1 FSAR section 9.1.2.2.1) is rubidiums):
infinity assumed to be the water coverage over the reactor Iodine: 200, corresponding to core. This is the worst-case a 23-ft water depth for an location for a fuel drop FHA to assembly drop into the reactor take place (significantly more vessel damage is produced than a I drop in the fuel pool).
CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGENO. 13N Parameter or Method: :AST Value:
 
==Reference:==
 
and Comments Iodine chemical distribution 95% Csl, instantaneously RG 1.183, Sections 1.3 & 2 dissociating in the pool water and re-evolving as elemental iodine. Since the pH of the pool water is not maintained above 7, iodine is assumed to be 57% elemental and 43%organic in the air space above the pool.Activity Transport to the Activity reaching the refuel RG 1.183, Section 5.3.Environment floor airspace will essentially be all exhausted within 2 hours by using an artificially high exhaust rate.Release Pathways The release pathways are No credit is taken for filtration described in this table, by the SGTS, or the elevated release resulting from exhaust through the Oyster Creek Main Stack.Dose Conversion Factors EPA Federal Guidance EPA Federal Guidance Reports 11 and 12 Reports 11 and 12 Offsite Dose Limit 6.3 rem TEDE 10CFR50.67 and RG 1.183 Control Room Dose Limit 5 rem TEDE for the duration of Per 10CFR50 App. A, GDC 19 the accident and 10CFR50.67 CR Volume Volume 27,500 ft7 For the FHA, the expected mode of operation occurs at CR Intake Rate 2,000 cfm 2,000 cfm. See attachment E for sensitivity study.Refuel Floor Ventilation Rate For this analysis, an artificial This evacuates 99.99% of all and Volume volume of 100 ft 3 with an activity within 2-hours.artificially high exhaust rate (7.675 cfm) is assumed for simplicity.
I I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGENO. 14N Param eter .or Method .:::'. .AST Value: ': :::Refeerenceand Comments CR Potential Release Points Drywell Access Facility (West Wall)Drywell Access facility (South Wall)Commodities Penetration on the RB South Wall Commodities Penetration on the RB North Wall MAC Facility Personnel Airlock MAC Facility Entrance RB Roof Hatch Stack Tunnel Door East Airlock Door Trunion Room Door to Turbine Bldg.Reactor Building Wall (Diffuse Area)Limiting X/Qs (0 -2 hr)1.61E-03 sec/m 3 1.93E-03 sec/m 3 1.77E-03 sec/m 3 5.21 E-03 sec/m 3 6.75E-03 sec/m 3 6.62E-03 sec/m 3 1.82E-03 sec/m 3 8.55E-04 sec/m 3 1.40E-03 sec/m 3 3.73E-03 sec/m 3 2.15E-03 sec/m 3 From Calculation C-1302-822-E310-081, Revision 0. All releases considered as ground level releases.Permitted to be open during fuel movement Permitted to be open during fuel movement Permitted to be open during fuel movement Not permitted to be open during fuel movement Not permitted to be open during fuel movement Not permitted to be open during fuel movement Permitted to be open during fuel movement Permitted to be open during fuel movement Permitted to be open during fuel movement Not permitted to be open during fuel movement.
X/Q value from Calculation C-1302-826-E540-017, Revision 0 The Reactor Building Wall Diffuse Source is the highest X/Q evaluated yielding acceptable dose consequence and is the bounding design basis potential release point.Other release locations with higher X/Q values will be maintained closed during fuel movement using administrative controls.
CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 15 Parameter or Method , AST Value .
 
==Reference:==
and:Comments EAB Release Point Basis and Normal RB exhaust stack and All releases considered as Distance to EAB 414 m (considered as ground level releases.applicable to all release.locations)
Limiting Dispersion From calculation C-1302-826-Factors (0 -2 hr) 1.41 E-03 sec/i 3  E310-018 Rev. 0 (Ref 7)LPZ Release.Point Basis and Normal RB exhaust stack and All releases considered as Distance to LPZ 3218 m (considered as ground level releases.applicable to all release locations)
Limiting Dispersion From calculation C-1302-826-Factors (0 -2 hr) 1.35E-04 sec/m 3  E310-018 Rev. 0 (Ref 7)5. REFERENCES
: 1. Oyster Creek Nuclear Generating Station, UFSAR, Revision 14.2. Regulatory Guide 1.183, "Alternative Radiological Source Terms For Evaluating Design Basis Accidents At Nuclear Power Reactors", July 2000.3. NUREG/CR-6604, "RADTRAD:
A Simplified Model for RADionuclide Transport and Removal And Dose Estimation", April1998, and Supplements 1, June 1999, and 2, October 2002.4. Federal Guidance Report No. 11, "Limiting Values of Radionuclide Intake and Air Concentration and Dose Conversion Factors for Inhalation, Submersion, and Ingestion", 1988.5. Federal Guidance Report No. 12, "External Exposure to Radionuclides in Air, Water, and Soil", 1993.6. NUREG-1465, "Accident Source Terms for Light-Water Nuclear power Plants", 1995.7. OCNGS C-1 302-826-E310-018, "Oyster Creek Offsite Atmospheric Dispersion (x/0)Values for Alternative Source Term", Rev. 0.8. G. Burley, "Evaluation of Fission Product Release and Transport", Staff Technical Paper, 1971.9. OCNGS C-1 302-822-E310-081, Revision 0, "Oyster Creek Onsite Atmospheric Dispersion (x/Q) for Fuel Handling Accident (FHA)", Rev. 0.10. OCNGS C-1 302-226-E620-369, "Oyster Creek Source Term for Two Year Cycles", Rev.0.
CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGENO. 16N 11. PSAT 05201 H.08, "Dose Assessment for Oyster Creek Control Room Habitability", Rev.3.12. OCNGS C-1302-826-E540-017, "Calculation of OC Control Room Air Intake X/Q's for Ground Level Releases Using ARCON96", Rev. 3.13. NEDE-2401 1-P-A-1 5-US, General Electric Standard Application for Reactor Fuel, Licensing Topical Report, September 2005.14. 10 CFR 50.67, Accident Source Term 15. Exelon Procedure NF-AB-110-2210, Revision 7; Core Loading Pattern Development
: 16. Oyster Creek TS Amendment No. 262 dated April 26, 2007.17. Oyster Creek Technical Specification 2.3, Limiting Safety System Settings 6. CALCULATIONS This calculation evaluates the radiological dose to an operator in the Control Room and a person at the EAB and LPZ locations following a design basis FHA involving irradiated fuel that has decayed for 24 hours after occupying a critical reactor core shutdown.
This analysis uses Alternative Source Term assumptions per guidance in RG 1.183.The RADTRAD v. 3.03 computer code was used for this calculation to determine FHA doses at the three dose points cited in RG 1.183; the Exclusion Area Boundary (EAB), Low Population Zone (LPZ), and the Control Room. RADTRAD (Ref. 3) is a simplified model of RADionuclide Transport and Removal And Dose Estimation developed for the NRC and endorsed by the NRC as an acceptable methodology for reanalysis of the radiological consequences of design basis accidents.
The RADTRAD code uses a combination of source term, activity transport mechanisms, and/or numerical values of applicable design inputs to determine the time-dependent dose at user-specified locations for a given accident scenario.
The code also provides the inventory, decay chain, and dose conversion factor tables needed for the dose calculation.
See Section 2 and subsequent sections for descriptions of the calculational simulations detailed in the tables that follow.
CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 17 6.1. RADTRAD Run Compartment Information RAD.RAD Compartments
______-t________
Compartment 2 3 Number Name Refuel Floor Airspace Environment Control Room Type Other Environment Control Room Volume (ft 3) 100 0 27,500 Source Term 1.000 0.000 0.000 Fraction Compartment Used to represent the Features ventilated radionuclide release region above the Environment No removal mechanisms credited spent fuel pool and Reactor Well during refueling.
Comments Actual volume is irrelevant, as N/A Actual CR volume is used.the ventilated fraction is used.RADTRAD input is set to 100_ft 3 for exhaust purposes.
II 6.2. RADTRAD Run Transfer Pathway Information
..DTRAD.. T.ra..sfer P:thwavs Pathway Number 1 2 3 Name Refuel floor airspace to (High Volume-Purge+ (Control Room Exhaust)Environment Intake) Environment to Control Room to Control Room Environment From -To 1-2 2-3 3-2 Transfer Mechanism Filter Filter Filter Transfer Mechanism Filter Panel -Flow rate for 2 hour Filter Panel -Flow rate for 24 hour Filter Panel -Flow rate for 24 hour release period at 7.675 cfm period at 2,000 cfm. period at 2,000 cfm.Details Filter Efficiency
-Efficiency is Filter Efficiency
-0.0% filter Filter Efficiency
-0.0% filter entered as 0.0% for all chemical efficiency efficiency forms of iodine, for the accident duration.Comments Vented at an artificially high air change rate without credit for SGTS filtration.
CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGENO. 18 6.3. RADTRAD Run Dose Location Information
__________...
y .RADTRAD Dqse Locations Dose Location 1 2 3 Number Name Exclusion Area Boundary Low Population Zone (LPZ) Control Room (EAB)In Compartment Environment (2) Environment (2) Control Room (3)Breathing Rate (m 3/sec) 0-end: 3.5E-04 0-8-hour Period: 3.5E-04 0-end 3.5 E-04 8-24 hour Period: 1 .8E-04 24-end: 2.3E-04 Occupancy 0-48-hour Period: 1.0 Fractions N/A N/A 48 hour- 120 hr: 0.6 120-744 hrs: 0.4 Dispersion Ground Level Release: Ground Level Release: Ground Level Release: Factors 2-hour Period: 1.41E-03 2-hour Period: 1.35E-04 2-hour Period: 2.15E-03 Comments Ground level release dispersion Ground level release dispersion Ground level release dispersion factors factors are used because the factors are used because the are used because the analyses do not analyses do not credit SGTS or analyses do not credit SGTS or credit SGTS or Secondary Containment Secondary Containment.
Secondary Containment.
Release is for two hours. Control Room Since the release is only for a 2- Since the release is only for a 2- dose calculated until effectively all hour period, the 0-2 hour XIQ and hour period, the 0-2 hour X/Q value activity has been exhausted.
0-8 hour breathing rate values are is used over the entire 744 hours used over the entire 744 hours for for conservatism.
Since the release is only for a 2-hour conservatism, period, the 0-2 hour X/Q value is used over the entire 744 hours for conservatism.
 
===6.4. RADTRAD===
Run Source Term & Dose Conversion Factor Information
'RADTRAD Source Term & Dose-Con','
Core Power 1969 MWth; 560 assemblies; 140 damaged rods with 74 rods/assembly; and radial peaking factor of 1.7 =1969 MWth
* 0.003378
* 1.7 = 11.31 MWth.See Section 2.1.Nuclide Inventory Attachment C ORIGEN calculated core inventory for 60 MACCS isotopes.
Inventory, calculated at DBA power shown above, and See Attachment C.input into the FHA NIF file with adjustments for Kr-85 and 1-131 (Attachment C).Release Fractions User defined Release Fractions to calculate& Timing as effectively instantaneous release, consistent with RG 1.183 guidance.
Fractions See Attachment D.shown in RFT file includes gap activity fractions combined with the applicable decontamination factors.Dose Conversion User defined RADTRAD Library (OC 60.inp).Factors This is the same file used for the LOCA analysis previously reviewed and See Attachment A approved by the NRC in TS Amendment No. 262 dated April 26, 2007 Decay &Daughter Products Enabled -Consideration of daughter products Reference 2, Section 4.1.1 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 19 1 Aerosol: 0.0000 User defined iodine chemical fractions, Elemental:
0.5700 consistent with RG 1.183, Appendix B, Section Organic: 0.4300 2 guidance.Note that no filters are credited so chemical fractions are not important.
I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 20 II CACLTO O -3282E1 8 RE.N.1I PGNO20 I 7. RESULTS AND CONCLUSIONS The RADTRAD code was used to examine the effect of the alternative source term release on.offsite and CR doses. Shown below are the results, as well as the dose acceptance criteria.Table 7-1 RADTRAD Analysis Results and Comparisons to the Acceptance Criteria Dose EAB LPZ CR Rem TEDE 2.71 0.26 2.94 Acceptance Criteria 6.3 6.3 5 (Rem TEDE)These results indicate that the calculated consequences of a design basis Fuel Handling Accident at or after 24 hours after shutdown will be within regulatory limits.Since the above analyses are performed without credit for SGTS filtration or with specified secondary containment release paths open, these results indicate that immediate suspension of movement of irradiated fuel assemblies in the secondary containment would not be necessary if secondary containment isolation were lost.Secondary Containment Openings Permitted During Movement Of Fuel That Has Decayed At Least 24 Hours:* Drywell Access Facility (West Wall)" Drywell Access Facility (South Wall)* Commodities Flanged Penetration (South Reactor Building Wall)* Reactor Building Roof Hatch* Stack Tunnel Door" All Reactor Building Airlock Doors" Reactor Building Truck Airlock (bounded by RB South Commodities Penetration)
* Isolation Condenser Vents (Bounded by RB Roof Hatch)Secondary Containment Openings NOT Permitted During Movement Of Fuel That Has Decayed At Least 24 Hours:* Commodities Flanged Penetration (North Reactor Building Wall)* MAC Facility Personnel Airlock* MAC Facility Entrance* Trunion Room Door* Any other opening not indicated above (unless specific evaluation is performed)
I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 21 ATTACHMENT A Oyster Creek RADTRAD Dose Conversion Factor Input File -oc60.inp FGRDCF 10/24/95 03:24:50 beta-test version 1.10, minor FORTRAN fixes 5/4/95 Implicit daughter halflives (m) less than 90 and less than 0.100 of parent 9 ORGANS DEFINED IN THIS FILE: GONADS BREAST LUNGS RED MARR BONE SUR THYROID REMAINDER EFFECTIVE SKIN (FGR)60 NUCLIDES DEFINED IN THIS FILE: Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 Rb-86 D Sr-89 Y Sr-90 Y Sr-91 Y Including:Y-91m Sr-92 Y Y-90 Y Y-91 Y Y-92 Y Y-93 Y Zr-95 D Zr-97 Y Including:Nb-97m , Including:Nb-97 Nb-95 Y Mo-99 Y Tc-99m D Ru-103 Y Including:Rh-103m Ru-105 Y Ru-106 Y Including:Rh-106 Rh-105 Y Sb-127 w Sb-129 W Te-127 W Te-127m W Te-129 W Te-129m W Including:Te-129 Te-131m W Including:Te-131 Te-132 W 1-131 D 1-132 D 1-133 D 1-134 D 1-135 D Including:Xe-135m Xe-133 Xe-133m Xe-135 Xe-135m Xe-137 Xe-138 Cs-134 Cs-136 Cs-137 Including:Ba-137m CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO.22 Ba-137m Ba-139 D Ba-140 D La-14,0 W La-141 D La-142 D Ce-141 Y Ce-143 Y Ce-144 Y Including:Pr-144m, Including:Pr-144 Pr-143 Y Nd-147 Y Np-239 W Pu-238 Y Pu-239 Y CLOUDSHINE GROUND GROUND GROUND INHALED INHALED INGESTION SHINE 8HR SHINE 7DAY SHINE RATE ACUTE CHRONIC Kr-83m GONADS 7.310E-15 2.594E-12 3.653E-12 1.570E-16-1.0OOE+00 0.OOOE+00 0.000E+00 BREAST 8.410E-15 2.527E-12 3.560E-12 1.530E-16-.D000E+oD D.OD0E+D0 0.000E+0D LUNGS 7.040E-15 2.379E-12 3.351E-12 1.440E-16-.0OO0E+00 0.DO0E+00 0.000E+00 RED MARR 6.430E-15 2.346E-12 3.304E-12 1.420E-16-l.DO0E+00 DO.OOE+00 O.000E+00 BONE SUR 1.880E-14 5.286E-12 7.446E-12 3.200E-16-l.D00E+00 0.DDDE+00 D.ODDE+00 THYROID 7.330E-15 2.395E-12 3.374E-12 1.450E-16-I.OD0E+00
.000E+00 O.0O0E+00 REMAINDER 6.640E-15 2.313E-12 3.257E-12 1.400E-16-1.DO0E+00 0.OOOE+00 0.OOE+00 EFFECTIVE 7.480E-15 2.511E-12 3.537E-12 1.520E-16-1o000E+00 O.OOE+00 D.OO0E+00 SKIN(FGR) 2.240E-14 2.247E-11 3.164E-11 1.360E-15-1.OOOE+00
.000E+00 O.0O0E+00 Kr-85m GONADS 7.310E-15 2.594E-12 3.653E-12 1.570E-16-1.0OOE+00 O.0O0E+00 0.000E+00 BREAST 8.410E-15 2.527E-12 3.560E-12 1.530E-16-1,OO0E+00 O.0OOE+00 O.000E+00 LUNGS 7.040E-15 2.379E-12 3.351E-12 1.440E-16-1.000E+00 O.000E+00 C.00CE+O0 RED MARR 6.430E-15 2.346E-12 3.304E-12 1.420E-16-1.000E+00 O.OOE+00 C.OOOE+00 BONE SUR 1.880E-14 5.286E-12 7.446E-12 3.200E-16-1.000E+00 O.OOE+00 0.OOE+00 THYROID 7.330E-15 2.395E-12 3.374E-12 1.450E-16-1.DDDE+00 O.DODE+00 D.DDDE+00 REMAINDER 6.640E-15 2.313E-12 3.257E-12 1.400E-16-1.000E+00 0.OOOE+00 0.OOOE+00 EFFECTIVE 7.480E-15 2.511E-12 3.537E-12 1.520E-16-1.0O0E+00 O.0O0E+00 0.OO0E+00 SKIN(FGR) 2.240E-14 2.247E-11 3.164E-11 1.360E-15-1.OOE+00 O.000E+00 0.0O0E+00 Kr-85 GONADS 1.170E-16 8.121E-14 1.704E-12 2.820E-18-.OO0E+00 0 00DE+00 0.DO0E+00 BREAST 1.340E-16 7.891E-14 1.656E-12 2.740E-18-.OOE+00 O.00E+00 O.OO0E+00 LUNGS 1.140E-16 7.056E-14 1.481E-12 2.450EJ18-1.DO0E+00 O.ODE+00 0.OO0E+00 RED MARR 1.090E-16 6.998E-14 1.469E-12 2.430E-18-i.Q00E+00 C.OO0E+00 0.OQ0E+00 BONE SUR 2.200E-16 1.287E-13 2.702E-12 4.470E-18-I.OC0E+00
.0D0E+00 .0OO0E+00 THYROID 1.180E-16 7.459E-14 1.565E-12 2.590E-18-.OO0E+00 0.OO0E+00 O.OOOE+00 REMAINDER 1.090E-16 6.941E-14 1.457E-12 2.410E-18-1.DDDE+00 0.ODDE+00 D.000E+00 EFFECTIVE 1.190E-16 7.603E-14 1.596E-12 2.640E-18-I.CO0E+00 O.D00E+00 O.0OOE+00 SKIN(FGR) 1.320E-14 2.304E-11 4.835E-10 8.OOOE-16-I.OODE+00 0.OOOE+00 O.000E+00 Kr-87 GONADS 4.OOOE-14 4.962E-12 5.026E-12 7.610E-16-1.OOOE+00 0.00E+00 O.OOOE+00 BREAST 4.500E-14 4 740E-12 4.802E-12 7.270E-16-1.000E+00 0.00DE+00 0.00E+00 LUNGS 4.040E-14 4.603E-12 4.663E-12 7.060E-16-1.0O0E+00 0.OOOE+00 O.000E+00 RED MARR 4.O00E-14 4.708E-12 4.769E-12 7.220E-16-1.OO0E+00 O.OOOE+00 0.OOE+00 BONE SUR 6.020E-14 6.514E-12 6.598E-12 9.990E-16-1.000E+00 O.000E+00 O.0D0E+00 THYROID 4.130E-14 4.473E-12 4.531E-12 6.860E-16-1.000E+00 O.O00E+00 D.OOE+00 REMAINDER 3.910E-14 4.590E-12 4.650E-12 7.040E-16-1.OOOE+00 O.0OOE+00 0.000E+00 EFFECTIVE 4.120E-14 4.773E-12 4.835E-12 7.320E-16-1.DDDE+00 D.DDDE+00 D.DDDE+00 SKIN(FGR) 1.370E-13 8.802E-11 8.916E-11 1.350E-14-1.0O0E+00 O.00E+00 O.000E+00 Kr-88 GONADS 9.900E-14 2.278E-11 2.655E-11 1.800E-15-1.000E+00 O.0D0E+00 0.000E+00 BREAST 1.11OE-13 2.177E-11 2.537E-11 1.720E-15-1.OOOE+00 D.0O0E+00 0.0ODE+00 LUNGS 1.010E-13 2.139E-11 2.493E-11 1.690E-15-1.OO0E+00 O.OOOE+00 O.000E+00 RED MARR 1.OOOE-13 2.190E-11 2.552E-11 1.730E-15-1.OO0E+00 0.D00E+00 0.0D0E+00 BONE SUR 1.390E-13 2.886E-11 3.363E-I1 2.280E-15-1.000E+00 O.000E+00 O.000E+00 THYROID 1.030E-13 2.012E-11 2.345E-11 1.590E-15-1.DOQE+00 0.OO0E+00 0.OO0E+00 I CALCULATION NO. C-1302-822-E310-082 REV. No. 1 1 PAGE NO. 23 REMAINDER 9.790E-14 2.139E-11 2.493E-11 1.690E-15-1.OOE+00 D.D0DE+00 D.000E+00 EFFECTIVE 1.020E-13 2.202E-11 2.567E-11 1.740E-15-1.0O0E+00 0.000E+00 0.000E+00 SKIN(FGR) 1.350E-13 5.607E-I1 6.534E-11 4.430E-15-1.000E+00 O.0OOE+00 O.OOOE+00 Kr-89 GONADS 9.900E-14 2.278E-11 2.655E-11 1.800E-15-1.O0OE+00 0.000E+00 O.000E+00 BREAST 1.11OE-13 2.177E-11 2.537E-11 1.720E-15-1.OO0E+00 0.OOE+00 0.OO0E+00 LUNGS 1.010E-13 2.139E-11 2.493E-11 1.690E-15-1.000E+00 O.OOE+00 0.0OOE+00 RED MARR 1.OOOE-13 2.190E-II 2.552E-11 1.730E-15-1.0O0E+00 O.OOE+00 Q.OO0E+00 BONE SUR 1.390E-13 2.886E-II 3.363E-11 2.280E-15-1.000E+00 0.000E+00 0.OSSE+00 THYROID 1.030E-13 2.012E-II 2.345E-II 1.590E-15-1.000E+00 0.000E+00 0.00OE+00 REMAINDER 9.790E-14 2.139E-II 2.493E-II 1.690E-15-1.000E+00 0.000E+00 0.S00E+00 EFFECTIVE 1.020E-13 2.202E-II 2.567E-II 1.740E-15-1.OOOE+00 0.OO0E+00 0.OOOE+00 SKIN(FGR) 1.350E-13 5.607E-1I 6.534E-I1 4.430E-15-1.000E+00 0.000E+00 0.OSOE+00 Rb-86 GONADS 4.710E-15 2.788E-12 5.187E-II 9.740E-17-1.000E+00 1.340E-09 2.150E-09 BREAST 5.340E-15 2.662E-12 4.953E-I1 9.300E-17-1.OOE+00 1.330E-09 2.140E-09 LUNGS 4.710E-15 2.553E-12 4.750E-li 8.920E-17-1.OO0E+00 3.300E-09 2.140E-09 RED MARR 4.640E-15 2.619E-12 4.873E-lI 9.150E-17-1.0OE+00 2.320E-09 3.720E-09 BONE SUR 7.05SE-15 3.635E-12 6.764E-II 1.270E-16-1.00OE+00 4.27SE-09 6.860E-09 THYROID 4.840E-15 2.599E-12 4.836E-II 9.080E-17-1.00OE+00 1.330E-09 2.140E-09 REMAINDER 4.520E-15 2.542E-12 4.729E-II 8.880E-17-1.000E+00 1.380E-09 2.330E-09 EFFECTIVE 4.810E-15 2.665E-12 4.958E-II 9.310E-17-1.0OE+00 1.790E-09 2.530E-09 SKIN.(FGR) 4.850E-14 2.210E-I0 4.111E-09 7.720E-15-1.0O0E+00 0.00E+0 0.00S-OE+00 Sr-89 GONADS 7.730E-17 7.155E-14 1.436E-12 2.490E-18-1.O00E+00 7.950E-12 8.050E-12 BREAST 9.080E-17 7.212E-14 1.447E-12 2.510E-18-1.000E+00 7.960E-12 7.980E-12 LUNGS 7.080E-17 5.689E-14 1.142E-12 1.980E-18-1.000E+00 8.350E-08 7.970E-12 RED MARR 6.390E-17 5.345E-14 1.073E-12 1.860E-18-1.000E+00 1.070E-10 1.080E-10 BONE SUP 1.940E-16 1.560E-13 3.131E-12 5.430E-18-1.00SE+00 1.590E-I0 1.610E-10 THYROID 7.600E-17 6.063E-14 1.217E-12 2.110E-iS-1.000E+00 7.960E-12 7.970E-12 REMAINDER 6.710E-17 5.603E-14 1.124E-12 1.950E-18-1.OOE+00 3.970E-09 8.250E-09 EFFECTIVE 7.730E-17 6.523E-14 1.309E-12 2.270E-18-1.OOE+00 1.120E-08 2.500E-09 SKIN(FGR) 3.690E-14 1.914E-10 3.841E-09 6.660E-15-1.000E+00 O.OO0E+00 O.O0OE+00 Sr-90 GONADS 7.780E-18 9.590E-15 2.014E-13 3.330E-19-1.0O0E+00 2.690E-I0 5.040E-II BREAST 9.490E-18 1.008E-14 2.116E-13 3.500E-19-1.000E+00 2.690E-i0 5.040E-I1 LUNGS 6.440E-18 6.307E-15 1.324E-13 2.190E-19-1.000E+00 2.860E-06 5.040E-II RED MARR 5.440E-18 5.558E-15 1.167E-13 1.930E-19-1.OOE+00 3.280E-08 6.450E-09 BONE SUR 2.280E-17 2.393E-14 5.025E-13 8.310E-19-1.OOE+00 7.090E-08 1.390E-08 THYROID 7.330E-18 7.171E-15 1.506E-13 2.490E-19-1.O0E+00 2.690E-i0 5.040E-I REMAINDER 6.11SE-18 6.422E-15 1.348E-13 2.230E-19-i.000E+00 5.730E-09 6.700E-09 EFFECTIVE 7.530E-18 8.179E-15 1.717E-13 2.840E-19-1.000E+00 3.510E-07 3.230E-09 SKIN(FGR) 9.200E-15 4.032E-12 8.465E-il 1.400E-16-1.OF0E+00 0.000E+00 0.000E+00 Sr-91 GONADS 4.819E-14 2.155E-I1 5.062E-I1 1.026E-15-1.0O0E+00 5.669E-il 2.520E-I0 BREAST 5.477E-14 2.059E-I1 4.838E-lI 9.806E-16-1.0O0E+00 1.775E-II 3.676E-II LUNGS 4.803E-14 1.970E-Il 4.626E-II 9.376E-16-1.OO0E+00 2.170E-09 1.055E-Il RED MARR 4.691E-14 2.011E-11 4.722E-II 9.570E-16-1.OOE+00 2.275E-I1 5.659E-1I BONE SUR 7.674E-14 2.852E-II 6.709E-Il 1.360E-15-1.000E+00 1.306E-I1 2.070E-II THYROID 4.938E-14 2.035E-I1 4.782E-II 9.693E-16-1.000E+00 9.930E-12 1.968E-12 REMAINDER 4.610E-14 1.948E-II 4.573E-1I 9.268E-16-1.000E+00 5.802E-I0 2.557E-09 EFFECTIVE 4.924E-14 2.057E-II 4.832E-II 9.793E-16-1.000E+00 4.547E-I0 8.455E-I0 SKIN(FGR) 9.938E-14 1.748E-I0 3.987E-I0 8.080E-15-1.000E+00 0.000E+00 0.000E+0O Sr-92 GONADS 6.610E-14 1.593E-lI 1.830E-II 1.300E-15-1.000E+00 1.020E-Il 8.180E-li BREAST 7.480E-14 1.520E-II 1.745E-II 1.240E-15-1.000E+00 6.490E-12 1.700E-I1 LUNGS 6.670E-14 1.483E-Il 1.703E-II 1.210E-15-1.000E+00 1.050E-09 7.220E-12 RED MARR 6.620E-14 1.520E-il 1.745E-II 1.240E-15-1.000E+00 6.980E-12 2;290E-II BONE SUR 9.490E-14 2.010E-i1 2.308E-Il 1.640E-15-1.OOE+00 4.360E-12 8.490E-12 THYROID 6.820E-14 1.446E-II 1.661E-II 1.180E-15-1.000E+00 3.920E-12 1.300E-12 REMAINDER 6.450E-14 1.471E-II 1.689E-il 1.200E-15-1.000E+00 2.900E-I0 1.720E-09 EFFECTIVE 6.790E-14 1.532E-II 1.759E-1I 1.250E-15-1.000E+00 2.180E-I0 5.430E-i0 SKIN(FGR) 8.560E-14 2.280E-I1 2.618E-1I 1.860E-15-1.O00E+00 0.000E+00 0.000E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 24 Y-90 GONADS 1.890E-16 1.586E-13 1.601E-12 5.750E-18-l.OO0E+00 5.170E-13 1.430E-14 BREAST 2.200E-16 1.578E-13 1.593E-12 5.720E-18-l.OOE+00 5.170E-13 1.270E-14 LUNGS 1.770E-16 1.313E-13 1.326E-12 4.760E-18-1.OD0E+00.9.310E-09 1.260E-14 RED MARR 1.620E-16 1.261E-13 1.273E-12 4.570E-18-1.OOOE+00 1.520E-11 3.700E-13 BONE SUR 4.440E-16 3.228E-13 3.259E-12 1.170E-17-1.OOE+00 1.510E-11 3.670E-13 THYROID 1.870E-16 1.385E-13 1.398E-12 5.020E-18-.0OO0E+00 5.170E-13 1.260E-14 REMAINDER 1.680E-16 1.291E-13 1.303E-12 4.680E-18-1.OOOE+00 3.870E-09 9.680E-09 EFFECTIVE 1.900E-16 1.468E-13 1.482E-12 5.320E-18-1.OOOE+00 2.280E-09 2.910E-09 SKIN(FGR) 6.240E-14 2.897E-10 2.924E-09 1.050E-14-1.O0OE+00
.000E+00 0.OOOE+00 Y-91 GONADS 2.560E-16 1.756E-13 3.546E-12 6.1IE-18-1.CO0E+00 8.200E-12 3.540E-12 BREAST 2.930E-16 1.713E-13 3.459E-12 5.960E-18-1.OOOE+00 8.920E-12 5.540E-13 LUNGS 2.500E-16 1.526E-13 3.082E-12 5.310E-18-1.0OE+00 9.870E-08 2.020E-13 RED MARR 2.410E-16 1.521E-13 3.070E-12 5.290E-18-I.OO0E+00 3.190E-10 6.590E-12 BONE SUR 4.560E-16 2.903E-13 5.862E-12 1.010E-17-1.000E+00 3.180E-I0 6.130E-12 THYROID 2.600E-16 1.564E-13 3.157E-12 5.440E-18-1.OOOE+00 8.500E-12 1.290E-13 REMAINDER 2.390E-16 1.509E-13 3.047E-12 5.250E-18-.I000E+00 4.200E-09 8.570E-09 EFFECTIVE 2.600E-16 1.650E-13 3.332E-12 5.740E-18-.I000E+00 1.320E-08 2.570E-09 SKIN(FGR) 3.850E-14 1.989E-10 4.016E-09 6.920E-15-1.000E+00 0.000E+00 0.000E+00 Y-92 GONADS 1.270E-14 3.855E-12 4.872E-12 2.650E-16-1.OOOE+00 2.610E-12 1.960E-11 BREAST 1.440E-14 3.680E-12 4.652E-12 2.530E-16-1.OOOE+00 1.500E-12 3.550E-12 LUNGS 1.270E-14 3.535E-12 4.468E-12 2.430E-16-1.ODOE+00 1.240E-09 1.390E-12 RED MARR 1.250E-14 3.608E-12 4.560E-12 2.480E-16-1.OOOE+00 2.070E-12 4.910E-12 BONE SUR 1.950E-14 5.091E-12 6.435E-12 3.500E-16-1.OOOE+00 1.510E-12 1.750E-12 THYROID 1.300E-14 3.579E-12 4.523E-12 2.460E-16-1.OOOE+00 1.050E-12 1.770E-13 REMAINDER 1 .220E-14 3.506E-12 4.431E-12 2.410E-16-1.OOOE+00 2.030E-10 1.700E-09 EFFECTIVE 1.300E-14 3.680E-12 4.652E-12 2.530E-16-1.OOOE+00 2.11OE-10 5.150E-10 SKIN(FGR) 1.140E-13 2.022E-10 2.556E-10 1.390E-14-1.OOOE+00 0.000E+00 0.000E+00 Y-93 GONADS 4.670E-15 2.108E-12 4.989E-12 9.510E-17-1.OOOE+00 5.310E-12 2.200E-11 BREAST 5.300E-15 2.026E-12 4.794E-12 9.140E-17-1.ODOE+00 1.740E-12 3.130E-12 LUNGS 4.680E-15 1.937E-12 4.585E-12 8.740E-17-.OOOE+00 2.520E-09 8.670E-13 RED MARR 4.580E-15 1.972E-12 4.669E-12 8.900E-17-1.OOOE+00 4.040E-12 4.930E-12 BONE SUR 7.580E-15 2.948E-12 6.977E-12 1.330E-16-1.OOOE+00 3.140E-12 1.730E-12 THYROID 4.790E-15 1.908E-12 4.516E-12 8.610E-17-1.OOOE+00 9.260E-13 1.260E-13 REMAINDER 4.510E-15 1.919E-12 4.543E-12 8.660E-17-1.000E+00 9.250E-10 4.090E-09 EFFECTIVE 4.800E-15 2.021E-12 4.784E-12 9.120E-17-1.OOOE+00 5.820E-10 1.230E-09 SKIN(FGR) 8.5005-14 2.726E-10 6.452E-10 1.230E-14-1.OOOE+00 0.DO0E+00 D.OODE+00 Zr-95 GONADS 3.530E-14 2.182E-11 4.421E-10 7.590E-16-1.OOOE+00 1.880E-09 8.160E-10 BREAST 4.010E-14 2.084E-11 4.223E-10 7.250E-16-1.OOOE+00 1.910E-09 1.050E-10 LUNGS 3.510E-14 1.989E-11 4.030E-10 6.920E-16-1.000E+00 2.170E-09 2.340E-11 RED MARR 3.430E-14 2.030E-11 4.112E-10 7.060E-16-1.OOOE+00 1.300E-08 2.140E-10 BONE SUR 5.620E-14 2.875E-11 5.824E-10 1.OOOE-15-1.OOOE+00 1.030E-07 4.860E-10 THYROID 3.610E-14 2.076E-11 4.205E-10 7.220E-16-1.000E+00 1.440E-09 8.270E-12 REMAINDER 3.360E-14 1.963E-11 3.978E-10 6.830E-16-1.OOOE+00 2.280E-09 2.530E-09 EFFECTIVE 3.600E-14 2.078E-11 4.211E-10 7.230E-16-1.OOOE+00 6.390E-09 1.020E-09 SKIN(FGR) 4.500E-14 2.561E-11 5.190E-10 8.910E-16-1.OOOE+00 0.OOOE+00 0.OOOE+00 Zr-97 GONADS 4.331E-14 2.179E-11 7.799E-11 9.253E-16-1.OODE+00 1.840E-10 6.228E-I0 BREAST 4.928E-14 2.083E-11 7.455E-11 8.846E-16-1.OOOE+00 4.706E-11 8.137E-11 LUNGS 4.322E-14 1.992E-11 7.127E-11 8.456E-16-1.OOOE+00 4.108E-09 1.770E-11 RED MARR 4.224E-14 2.034E-11 7.279E-11 8.634E-16-1.OOOE+00 6.376E-11 1.302E-10 BONE SUR 6.897E-14 2.881E-11 1.031E-10 1.224E-15-1.OOOE+00 3.504E-11 4.558E-11 THYROID 4.443E-14 2.061E-11 7.377E-11 8.755E-16-1.OOOE+00 2.315E-11 2.671E-12 REMAINDER 4.139E-14 1.966E-11 7.035E-11 8.345E-16-1.OOOE+00 2.041E-09 6.990E-09 EFFECTIVE 4.432E-14 2.078E-11 7.438E-11 8.824E-16-1.OOOE+00 1.171E-09 2.283E-09 SKIN(FGR) 9.835E-14 2.281E-10 8.148E-10 9.587E-15-1.ODDE+00 D.DDDE+00 D.ODDE+00 Nb-95 GONADS 3.660E-14 2.253E-11 4.435E-10 7.850E-16-1.OOOE+00 4.320E-10 8.050E-10 BREAST 4.160E-14 2.150E-11 4.231E-10 7.490E-16-1.OOOE+00 4.070E-10 1.070E-10 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO.25 LUNGS 3.650E-14 2.055E-11 4.045E-10 7.160E-16-1.DD0E+00 8.320E-09 2.740E-11 RED MARR 3.560E-14 2.101E-11 4.135E-10 7.320E-16-1.OOOE+00 4.420E-10 1.990E-10 BONE SUR 5.790E-i4 2.957E-11 5.819E-10 1.030E-15-1.OOCE+00 5.130E-10 2.940E-10 THYROID 3.750E-14 2.144E-11 4.220E-10 7.470E-16-1.OOOE+00 3.580E-10 1.180E-11 REMAINDER 3.490E-14 2.032E-11 4.0O0E-10 7.080E-16-1.0OOE+00 1.070E-09 1.470E-09 EFFECTIVE 3.740E-14 2.147E-11 4.226E-10 7.480E-16-1.OOOE+00 1.570E-09 6.950E-10 SKIN(FGR) 4.300E-14 2.598E-11 5.112E-10 9.050E-16-1.OO0E+00 0.0OOE+00 O.000E+00 Mo-99 GONADS 7.130E-15 4.282E-12 4.403E-11 1.550E-16-1.O00E+00 9.510E-11 2.180E-10 BREAST 8.130E-15 4.116E-12 4.233E-11 1.490E-16-1.000E+00 2.750E-11 3.430E-11 LUNGS 7.060E-15 3.867E-12 3.977E-11 1.400E-16-1.000E+00 4.290E-09 1.510E-11 RED MARR 6.820E-15 3.923E-12 4.034E-11 1.420E-16-1.OOOE+00 5.240E-11 8.320E-11 BONE SUR 1.240E-14 6.105E-12 6.278E-11 2.210E-16-1.OOE+00 4.130E-11 6.320E-11 THYROID 7.270E-15 4.033E-12 4.147E-11 1.460E-16-1.000E+00 1.520E-11 1.030E-11 REMAINDER 6.740E-15 3.812E-12 3.920E-11 1.380E-16-1.000E+00 1.740E-09 4.280E-09 EFFECTIVE 7.280E-15 4.061E-12 4.176E-11 1.470E-16-1.OOOE+00 1.070E-09 1.360E-09 SKIN(FGR) 3.140E-14 1.039E-10 1.068E-09 3.760E-15-1.OOOE+00 0.DOOE+00.0.OO0E+00.
Tc-99m GONADS 5.750E-15 2.334E-12 3.877E-12 1.240E-16-1.O00E+00 2.770E-12 9.750E-12 BREAST 6.650E-15 2.258E-12 3.752E-12 1.200E-16-1.000E+00 2.150E-12
.3.570E-12 LUNGS 5.490E-15 2.127E-12 3.533E-12 1.130E-16-1.OD0E+00 2.280E-11 3.140E-12 RED MARR 4.910E-15 2.070E-12 3.439E-12 1.100E-16-1.OOOE+00 3.360E-12 6.290E-12 BONE SUR 1.630E-14 5.383E-12 8.942E-12 2.860E-16-1.000E+00 2.620E-12 4.060E-12 THYROID 5.750E-15 2.145E-12 3.564E-12 1.140E-16-1.00DE+00 5.010E-11 8.460E-11 REMAINDER 5.150E-15 2.070E-12 3.439E-12 1.100E-16-1.OOE+00 1.020E-11 3.340E-11 EFFECTIVE 5.890E-15 2.277E-12 3.783E-12 1.210E-16-1.000E+00 8.800E-12 1.680E-11 SKIN(FGR) 7.140E-15 2.710E-12 4.502E-12 1.440E-16-1.0OOE+00 O.0OOE+00 O.0OOE+00 Ru-103 GONADS 2.191E-14 1.404E-11 2.783E-10 4.892E-16-1.DE-D+00 3.070E-10 5.720E-lD BREAST 2.512E-14 1.350E-11 2.677E-10 4.705E-16-1.0OOE+00 3.110E-10 1.200E-10 LUNGS 2.180E-14 1.273E-11 2.522E-10 4.432E-16-1.OOOE+00 1.561E-08 7.310E-11 RED MARR 2.100E-14 1.287E-11 2.551E-10 4.483E-16-1.OOOE+00 3.190E-10 1.660E-10 BONE SUR 3.892E-14 1.958E-11 3.882E-10 6.823E-16-1.OOOE+00 2.370E-10 9.631E-11 THYROID 2.241E-14 1.331E-11 2.639E-10 4.638E-16-1.000E+00 2.570E-10 6.250E-11 REMAINDER 2.080E-14 1.248E-11 2.472E-10 4.346E-16-1.OOOE+00 1.250E-09 2.110E-09 EFFECTIVE 2.251E-14 1.332E-11 2.641E-10 4.642E-16-1.OOE+00 2.421E-09 8.271E-10 SKIN(FGR) 2.774E-14 1.785E-11 3.543E-10 6.229E-16-1.OOE+00 O.OO0E+00 O.OOE+00 Ru-105 GONADS 3.720E-14 1.327E-11 1.861E-1i 8.070E-16-1.OODE+00 1.590E-11 9.670E-11 BREAST 4.240E-14 1.271E-11 1.783E-11 7.730E-16-1.OODE+00 6.610E-12 1.590E-11 LUNGS 3.700E-14 1.210E-11 1.697E-11 7.360E-16-1.OOOE+00 5.730E-10 6.210E-12 RED MARR 3.590E-14 1.230E-11 1.725E-11 7.480E-16-1.000E+00 7.700E-12 2.350E-11 BONE SUR 6.280E-14 1.809E-11 2.537E-11 1.100E-15-1.O0OE+00 4.620E-12 8.890E-12 THYROID 3.800E-14 1.260E-11 1.766E-11 7.660E-16-1.QOCE+00 4.150E-12 1.820E-12 REMAINDER 3.540E-14 1.189E-11 1.667E-11 7.230E-16-1.0.00E+00 1.610E-10 8.540E-10 EFFECTIVE 3.810E-14 1.265E-11 1.773E-11 7.690E-l6-1.OO0E+00 1.230E-10 2.870E-10 SKIN(FGR) 6.730E-14 7.368E-11 1.033E-10 4.480E-15-1.OOOE+00 O.0OOE+00 O.OOOE+00 Ru-106 GONADS l.010E-14 6.411E-12 1.340E-10 2.230E-16-1.OOOE+00 1.300E-09 1.640E-09 BREAST 1.160E-14 6.152E-12 1.286E-10 2.140E-16-1.OOOE+00 1.780E-09 1.440E-09 LUNGS 1.010E-14 5.836E-12 1.220E-10 2.030E-16-1.OOOE+00 1.040E-06 1.420E-09 RED MARR 9.750E-15 5.893E-12 1.232E-O '2.050E-16-1.0OOE+00 1.760E-09 1.460E-09 BONE SUR 1.720E-14 8.883E-12 1.856E-10 3.090E-16-1.OOOE+00 1.610E-09 1.430E-09 THYROID 1.030E-14 6.066E-12 1.268E-10 2.110E-16-1.OOOE+00 1.720E-09 1.410E-09 REMAINDER 9.630E-15 5.721E-12 1.196E-10 1.990E-16-1.OOOE+00 1.200E-08 2.110E-08 EFFECTIVE 1.040E-14 6.095E-12 1.274E-l0 2.120E-16-1.OOOE+00 1.290E-07 7.400E-09 SKIN(FGR) 1.090E-13 4.082E-10 8.531E-09 1.420E-14-1.OOOE+00 O.OOOE+00 O.OOOE+00 Rh-105 GONADS 3.640E-15 2.127E-12 1.411E-11 7.980E-17-1.OOOE+00 2.110E-11 5.800E-11 BREAST 4.160E-15 2.063E-12 1.369E-11 7.740E-17-1.OODE+00 5.610E-12 8.970E-12 LUNGS 3.570E-15 1.935E-12 1.284E-11 7.260E-17-1.OOOE+00 9.580E-l0 3.860E-12 RED MARR 3.380E-15 I*946E-12 1.291E-1l 7.300E-17-1.OOOE+00 7.770E-12 1.470E-11 BONE SUR 7.530E-15 3.332E-12 2.210E-11 1.250E-16-1.OOOE+00 4.460E-12 6.750E-12 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 26 THYROID 3.680E-15 1.983E-12 1.316E-ll 7.440E-17-1.O00E+00 2.880E-12 2.910E-12 REMAINDER 3.390E-15 1.885E-12 1.250E-11 7.070E-17-1.OOE+00 4.530E-10 1.270E-09 EFFECTIVE 3.720E-15 2.031E-12 1.347E-11 7.620E-17-1.000E+00 2.580E-10 3.990E-10 SKIN(FGR) 1.070E-14 4.691E-12 3.112E-11 1.760E-16-1.OO0E+00 O.OOOE+00 O.OOE+00 Sb-127 GONADS 3.260E-14 1.985E-11 2.441E-10 7.100E-16-1.OOOE+00 2.520E-10 6.140E-10 BREAST 3.720E-14 1.904E-11 2.341E-10 6.810E-16-1.OOOE+00 9.120E-11 7.600E-11 LUNGS 3.240E-14 1.809E-11 2.224E-10 6.470E-16-1.OOE+00 6.940E-09 1.570E-11 RED MARR 3..140E-14 1.834E-11 2.255E-10 6.560E-16-1.000E+00 1.610E-10 1.330E-10 BONE SUR 5.520E-14 2.720E-11 3.345E-10 9.730E-16-1.OOOE+00 1.340E-10 5.240E-11 THYROID 3.330E-14 1.884E-11 2.317E-10 6.740E-16-1.OOOE+00 6.150E-11 4.640E-12 REMAINDER 3.090E-14 1.775E-11 2.183E-10 6.350E-16-1.OOOE+00 2.330E-09 5.870E-09 EFFECTIVE 3.330E-14 1.890E-11 2.324E-10 6.760E-16-1.OOOE+00 1.630E-09 1.950E-09 SKIN(FGR) 5.580E-14 7.967E-11 9.799E-10 2.850E-15-1.OOOE+00 0.0OOE+00 0.0OOE+00 Sb-129 GONADS 6.970E-14 2.336E-11 3.231E-11 1.440E-15-1.OOOE+00 2.150E-11 1.510E-10 BREAST 7.910E-14 2.222E-11 3.074E-11 1.370E-15-1.0O0E+00 1.280E-11 2.560E-11 LUNGS 6.980E-14 2.141E-11 2.962E-11 1.320E-15-1.0OOE+00 8.980E-10 9.390E-12 RED MARR 6.860E-14 2.190E-11 3.029E-11 1.350E-15-1.0OOE+00 1.700E-11 3.670E-11 BONE SUR 1.070E-13 3.033E-11 4.196E-11 1.870E-15-1.OOOE+00 1.460E-11 1.340E-11 THYROID 7.160E-14 2.174E-11 3.007E-11 1.340E-15-1.OOE+00 9.720E-12 1.470E-12 REMAINDER 6.710E-14 2.125E-11 2.939E-11 l.310E-15-1.0OOE+00 1.870E-10 1.450E-09 EFFECTIVE 7.140E-14 2.238E-11 3.096E-11 1.380E-15-1.O0OE+00 1.740E-10 4.840E-10 SKIN(FGR) 1.050E-13 8.273E-11 1.144E-10 5.100E-15-1.OOOE+00 0.000E+00 0.QO0E+00 Te-127 GONADS 2.370E-16 1.191E-13 2.661E-13 5.480E-18-I.OO0E+00 2.020E-12 4.020E-12 BREAST 2.730E-16 1.158E-13 2.588E-13 5.330E-18-I.OOE+00 1.880E-12 3.OO0E-12 LUNGS 2.320E-16 1.060E-13 2.370E-13 4.880E-18-I.CO0E+00 4.270E-10 2.890E-12 RED MARR 2.210E-16 1.058E-13 2.365E-13 4.870E-18-I.OO0E+00 4.090E-12 6.570E-12 BONE SUR 4.650E-16 1.862E-13 4.162E-13 8.570E-18-.I000E+00 4.090E-12 6.460E-12 THYROID 2.400E-16 1.106E-13 2.472E-13 5.090E-18-.0OO0E+00 1.840E-12 2.860E-12 REMAINDER 2.210E-16 1.036E-13 2.316E-13 4.770E-18-I.OOOE+00 1.11OE-10 6.130E-10 EFFECTIVE 2.420E-16 1.125E-13 2.515E-13 5.180E-18-.OOOE+00 8.600E-11 1.870E-10 SKIN(FGR) 1.140E-14 1.173E-I1 2.622E-11 5.400E-16-I.OOOE+00 O.OOE+00 O.OOE+00 Te-127m GONADS 1.900E-16 4.689E-13 9.642E-12 1.630E-17-.OOOE+00 1.100E-10 1.250E-l0 BREAST 2.690E-16 5.150E-13 1.059E-11 1.790E-17-.OOOE+00 1.100E-10 9.740E-11 LUNGS 7.620E-17 1.602E-13 3.295E-12 5.570E-18-.O0OE+00 3.340E-08 9.620E-11 RED MARR 6.430E-17 1.249E-13 2.567E-12 4.340E-18-I.OOOE+00 5.360E-09 5.430E-09 BONE SUR 3.940E-16 9.005E-13 1.852E-11 3.130E-17-.OOOE+00 2.040E-08 2.070E-08 THYROID 1.500E-16 2.779E-13 5.714E-12 9.660E-18-I.OO0E+00 9.660E-11 9.430E-11 REMAINDER 8.640E-17 1.999E-13 4.1lE-12 6.950E-18-1.OOOE+00 1.660E-09 2.980E-09 EFFECTIVE 1.470E-16 3.251E-13 6.684E-12 1.130E-17-l.
OE+00 5.810E-09 2.230E-09 SKIN(FGR) 8.490E-16 1.496E-12 3.076E-11 5.200E-17-l.0OOE+00 O.OOE+00 .0O0E+00 Te-129 GONADS 2.710E-15 3.889E-13 3.922E-13 6.510E-17-.OOOE+00 5.050E-13 1.590E-12 BREAST 3.120E-15 3.800E-13 3.832E-13 6.360E-17-l.000E+00 5.390E-13 6.050E-13 LUNGS 2.640E-15 3.298E-13 3.326E-13 5.520E-17-.OOOE+00 1.530E-10 4.910E713 RED MARR 2.540E-15 3.298E-13 3.326E-13 5.520E-17-.OOE+00 6.190E-13 7.640E-13 BONE SUR 4.880E-15 5.753E-13 5.802E-13 9.630E-17-.OO0E+00 6.220E-13 5.400E-13 THYROID 2.740E-15 3.525E-13 3.555E-13 5.900E-17-I.
OE+00 5.090E-13 3.360E-13 REMAINDER 2.520E-15 3.262E-13 3.289E-13 5.460E-17-.OOOE+00 7.280E-12 1.790E-10 EFFECTIVE 2.750E-15 3.590E-13 3.621E-13 6.010E-17-I.QO0E+00 2.090E-11 5.450E-11 SKIN(FGR) 3.570E-14 3.429E-11 3.458E-11 5.740E-15-.OO0E+00 .OOOE+00 0.OO0E+00 Te-129m GONADS 3.321E-15 2.206E-12 4.799E-11 8.561E-17-1.OOE+00 1.783E-10 2.420E-10 BREAST 3.838E-15 2.181E-12 4.739E-11 8.454E-17-1.OOE+00 1.694E-10 1.664E-10 LUNGS 3.176E-15 1.741E-12 3.815E-11 6.808E-17-1.OOOE+00 4.040E-08 1.593E-10 RED MARR 3.071E-15 1.729E-12 3.793E-11 6.768E-17-1.000E+00 3.100E-09 3.500E-09 BONE SUR 5.772E-15 3.287E-12 7.147E-11 1.275E-16-1.O0OE+00 7.050E-09 7.990E-09 THYROID 3.341E-15
.1.923E-12 4.201E-11 7.495E-17-1.000E+00 1.563E-10 1.572E-10 REMAINDER 3.048E-15 1.746E-12 3.822E-11 6.819E-17-1.000E+00 3.275E-09 7.196E-09 EFFECTIVE 3.337E-15 1.974E-12 4.308E-11 7.686E-17-1.000E+00 6.484E-09 2.925E-09 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 27.SKIN(FGR) 3.811E-14 1.501E-10 3.360E-09 6.001E-15-1.000E+00 0.OC0E+00 0.000E+00 Te-131m GONADS 7.292E-14 4.020E-11 2.343E-10 1.535E-15-1.000E+00 2.345E-10 7.415E-10 BREAST 8.286E-14 3.853E-11 2.246E-C0 1.472E-15-1.000E+00 9.309E-11 1.361E-10 LUNGS 7.265E-14 3.657E-I1 2.131E-10 1.397E-15-1.000E+00 2.296E-09 6.335E-I1 RED MARR 7.097E-14 3.736E-11 2.178E-I0 1.427E-15-1.000E+00 1.417E-I0 2.435E-10 BONE SUR 1.174E-13 5.467E-11 3.189E-I0 2.090E-15-1.000E+00 2.276E-10 3.248E-10 THYROID 7.471E-14 3.741E-11 2.181E-10 1.429E-15-1.000E+00 3.669E-08 4.383E-08 REMAINDER 6.965E-14 3.626E-11 2.113E-10 1.385E-15-1.000E+00 9.509E-10 3.153E-09 EFFECTIVE 7.463E-14 3.825E-11 2.229E-i0 1.461E-15-1.0CCE+00 1.758E-09 2.514E-09 SKIN(FGR) 1.038E-13 1.033E-10 6.188E-i0 4.056E-15-1.000E+0o C.000E+00 0.000E+00 Te-132 GONADS 1.020E-14 6.812E-12 7.706E-11 2.450E-16-1.000E+00 4.150E-I0 5.410E-I0 BREAST 1.180E-14 6.756E-12 7.643E-11 2.430E-16-1.000E+00 3.630E-I0 3.500E-I0 LUNGS 9.650E-15 5.727E-12 6.479E-I1 2.060E-16-1.000E+00 1.670E-09 3.300E-10 RED MARR 8.950E-15 5.588E-12 6.322E-11 2.010E-16-1.00CE+00 4.270E-10 4.440E-10 BONE SUR 2.420E-14 1.273E-iI 1.441E-10 4.580E-16-1.000E+00 7.120E-I0 8.300E-I0 THYROID 1.020E-14 5.978E-12 6.762E-11 2.150E-16-1.000E+00 6.280E-08 5.950E-08 REMAINDER 9.160E-15 5.644E-12 6.385E-1I 2.030E-16-1.C00E+00 7.890E-I0 1.490E-09 EFFECTIVE 1.030E-14 6.339E-12 7.171E-II 2.280E-16-1.00CE+00 2.550E-09 2.540E-09 SKIN(FGR) 1.390E-14 8.313E-12 9.405E-11 2.990E-16-1.000E+00 0.000E+00 C.000E+00 1-131 GONADS 1.780E-14 I.119E-1I 1.789E-10 3.940E-16-1.C00E+00 2.530E-II 4.070E-I1 BREAST 2.040E-14 1.082E-II 1.730E-10 3.810E-16-1.000E+00 7.880E-I1 1.210E-10 LUNGS 1.760E-14 1.016E-11 1.626E-10 3.580E-16-1.000E+00 6.570E-I0 1.020E-10 RED MARR 1.680E-14 1.022E-II 1.635E-I0 3.600E-16-1.000E+00 6.260E-11 9.440E-11 BONE SUR 3.450E-14 1.675E-II 2.679E-10 5.900E-16-1.0C0E+00 5.730E-1I 8.720E-I1 THYROID 1.810E-14 1.053E-1I 1.685E-I0 3.710E-16-1.000E+00 2.920E-07 4.760E-07 REMAINDER 1.670E-14 9.908E-12 1.585E-10 3.490E-16-1.000E+00 8.030E-iI 1.570E-i0 EFFECTIVE 1.820E-14 1.067E-i1 1.707E-i0 3.760E-16-1.000E+00 8.890E-09 1.440E-08 SKIN(FGR) 2.980E-14 1.825E-I1 2.920E-I0 6.430E-16-1.000E+00 0.000E+00 0.000E+00 1-132 GONADS 1.090E-13 2.523E-1l 2.771E-ll 2.320E-15-1.000E+00 9.950E-12 2.330E-Il BREAST 1.240E-13 2.414E-11 2.652E-1l 2.220E-15-1.C00E+00 1.410E-ll 2.520E-1l LUNGS 1.090E-13 2.305E-ll 2.532E-1l 2.120E-15-1.0O0E+00 2.710E-i0 2.640E-Il RED MARR 1.070E-13 2.360E-lI 2.592E-l1 2.170E-15-1.C00E+00 1.400E-11 2.460E-l1 BONE SUR. 1.730E-13 3.327E-l1 3.655E-l1 3.060E-15-1.000E+00 1.240E-ll 2.190E-l1 THYROID 1.120E-13 2.381E-11 2.616E-1I 2.190E-15-1.0C0E+00 1.740E-09 3.870E-09'REMAINDER 1.050E-13 2.283E-ll 2.509E-I1 2.100E-15-1.C0CE+00 3.780E-II 1.650E-10 EFFECTIVE 1.120E-13 2.403E-11 2.640E-11 2.210E-15-1.000E+00 1.030E-10 1.820E-I0 SKIN(FGR) 1.580E-13 8.199E-11 9.007E-11 7.540E-15-1.000E+00 C.CC0E+00 C.C00E+00 1-133 GONADS 2.870E-14 1.585E-II 6.748E-11 6.270E-16-1.000E+00 1.950E-li 3.630E-11 BREAST 3.280E-14 1.519E-11 6.468E-11 6.010E-16-1.000E+00 2.940E-ii 4.680E-li LUNGS 2.860E-14 1.446E-11 6.156E-11 5.720E-16-1.000E+00 8.200E-l0 4.530E-li RED MARR 2.770E-14 1.466E-11 6.242E-11 5.800E-16-1.000E+00 2.720E-11 4.300E-lI BONE SUR 4.870E-14 2.161E-ii 9.202E-II 8.550E-16-1.C00E+00 2.520E-li 4.07CC-il THYROID 2.930E-14 1.502E-ii 6.393E-1i 5.940C-16-1.00CE+00 4.860E-08 9.100E-08 REMAINDER 2.730E-14 1.418E-11 6.038E-11 5.610E-16-1.000E+00 5.CC0E-II 1.550E-I0 EFFECTIVE 2.940E-14 1.509E-I1 6.425E-I1 5.970E-16-1.C0CE+00 1.580E-09 2.800E-09 SKIN(FGR) 5.830E-14 1.150E-10 4.897E-10 4.550E-15-1.000E+00 0.000E+00 0.00CE+00 1-134 GONADS 1.270E-13 1.200E-i1 1.202E-11 2.640E-15-1.00CE+00 4.250E-12 1.100E-Il BREAST 1.440E-13 1.145E-I1 1.147E-II 2.520E-15-1.OOE+00 6.170E-12 1.170E-il LUNGS 1.270E-13 1.100E-l1 1.102E-I1 2.420E-15-1.OOOE+00 1.430E-i0 1.260E-Il RED MARR 1.250E-13 1.127E-1I 1.129E-II 2.480E-15-1.000E+00 6.080E-12 1.090C-li BONE SUR 1.960E-13 1.568E-II 1.571E-11 3.450E-15-1.C00E+00 5.310E-12 9.320E-12 THYROID 1.300EL13 1.127E-II 1.129E-1I 2.480E-15-1.000E+00 2.880E-i0 6.210E-i0 REMAINDER 1.220E-13 1.091E-11 1.093E-11 2.400E-15-1.OC0E+00 2.270E-li 1.340E-i0 EFFECTIVE 1.300E-13 1.150E-li 1.152E-II 2.530E-15-1.000E+00 3.550E-li 6.660E-II SKIN(FGR) 1.870E-13 4.477E-1I 4.485E-Il 9.850E-15-1.OOCE+0C 0.COCE+00 0.CC0E+00 1-135 GONADS 8.078E-14 3.113E-II 5.489E-1I 1.599E-15-1.000E+00 1.700E-il 3.610E-li CALCULATION NO. C-1302-822-E310-082 REV. No. 1 1 PAGE NO. 28 BREAST 9.143E-14 2.971E-l1 5.240E-11 l.526E-15-1.OOOE+00 2.340E-11 3.850E-11 LUNGS 8.145E-14 2.886E-11 5.089E-11 1.482E-15-1.0OOE+00 4.410E-10 3.750E-11 RED MARR 8.054E-14 2.965E-11 5.228E-11 1.523E-15-1.000E+00 2.240E-11 3.650E-11 BONE SUR 1.184E-13 3.983E-11 7.024E-11 2.046E-15-1.OOE+00
.2.010E-lf 3.360E-11 THYROID 8.324E-14 2.852E-11 5.030E-11 1.465E-15-1.0O0E+00 8.460E-09 1.790E-08 REMAINDER 7.861E-14 2.883E-11 5.084E-11 1.481E-15-1.0OOE+00 4.700E-11 1.540E-10 EFFECTIVE 8.294E-14 2.989E-11 5.271E-11 1.535E-15-1.OOE+00 3.320E-10 6.080E-10 SKIN(FGR) 1156E-13 9.826E-11 1.733E-10 5.047E-15-1.OOE+00 O.OOE+00 O.OOE+00 Xe-133 GONADS 1.610E-15 1.465E-12 2.052E-11 5.200E-17-.OOOE+00 0.OOOE+00 O.OOOE+00 BREAST 1.960E-15 1.505E-12 2.107E-11 5.340E-17-.OOOE+00 O.0O0E+00 O.00E+00 LUNGS 1.320E-15 1.045E-12 1.464E-11 3.710E-17-1.OOIE+00 O.0OOE+00 O.OOOE+00 RED MARR 1.070E-15 8.791E-13 1.231E-11 3.120E-17-.OOOE+00 O.OOE+00 O.OOOE+00 BONE SUR 5.130E-15 4.254E-12 5.958E-11 1.510E-16-.OOOE+00 0.OOOE+00 O.000E+00 THYROID 1.510E-15 1.181E-12 1.653E-11 4.190E-17-.OOOE+00 O.000E+00 O.000E+00 REMAINDER 1.240E-15 1.042E-12 1.460E-11 3.700E-17-.OOE+00 O.OOOE+00 O.OOOE+00 EFFECTIVE 1.560E-15 1.299E-12 1.819E-11 4.610E-17--.OOOE+00 O.OOOE+00 O.0OOE+00 SKIN(FGR) 4.970E-15 1.953E-12 2.734E-11 6.930E-17-i.
OE+00 0.000E+00 0.OO0E+00 Xe-133m GONADS 1.610E-15 1.465E-12 2.052E-11 5.200E-17-l.QO0E+00
.000E+00 0.OOE+00 BREAST 1.960E-15 1.505E-12 2.107E-11 5.340E-17-l.GO0E+00 O.OOOE+00 O.OOOE+00 LUNGS 1.320E-15 1.045E-12 1.464E-11 3.710E-17-.OOOE+00 O.OOE+00 0.OOE+00 RED MARR 1.070E-15 8.791E-13 1.231E-11 3.120E-17-I.0OOE+00 O.OOE+00 O.000E+00 BONE SUR 5.130E-15 4.254E-12 5.958E-11 1.510E-16-I.OOE+00
.000E+00 0.000E+00 THYROID 1.510E-15 1.181E-12 1.653E-11 4.190E-17-I.QO0E+00
.0OO0E+00 0.0O0E+00 REMAINDER 1.240E-15 1.042E-12 1.460E-11 3.700E-17-l.000E+00 O.OOE+00 o.oooE+00 EFFECTIVE 1.560E-15 1.299E-12 1.819E-11 4.610E-17-.0OO0E+00 0.OO0E+00 O.00E+00 SKIN(FGR) 4,970E-15 1.953E-12 2.734E-11 6.930E-17-l.000E+00 O.OOE+00 O.000E+00 Xe-135 GONADS 1.170E-14 5.455E-12 1.194E-11 2.530E-16-1.OOOE+00 O.0O0E+00 O.0O0E+00 BREAST 1.330E-14 5.325E-12 1.166E-11 2.470E-16-1.UOOE+00 U.OOOE+00 O.OOOE+00 LUNGS 1.130E-14 4.959E-12 1.086E-11 2.300E-16-I.QO0E+00 0.0OOE+00 O.OOOE+00 RED MARR 1.070E-14 4.959E-12 1.086E-11 2.300E-16-l.OOE+00
.0C0E+00 O.0OOE+00 BONE SUR 2.570E-14 9.120E-12 1.997E-11 4.230E-16-.OOE+00 O.OOOE+00 O.OOOE+00 THYROID 1.180E-14 5.023E-12 1.100E-11 2.330E-16-.OOOE+00 O.OOOE+00 0.OOOE+00 REMAINDER 1.080E-14 4.829E-12 1.058E-11 2.240E-16-.OOOE+00 O.OOE+00 O.OOOE+00 EFFECTIVE 1.190E-14 5.217E-12 1.142E-11 2.420E-16-I.QO0E+00 O.OOE+00 O.OOOE+00 SKIN(FGR) 3.120E-14 4.506E-11 9.867E-11 2.090E-15-.0OO0E+00 O.OOOE+00 O.OOOE+00 Xe-135m GONADS 1.170E-14 5.455E-12 1.194E-11 2.530E-16-1.OUE+00 O.00E+00 O.OO0E+00 BREAST 1.330E-14 5.325E-12 1.166E-11 2.470E-16-.OOOE+00 0.OOOE+00 O.OOOE+00 LUNGS 1.130E-14 4.959E-12 1.086E-11 2.300E-16-.0OO0E+00 O.OOE+00 0.OOOE+00 RED MARR 1.070E-14 4.959E-12 1.086E-11 2.300E-16-.OOOE+00 O.OOOE+00 O.0OOE+00 BONE SUR 2.570E-14 9.120E-12 1.997E-11 4.230E-16-.OOE+00 O.OOOE+00 O.OOE+00 THYROID 1.180E-14 5.023E-12 1.100E-11 2.330E-16-.OOOE+00 O.OOE+00 0.OOOE+00 REMAINDER 1.080E-14 4.829E-12 1.058E-11 2.240E-16-1.OOE+00 O.OQ0E+00 O.OOE+00 EFFECTIVE 1.190E-14 5.217E-12 1.142E-11 2.420E-16-.0OO0E+00 O.OOE+00 O.OOOE+00 SKIN(FGR) 3.120E-14 4.506E-11 9.867E-11 2.090E-15-I.OOOE+00 O.OOE+00 0.000E+00 Xe-137.GONADS 1.170E-14 5.455E-12 1.194E-11 2.530E-16-.OO0E+00 C.0O0E+00 O.0OOE+00 BREAST 1.330E-14 5.325E-12 1.166E-11 2.470E-16-.OOOE+00 O.0O0E+00 O.OOOE+00 LUNGS 1.130E-14 4.959E-12 1.086E-11 2.300E-16-.OOOE+00 O.OOOE+00 O.OOE+00 RED MARR 1.070E-14 4.959E-12 1.086E-11 2.300E-16-i.OOOE+00 O.OCUE+00 0.000E+00 BONE SUR 2.570E-14 9.120E-12 1.997E-11 4.230E-16-1.C00E+00 0.OOOE+00 0.0OOE+00 THYROID 1.180E-14 5.023E-12 1.100E-11 2.330E-16-I.OO0E+00 O.OOOE+00 O.0O0E+00 REMAINDER 1.080E-14 4.829E-12 1.058E-11 2.240E-16-I.OOOE+00 O.OOOE+00 0.0O0E+00 EFFECTIVE 1.190E-14 5.217E-12 1.142E-11 2.420E-16-1.OOE+00 O.OOOE+00 O.0O0E+00 SKIN(FGR) 3.120E-14 4.506E-11 9.867E-I1 2.090E-15-1.000E+00 O.OOOE+00 O.OOOE+00 Xe-138 GONADS 1.170E-14 5.455E-12 1.194E-11 2.530E-16-1.000E+00 O.000E+00 Q.OOE+00 BREAST 1.330E-14 5.325E-12 1.166E-11 2.470E-16-1.000E+00 0.0O0E+00 0.000E+00 LUNGS 1.130E-14 4.959E-12 1.086E-11 2.300E-16-1.0OOE+00 0.000E+00 0.000E+00 RED MARR 1.070E-14 4.959E-12 1.086E-11 2.300E-16-1.O00E+00 O.OOE+00 O.OOOE+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGENO. 29 BONE SUR 2.570E-14 9.120E-12 1.997E-11 4.230E-16-1.OOOE+00 0.000E+00 0.000E+00 THYROID 1.180E-14 5.023E-12 1.100E-11 2.330E-16-1.0OOE+00 O.OOE+00 0.000E+00 REMAINDER 1.080E-14 4.829E-12 1.058E-I1 2.240E-16-1.OOE+00 0.OOE+00 O.0O0E+00 EFFECTIVE 1.190E-14 5.217E-12 1.142E-11 2.420E-16-1.OOE+00 O.OOOE+00 O.OOOE+00 SKIN(FGR) 3.120E-14 4.506E-11 9.867E-11 2.090E-15-1.OOE+00 0.OOE+00 O.DOE+00 Cs-134 GONADS 7.400E-14 4.607E-11 9.646E-10 1.600E-15-1.OOE+00 1.300E-08 2.060E-08 BREAST 8.430E-14 4.406E-I1 9.224E-10 1.530E-15-1.OOE+00 1.080E-08 1.720E-08 LUNGS 7.370E-14 4.204E-I1 8.802E-10 1.460E-15-1.000E+00 1.180E-08 1.760E-08 RED MARR 7.190E-14 4.262E-11 8.922E-10 1.480E-15-1.000E+00 1.180E-08 1.870E-08 BONE SUR 1.200E-13 6.105E-11 1.278E-09 2.120E-15-1.OOE+00 1.100E-08 1.740E-08 THYROID 7.570E-14 4.377E-11 9.163E-10 1.520E-15-1.000E+00 1.11OE-08 1.760E-08 REMAINDER 7.060E-14 4.147E-11 8.681E-10 1.440E-15-1.000E+00 1.390E-08 2.210E-08 EFFECTIVE 7.570E-14 4.377E-11 9.163E-10 1.520E-15-1.000E+00 1.250E-08 1.980E-08 SKIN(FGR) 9.450E-14 6.249E-11 1.308E-09 2.170E-15-1.000E+00 0.000E+00 0.000E+00 Cs-136 GONADS 1.040E-13 6.223E-11 1.102E-09 2.180E-15-1.O0OE+00 1.880E-09 3.040E-09 BREAST 1.180E-13 5.966E-I1 1.056E-09 2.090E-15-1.000E+00 1.670E-09 2.650E-09 LUNGS 1.040E-13 5.710E-11 1.011E-09 2.000E-15-1.000E+00 2.320E-09 2.620E-09 RED MARR 1.010E-13 5.824E-11 1.031E-09 2.040E-15-1.000E+00 1.860E-09 2.950E-09 BONE SUR 1.660E-13 8.422E-11 1.491E-09 2.950E-15-1.000E+00 1.700E-09 2.710E-09 THYROID 1.070E-13 5.852E-11 1.036E-09 2.050E-15-1.OOOE+00 1.730E-09 2.740E-09 REMAINDER 9.950E-14 5.652E-11 1.001E-09 1.980E-15-1.OOOE+00 2.190E-09 3.520E-09 EFFECTIVE 1.060E-13 5.966E-11 1.056E-09 2.090E-15-1.000E+00 1.980E-09 3.040E-09 SKIN(FGR) 1.250E-13 7.251E-11 1.284E-09 2.540E-15-1.OOOE+00 0.000E+00 0.OOOE+00 Cs-137 GONADS 2.669E-14 1.669E-11 3.530E-10 5.840E-16-1.OOOE+00 8.760E-09 1.390E-08 BREAST 3.047E-14 1.596E-11 3.376E-10 5.585E-16-1.OOOE+00 7.840E-09 1.240E-08 LUNGS 2.649E-14 1.517E-11 3.209E-10 5.309E-16-1.00OE+00 8.820E-09 1.270E-08 RED MARR 2.583E-14 1.542E-11 3.260E-10 5.394E-16-1.OOOE+00 8.300E-09 1.320E-08 BONE SUR 4.382E-14 2.238E-11 4.734E-10 7.832E-16-1.OOOE+00 7.940E-09 1.260E-08 THYROID 2.725E-14 1.588E-11 3.358E-10 5.556E-16-1.OOOE+00 7.930E-09 1.260E-08 REMAINDER 2.536E-14 1.490E-11 3.152E-10 5.215E-16-1.OOOE+00 9.120E-09 1.450E-08 EFFECTIVE 2.725E-14 1.585E-11 3.353E-10 5.546E-16-1.OOOE+00 8.630E-09 1.350E-08 SKIN(FGR) 4.392E-14 5.253E-11 1.11OE-09 1.836E-15-1.OOOE+00 0.OOOE+00 0.000E+00 Ba-137m GONADS 2.669E-14 1.669E-11 3.530E-10 5.840E-16-1.OOOE+00 8.760E-09 1.390E-08 BREAST 3.047E-14 1.596E-11 3.376E-10 5.585E-16-1.OOOE+00 7.840E-09 1.240E-08 LUNGS 2.649E-14 1.517E-11 3.209E-10 5.309E-16-1.000E+00 8.820E-09 1.270E-08 RED MARR 2.583E-14 1.542E-11 3.260E-10 5.394E-16-1.000E+00 8.300E-09 1.320E-08 BONE SUR 4.382E-14 2.238E-11 4.734E-10 7.832E-16-1.000E+00 7.940E-09 1.260E-08 THYROID 2.725E-14 1.588E-11 3.358E-10 5.556E-16-1.OOOE+00 7.930E-09 1.260E-08 REMAINDER 2.536E-14 1.490E-l1 3.152E-10 5.215E-16-1.000E+00 9.120E-09 1.450E-08 EFFECTIVE 2.725E-14 1.585E-11 3.353E-10 5.546E-16-1.000E+00 8.630E-09 1.350E-08 SKIN(FGR) 4.392E-14 5.253E-11 1.11OE-09 1.836E-15-1.000E+00 0.000E+00 0.000E+00 Ba-139 GONADS 2.130E-15 3.368E-13 3.429E-13 4.790E-17-1.000E+00 2.560E-12 1.560E-12 BREAST 2.450E-15 3.297E-13 3.357E-13 4.690E-17-1.000E+00 2.460E-12 5.170E-13 LUNGS 2.030E-15 3.002E-13 3.057E-13 4.270E-17-1.000E+00 2.530E-10 3.890E-13 RED MARR 1.870E-15 2.932E-13 2.985E-13 4.170E-17-1.000E+00 3.410E-12 8.590E-13 BONE SUR 5.290E-15 6.841E-13 6.965E-13 9.730E-17-1.000E+00 2.490E-12 4.380E-13 THYROID 2.130E-15 3.044E-13 3.100E-13 4.330E-17-1.000E+00 2.400E-12 2.660E-13 REMAINDER 1.920E-15 2.932E-13 2.985F-13 4.170E-17-1.000E+00 4.820E-11 3.570E-10 EFFECTIVE 2.170E-15 3.227E-13 3.286E-13 4.590E-17-1.000E+00 4.640E-11 1.080E-10 SKIN(FGR) 6.160E-14 7.241E-11 7.373E-11 1.030E-14-1.000E+00 0.OOOE+00 0.000E+00 Ba-140 GONADS 8.410E-15 5.451E-12 9.607E-11 1.910E-16-1.000E+00 4.300E-10 9.960E-10 BREAST 9.640E-15 5.280E-12 9.305E-11 1.850E-16-1.000E+00 2.870E-10 1.590E-10 LUNGS 8.270E-15 4.852E-12 8.550E-11 1.700E-16-1.000E+00 1.660E-09 6.630E-11 RED MARR 7.930E-15 4.880E-12 8.601E-11 1.710E-16-1.000E+00 1.290E-09 4.390E-10 BONE SUP 1.550E-14 8.020E-12 1.413E-10 2..810E-16-I.000E+00 2.410E-09 5.530E-10 THYROID 8.530E-15 5.109E-12 9.003E-11 1.790E-16-1.000E+00 2.560E-10 5.250E-11 REMAINDER 7.890E-15 4.766E-12 8.399E-11 1.670E-16-1.000E+00 1.410E-09 7.370E-09 I CALCULATION NO. C-1302-822-E310-082 REV. No. 1 1 PAGE NO. 30 EFFECTIVE 8.580E-15 5.137E-12 9.053E-11 1.800E-16-1.000E+00 1.010E-09 2.560E-09 SKIN(FGR) 2.520E-14 5.565E-11 9.808E-10 1.950E-15-1.OOQE+00 O.OOOE+00 O.OOOE+00 La-140 GONADS 1.140E-13 6.027E-11 4.425E-10 2.240E-15-1.OOOE+00 4.540E-10 1.340E-09 BREAST 1.290E-13 5.758E-I.
4.228E-10 2.140E-15-1.OOOE+00 1.450E-10 1.800E-10 LUNGS 1.150E-13 5.596E-11 4.109E-10 2.080E-15-1.OOOE+00 4.210E-09 4.010E-11 RED MARR 1.140E-13 5.731E-11 4.208E-10 2.130E-15-1.OOOE+00 2.140E-10 2.810E-10 BONE SUR 1.690E-13 7.776E-11 5.709E-10 2.890E-15-1.OOE+00 1.410E-10 9.770E-11 THYROID 1.180E-13 5.462E-11 4.010E-10 2.030E-15-1.OOOE+00 6.870E-11 6.400E-12 REMAINDER 1.I1OE-13 5.569E-11 4.089E-10 2.070E-15-1.OOOE+00 2.120E-09 6.260E-09 EFFECTIVE 1.170E-13 5.812E-11 4.267E-10 2.160E-15-1.OOOE+00 1.310E-09 2.280E-09 SKIN(FGR) 1.660E-13 2.217E-10 1.628E-09 8.240E-15-1.OOOE+00 O.OOOE+00 O.OOOE+00 La-141 GONADS 2.330E-15 7.315E-13 9.675E-13 4.740E-17-1.OOOE+00 1.010E-11 3.770E-12 BREAST 2.640E-15 7.007E-13 9.267E-13 4.540E-17-1.OOOE+00 9.840E-12 7.070E-13 LUNGS 2.340E-15 6.713E-13 8.879E-13 4.350E-17-I.OOOE+00 6.460E-10 2.720E-13 RED MARR 2.310E-15 6.852E-13 9.063E-13 4.440E-17-.OOOE+00 2.930E-11.
1.070E-12 BONE SUR 3.490E-15 9.923E-13 1.312E-12 6.430E-17-.OOE+00 1.200E-10 6.060E-13 THYROID 2.390E-15 6.590E-13 8.716E-13 4.270E-17-.OOE+00 9.400E-12 5.290E-14 REMAINDER 2.260E-15 6.682E-13 8.838E-13 4.330E-17-.O0OE+00 2.280E-10 1.240E-09 EFFECTIVE 2.390E-15 7.007E-13 9.267E-13 4.540E-17-1.OOOE+00 1.570E-10 3.740E-10 SKIN(FGR) 6.580E-14 1.667E-10 2.204E-10 1.080E-14-.OOOE+00 O.OOE+00 O.OOOE+00 La-142 GONADS 1.400E-13 1.978E-11 2.034E-11 2.540E-15-1.OOOE+00 1.660E-11 6.990E-11 BREAST 1.570E-13 1.885E-11 1.938E-1I1 2.420E-15-1.OOOE+00 1.130E-11 1.540E-I1 LUNGS 1.420E-13 1.846E-11 1.898E-11 2.370E-15-1.OOOE+00 3.010E-10 8.400E-12 RED MARR 1.420E-13 1.900E-1I 1.954E-11 2.440E-15-.OOOE+00 1.360E-I1 1.930E-11 BONE SUR 1.950E-13 2.484E-11 2.554E-11 3.190E-15-1.OOOE+00 1.110E-11 7.400E-12 THYROID 1.450E-13 1.768E-11 1.818E-11 2.270E-15-.OOOE+00 8.740E-12 1.160E-12 REMAINDER 1.380E-13 1.853E-I1 1.906E-1I 2.380E-15-.OOOE+00 8.070E-1I 5.200E-10 EFFECTIVE 1.440E-13 1.916E 1.970E-11 2.460E-15-.OOOE+00 6.840E-11 1.790E-10 SKIN(FGR) 2.160E-13 9.111E-11 9.368E-11 1.170E-14-1.OOE+00 O.OOOE+00 OOOOE+00 Ce-141 GONADS 3.380E-15 2.213E-12 4.332E-11 7.710E-17-I.OOOE+00 5.540E-11 1.080E-10 BREAST 3.930E-15 2.170E-12 4.247E-11 7.560E-17-I.OOOE+00 4.460E-11 1.11OE-11 LUNGS 3.170E-15 1.951E-12 3.820E-1I 6.800E-17-I.OOOE+00 1.670E-08 1.430E-12 RED MARR 2.830E-15 1.860E-12 3.641E-11 6.480E-17-1.OOOE+00 8.960E-11 3.390E-11 BONE SUR 9.410E-15 5.166E-12 1.011E-10 1.800E-16-1.OOE+00 2.540E-10 2.300E-1I THYROID 3.350E-15 2.003E-12 3.922E-11 6.980E-17-1.OOOE+00 2.550E-11 1.800E-13 REMAINDER 2.980E-15 1.894E-12 3.708E-11 6.600E-17-1.OOOE+00 1.260E-09 2.500E-09 EFFECTIVE 3.430E-15 2.118E-12 4.146E-11 7.380E-17-1.OOOE+00 2.420E-09 7.830E-10 SKIN(FGR) 1.020E-14 3.788E-12 7.416E-I1 1.320E-16-1.OOOE+00 0.000E+00 O.OOOE+00 Ce-143 GONADS 1.280EM14 7.900E-12 4.958E-11 2.980E-16-.OO0E+00 7.530E-I1 2.120E-10 BREAST 1.470E-14 7.688E-12 4.825E-11 2.900E-16-1.OOE+00 1.660E-I1 2.320E-I1 LUNGS 1.230E-14 6.893E-12 4.325E-11 2.600E-16-1.OOOE+00 3.880E-09 3.820E-12 RED MARR 1.170E-14 6.787E-12 4.259E-1I 2.560E-16-1.OOOE+00 2.960E-1I 5.070E-11 BONE SUR 2.520E-14 1.323E-11 8.302E-II 4.990E-16-1.OOOE+00 1.640E-11 1.610E-11 THYROID 1.280E-14 7.211E-12 4.525E-11 2.720E-16-1.OOE+00 6.230E-12 4.350E-13 REMAINDER 1.170E-14 6.734E-12 4.226E-11 2.540E-16-1.OOOE+00 1.420E-09 3.890E-09 EFFECTIVE 1.290E-14 7.396E-12 4.642E-11 2.790E-16-1.OOE+00 9.160E-10 1.230E-09 SKIN(FGR) 3.960E-14 1.058E-I0 6.638E-10 3.990E-15-1.0.OOE+00 O.OOOE+00 O.OOOE+00 Ce-144 GONADS 2.725E-15 6.328E-13 1.319E-11 6.088E-17-1.OOOE+00 2.390E-10 6.987E-l1 BREAST 3.129E-15 6.274E-13 1.307E-11 5.922E-17-I.OOOE+00 3.480E-10 1.223E-11 LUNGS 2.639E-15 5.228E-13 1.089E-11 5.362E-17-1.OOOE+00 7.911E-07 6.551E-12 RED MARR 2.507E-15 4.755E-13 9.907E-12 5.247E-17-1.OOE+00 2.880E-09 8.923E-1I BONE SUR 5.441E-15 1.646E-12 3.429E-11 1.127E-16-.OOOE+00 4.720E-09 1.280E-10 THYROID 2.753E-15 5.529E-13 1.152E-11 5.418E-17-1.OOOE+00 2.920E-10 5.154E-12 REMAINDER 2.534E-15 5.086E-13 1.060E-11 5.283E-17-1.OOOE+00 1.910E-08 1.890E-08 EFFECTIVE 2.773E-15 5.909E-13 1.231E-11 5.766E-17-1.OOOE+00 1.010E-07 5.711E-09 SKIN(FGR) 8.574E-14 7.648E-13 1.594E-11 1.250E-14-1.OOOE+00 0.000E+00 0.000E+00 Pr-143 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO.731 ]GONADS 2.130E-17 2.264E-14 4.032E-13 7.930E-19-1.000E+00 4.370E-18 8.990E-18 BREAST 2.550E-17 2.330E-14 4.149E-13 8.160E-19-1.OOOE+00 2.220E-18 1.090E-18 LUNGS 1.860E-17 1.642E-14 2.923E-13 5.750E-19-1.O0OE+00 1.330E-08 1.910E-19 RED MARR 1.620E-17 1.493E-14 2.659E-13 5.230E-19-1.OOE+00 1.480E-11 1.030E-12 BONE SUR 5.930E-17 5.454E-14 9.711E-13 1.910E-18-1.OOE+00 1.490E-11 1.030E-12 THYROID 2.050E-17 1.802E-14 3.208E-13 6.310E-19-1.O00E+00 1.680E-18 2.660E-20 REMAINDER 1.760E-17 1.642E-14 2.923E-13 5.750E-19-1.000E+00 1.970E-09 4.220E-09 EFFECTIVE 2.100E-17 2.002E-14 3.564E-13 7.010E-19-1.000E+00 2.190E-09 1.270E-09 SKIN(FGR) l..760E-14 5.711E-11 1.017E-09 2.D00E-15-1.00DE+00 D .DODE+00 D.ODDE+00 Nd-147 GONADS 6.130E-15 4.218E-12 7.235E-11 1.480E-16-1.000E+00 8.410E-11 1.790E-10 BREAST 7.120E-15 4.132E-12 7.088E-11 1.450E-16-1.00DE+00 3.450E-11 1.870E-11 LUNGS 5.820E-15 3.648E-12 6.257E-11 1.280E-16-1.DOOE+00 1.060E-08 2.440E-12 RED MARR 5.400E-15 3*505E-12 6.013E-11 1.230E-16-1.0D0E+00 9.190E-11 5.050E-11 BONE SUR 1.320E-14 8.265E-12 1.418E-10 2.900E-16-1.00DE+00 3.260E-10 2.220E-11 THYROID 6.120E-15 3.876E-12 6.648E-11 1.360E-16-1.0O0E+00 1.820E-11 2.640E-13 REMAINDER 5.530E-15 3.562E-12 6.111E-11 1.250E-16-1.DOE+00 1.760E-09 3.760E-09 EFFECTIVE 6.190E-15 3.961E-12 6.795E-11 1.390E-16-1.DDDE+00 1.850E-09 1.180E-09 SKIN(FGR) 1.950E-14 3.135E-11 5.377E-10 1.100E-15-1.00DE+00 O.DOE+00 O.ODE+00 Np-239 GONADS 7.530E-15 4.691E-12 4.380E-11 1.710E-16-1.OOOE+00 7.450E-11 1.620E-I0 BREAST 8.73CE-15 4.636E-12 4.329E-II 1.690E-16-1.C0CE+00 1.630E-II 1.720E-il LUNGS 7.180E-15 4.115E-12 3.842E-II 1.500E-16-1.0CCE+00 2.360E-09 2.400E-12 RED MARR 6.500E-15 4.005E-12 3.740E-II 1.460E-16-1.CCCE+00 2.080E-I0 4.660E-II BONE SUR 2.CCCE-14 1.001E-II 9.349E-I1 3.650E-16-1.CC0E+00 2.030E-09 3.590E-II THYROID 7.520E-15 4.197E-12 3.919E-II 1.530E-16-1.CCCE+00 7.620E-12 2.070E-13 REMAINDER 6.760E-15 4.005E-12 3.740E-il 1.460E-16-1.000E+00 9.590E-i0 2.770E-09 EFFECTIVE 7.690E-15 4.471E-12 4.175E-II 1.630E-16-1.CCCE+00 6.780E-I0 8.820E-I0 SKIN(FGR) 1.600E-14 7.215E-12 6.737E-II 2.630E-16-1.CCCE+00 C.CCCE+00 D.CCCE+00 Pu-238 GONADS 6.560E-18 4.291E-14 9.011E-13 1.490E-18-1.000E+00 1.040E-05 2.330E-09 BREAST 1.270E-17 5.558E-14 1.167E-12 1.930E-18-1.CCCE+00 4.400E-I0 1.800E-13 LUNGS 1.060E-18 2.267E-15 4.759E-14 7.870E-20-1.CCDE+00 3.200E-04 8.640E-14 RED MARR 1.680E-18 5.587E-15 1.173E-13 1.940E-19-1.CCCE+00 5.800E-05 1.270E-08 BONE SUR 9.300E-18 3.514E-14 7.378E-13 1.220E-18-1.CCCE+00 7.250E-04 1.580E-07 THYROID 4.010E-18 9.792E-15 2.056E-13 3.400E-19-1.0DCE+00 3.860E-I0 7.990E-14 REMAINDER 1.990E-18 9.216E-15 1.935E-13 3.200E-19-1.C0CE+00 2.740E-05 2.180E-08 EFFECTIVE 4.880E-18 2.413E-14 5.068E-13 8.380E-19-1.CCCE+00 7.790E-05 1.340E-08 SKIN(FGR) 4.090E-17 2.776E-13 5.830E-12 9.640E-18-1.CCDE+00 C.CCCE+00 C.C0CE+00 Pu-239 GONADS 4.840E-18 1.768E-14 3.713E-13 6.140E-19-1.000E+00 1.200E-05 2.640E-09 BREAST 7.550E-18 2.238E-14 4.699E-13 7.770E-19-1.CCCE+00 3.990E-I0 1.210E-13 LUNGS 2.650E-18 2.267E-15 4.760E-14 7.870E-20-1.CCCE+00 3.230E-04 7.890E-14 RED MARR 2.670E-18 3.456E-15 7.258E-14 1.200E-19-1.COCE+00 6.570E-05 1.410E-08 BONE SUR 9.470E-18 1.673E-14 3.514E-13 5.810E-19-1.CCCE+00 8.210E-04 1.760E-07 THYROID 3.880E-18 5.126E-15 1.077E-13 1.780E-19-1.0DCE+00 3.750E-I0 7.500E-14 REMAINDER 2.860E-18 4.838E-15 1.016E-13 1.680E-19-!.000E+00 3.020E-05 2.120E-08 EFFECTIVE 4.240E-18 1.057E-14 2.220E-13 3.670E-19-1.CCDE+00 8.330E-05 1.400E-08 SKIN(FGR) i.860E-17 1.057E-13 2.220E-12 3.670E-18-1.CCCE+00 C.CCCE+00 0.CCCE+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 32 ATTACHMENT B Oyster Creek RADTRAD Output File -Bounding Case 2,000 cfm Case#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:01:36#######################################################################
44####444##44#####4#########4##4##############4############4############
File information
#######################################################################
Plant file = C:\Program Files\radtrad3.03\OC AST\FHA 2007\FHA source release modified flow rates fixed inp file diffuse source xq less conservative iodine fractions 2000.cfm increased time steps.psf Inventory file = c:\program files\radtrad3.03\defaults\ocfhaikr.nif Release file = c:\program files\radtrad3.03\oc ast\oc fha.rft Dose Conversion file = c:\program files\radtrad3.03\oc ast\oc6O.inp 44#4#4 4 4 4#4444 4 4 4 4444 44444 4 4 4 4 4444 4444 44 44 4444 4 4 4 4 4 4 4 4 44 4 44 4 444 4 44 4 44 44444 4 *4 4 4 44444 4 4 4 4 44444 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 444# ##4 44#Radtrad 3.03 4/15/2001 2000 cfm Nuclide Inventory File: c:\program files\radtrad3.03\defaults\ocfhaikr.nif Plant Power Level: 1.1310E+01 Compartments:
3 Compartment 1: Refuel Floor Airspace 3 1.0000E+02 0 0 0.0 0 Compartment 2: Environment 2 0.0000E+00 0 0 0 0 0 Compartment 3:
I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 33 1 Control Room 1 2.7500E+04 0 0 0 0 0 Pathways: 3 Pathway 1: Refuel Floor Airspace to Environment 1 2 2 Pathway 2: Environment to Control Room 2 3 2 Pathway 3: Control Room to Environment 3 2 2 End of Plant Model File Scenario Description Name: Plant Model Filename: Source Term: 1 1 1.0000E+00 c:\program files\radtrad3.03\oc ast\oc60.inp c:\program files\radtrad3.03\oc ast\oc fha.rft 2.4000E+01 1 0.0O00E+00 5.7000E-01 4.3000E-01 1.OOOOE+00 Overlying Pool: 0 o.0000E+00 0 0 0 C Compartments:
3 Compartment 1: 0 1 0 0 0 0 0 0 0 Compartment 2: 0 1 0 0 0 i CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 34 0 0 Compartment 3: 0 1 0 0 0 0 0 Pathways: 3 Pathway 1: 0 0 0 0 0 1 2 2 .4000E+01 7.4400E+02 0 0 0 0 0 0 Pathway 2: 0 0 0 0 0 1 2 2 .4000E+01 7.4400E+02 0 0 0 0 0 0 Pathway 3: 0 0 0 0 0 1 2 2.4000E+01 7.4400E+02 0 0 0 0 0 7.6750E+00 0.0000E+00 o .CCCE+CC o .CCCE+CC o .CCCE+CC O .CCCE+0C o .CCOCE+/-C o .CCCE+CC 2.0000E+03 o.0000E+00 2.0000E+03 0.0000E+00 0.0000E+00 0.0000E+00 o.0000E+00 0.0000E+00 0.0000E+00 o.OOCE+00 C.0000E+00 C.0000E+00 C. CCCCE+CC C. CCCCE+CC C.. CCCE+CC 0. CCCCE+CC I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.35 0 Dose Locations:
3 Location 1: Exclusion Area Boundary 2 1 2 2.4000E+01 1.41OOE-03 7.4400E+02 O.OOOE+00 1 4 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 O.OO0E+00 0 Location 2: Low Population Zone 2 1 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01 3.2000E+01
: 4. 8000E+01 7.4400E+02 0 Location 3: Control Room 3 0 1 1.3500E-04 o.O000E+00 3.500OE-04 1.80OOE-04 2.3000E-04 o.0000E+00 2 2.4000E+01 3.5000E-04 7.4400E+02 0.0000E+00 1 4 2.4000E+01 1.0000E+00 4.8000E+01 6.OOOOE-01 1.2000E+02 4.OOOOE-01 7.4400E+02 0.OOOOE+00 Effective Volume Location: 1 2 2.4000E+01 2.1500E-03 7.4400E+02 0.OOOOE+00 Simulation Parameters:
2 2.4000E+01 2.OOOOE-03 7.4400E+02 0.OOOOE+00 Output Filename: C:\Program Files\radtrad3.o773 1 1 1 0 0 End of Scenario File CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 36#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:01:36########################################A###############################
########################################4############################4##
Plant Description
#######################################################################
Number of Nuclides = 60 Inventory Power = 1.0000E+00 MWth Plant Power Level = 1.1310E+01 MWth Number of compartments
= 3 Compartment information Compartment number 1 (Source term fraction = 1.OOOOE+00 Name: Refuel Floor Airspace Compartment volume = 1.OOOOE+02 (Cubic feet)Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Refuel Floor Airspace to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and Out of compartment 2 Inlet Pathway Number 1: Refuel Floor Airspace to Environment Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 2.7500E+04 (Cubic feet)Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Total number of pathways = 3 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 37 ]RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:01:36#######################################################################
#######################1#########J###################0###################
Scenario Description
#######################################################################
Time between shutdown and first release Radioactive Decay is enabled Calculation of Daughters is enabled 2.4000E+01 (Hours)Release Fractions and Timings NOBLES IODINE CESIUM TELLURIUM STRONTIUM BARIUM RUTHENIUM CERIUM LANTHANUM GAP 0.000001 hr 5.OOOOE-02 2.5000E-04 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 EARLY IN-VESSEL 0.0000 hrs 0. 0000E+00 0. 0000E+00 0.OOOOE+00
.OOOOE+00 0. OOOE+00 0. 0000E+00 0. 0000E+00 0 OOOOE+00 0. 0000E+00 LATE RELEASE 0.0000 hrs 0. 0000E+00 0. 0000E+00 0 OOOOE+00 0 OOOOE+00 0. 0000E+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.0000E+00 RELEASE MASS (gm)1. 329E+00 1. lOOE-03 0. 000E+00 0. OOOE+00 0. OOOE+00 0.OO0E+00 0. OOOE+00 0. OOOE+00 0. 000E+00 Inventory Power 11. MWt Nuclide Name Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 1-131 1-132 1-133 1-134 1-135 Xe-133 Xe-133m Xe-135 Xe-135m Xe-137 Xe-138 Nuclide Kr-85m Kr-87 Kr-88 Kr-89 Sr-90 Sr-91 Sr-92 Y-93 Zr-95 Zr-97 Mo-99 Group Specific Inventory (Ci/MWt)1 4.150E+03 1 6.940E+03 1 8.060E+02 1 1.290E+04 1 1.830E+04 1 3.980E+04 2 4.016E+04 2 3.660E+04 2 5.180E+04 2 5.600E+04 2 4.820E+04 1 5.230E+04 1 1.380E+03 1 1.810E+04 1 1.560E+04 1 5.100E+04 1 4.780E+04 half life (s)6. 696E+03 1. 613E+04 3. 386E+08 4.578E+03 1. 022E+04 1 .896E+02 6. 947E+05 8.280E+03 7.488E+04 3.156E+03 2. 380E+04 4 .532E+05 1. 927E+05 3.272E+04 9. 180E+02 2. 304E+02 8.520E+02 Whole Body DCF (Sv-m3/Bq-s) 7.480E-15 7 480E-15 1. 190E-16 4 120E-14 1. 020E-13 1. 020E-13 1.820E-14 1. 120E-13 2 940E-14 1 .300E-13 8. 294E-14 1. 560E-15 1. 560E-15 1. 190E-14 1. 190E-14 1.190E-14 1. 190E-14 Inhaled Thyroid (Sv/Bq)0.000E+00 0 .OOOE+00 0.OOOE+00 0.OOOE+00 0 .OO0E+00 0.OOOE+00 2. 920E-07 1.740E-09 4.860E-08 2.880E-10 8.460E-09 0 .OOOE+00 0 .OOOE+00 0 .OOOE+00 0.OOOE+00 0.000E+00 0.OOEE+00 Daughter none none none none none none none none none none none Inhaled Effective (Sv/Bq)0. 00E+00 0. O0E+00 0. OOOE+00 C.000E+00 0. 000E+00 0. 0O0E+00 8.890E-0C9
: 1. 030E-10 1.580E-09 3.550E-11 3.320E-10 0.0 00E+00 0. 000E+00 0. 000E+00 0.OO0E+00 0.000E+00 0. 000E+00 Fraction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Daughter Kr-85 Rb-87 Rb-88 Sr-89 Y-90 Y-91m Y-92 Zr-93 Nb-95m Nb-97m Tc-99m Fraction 0.21 1.00 1.00 1.00 1.00 0.58 1.00 1.00 0.01 0.95 0.88 Daughter none none none none none Y-91 none none Nb-95 Nb-97 Tc-99 Fraction 0.00 0.00 0.00 0.00 0.00 0.42 0.00 0.00 0.99 0.05 0.12 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 38 Tc-99m Ru-103 Ru-105 Ru-106 Sb-127 Sb-129 Te-127m Te-129 Te-129m Te-131m Te-132 1-131 1-133 1-135 Xe-133m Xe-135 Xe-135m Xe-137 Cs-137 Ba-140 La-141 Ce-143 Ce-144 Nd-147 Np-239 Pu-238 Pu-2 39 Tc-99 Rh-103m Rh-105 Rh-106 Te-127m Te-129m Te-127 1-129 Te-129 Te-131 1-132 Xe-131m Xe-133m Xe-135m Xe-133 Cs-135 Xe-135 Cs-137 Ba-137m La-140 Ce-141 Pr-143 Pr-144m Pm-147 Pu-239 U-234 U-235 1.00 1.00 1.00 1.00 0.18 0.22 0.98 1.00 0.65 0.22 1.00 0.01 0.03 0.15 1.00 1.00 0.99 1.00 0.95 1.00 1.00 1.00 0.02 1.00 1.00 1.00 1.00 none none none none Te-127 Te-129 none none 1-129 1-131 none none Xe-133 Xe-135 none none Cs-135 none none none none none Pr-144 none none none none 0.00 0.00 0.00 0.00 0.82 0.77 0.00 0.00 0.35 0.78 0.00 0.00 0.97 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0. 98 0.00 0.00 0.00 0.00 none none none none none none none none none none none none none none none none none none none none none none none none none none none 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0 oo0.0.00 0 00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Iodine fractions Aerosol Elemental
=Organic =COMPARTMENT DATA Compartment number Compartment number Compartment number 0.0000E+00 5.7000E-01
: 4. 3000E-01 1: Refuel Floor Airspace 2: Environment 3: Control Room PATHWAY DATA Pathway number 1: Refuel Floor Airspace to Environment Pathway Filter: Removal Data Time (hr)2,4000E+01 7,4400E+02 Flow Rate (cfm)7.6750E+00 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr)2 4000E+01 7,4400E+02 Flow Rate (cfm)2.0000E+03 C.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.000E+00 Pathway number 3: Control Room to Environment I CALCULATION NO. C-1302-822-E310-082
]REV. No. 1 1 PAGE NO. 39 Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate I (cfm)2.OOO0E+03 0.OOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic O.0O00E+00 O.0OOOE+00 0.0000E+00 O.OOOE+00 O.OOOOE+00 0.OOOE+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1. 4100E-03 0.0000E+00 Location Breathing Rate Data Time (hr) Breathing 2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 Location Low Population Zone Rate (m^3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 0.0000E+00 is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1.3500E-04 0.0000E+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3
* sec^-l)2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.30OOE-04 7.4400E+02 0.0000E+00 Location Control Room is in compartment 3 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 Location Breathing Time (hr)2.4000E+01 7.4400E+02 Location Occupancy Time (hr)2.4000E+01 4.8000E+01 1.2000E+02 7.4400E+02 X/Q (s
* m^-3)2.1500E-03 0.0000E+00 Rate Data Breathing Rate (m^3
* sec^-l)3.5000E-04 0.0000E+00 Factor Data Occupancy Factor 1.0000E+00 6.OOOOE-01 4.0000E-01 0.0000E+00 USER SPECIFIED TIME STEP DATA -SUPPLEMENTAL TIME STEPS Time Time step O.OOOOE+00 2.0000E-03 7.2000E+02 0.0000E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 40#######################################################################
RAkDTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:01:36#######################################################4################
it it#t it#t it#t#t#t#t#t it ititititit ititititit it it it it it it it it it it it it it it#it#it it it .it # it it it it it it #####iti it it it it it it#t ## it itititit itititit it it####################################################################
Dose Output####################################################################
Exclusion Area Boundary Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8911E-06 1.8911E-06 Low Population Zone Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h)= 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1. 8107E-07 1.8107E-07 Whole Body 1.6980E-13 1.6980E-13 Exclusion Area Boundary Doses: Time (h) = 32.0000 Whole Body Delta dose (rem) 8.0083E-01 Accumulated dose (rem) 8.0083E-01 Thyroid 1.4300E-04 1.4300E-04 Thyroid 1.3692E-05 1.3692E-05 Thyroid 4.7575E-10
: 4. 7575E-10 Thyroid 6. 2001E+01 6. 2001E+01 Thyroid 5.9363E+00 5.9363E+00 Thyroid 9 .4372E+01 9. 4372E+01 Thyroid 3.0249E-15 6.2001E+01
* TEDE 6.2941E-06 6.2941E-06 TEDE 6.0262E-07 6.0262E-07 TEDE 1.4818E-11 1.4818E-11 TEDE 2.7093E+00 2.7093E+00 TEDE 2.5940E-01 2.5940E-01 TEDE 2.9362E+00 2.9362E+00 TEDE 1.4301E-16 2.7093E+00 Low Population Zone Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 7.6675E-02 7.6675E-02 Whole Body 3.2219E-02 3.2219E-02 Exclusion Area Boundary Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 5.0380E-17
: 8. 0083E-01 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 41 Low Population Zone Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 4. 8236E-18 7.6675E-02 Whole Body 2.3514E-16
: 3. 2219E-02 Exclusion Area Boundary Doses: Time (h) = 120.0000 Whole Body Delta dose (rem) 2.9673E-49 Accumulated dose (rem) 8.0083E-01 Low Population Zone Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.8411E-50 7.6675E-02 Whole Body 4.5958E-47 3.2219E-02 Thyroid 2.8961E-16 5.9363E+00 Thyroid 1. 0177E-12 9. 4372E+01 Thyroid 3.5423E-47 6.2001E+01 Thyroid 3. 3916E-48 5.9363E+00 Thyroid 3.1003E-43
: 9. 4372E+01 Thyroid 2.6550-191
: 6. 2001E+01 Thyroid 2.5420-192 5.9363E+00 Thyroid 5.4352-180
: 9. 4372E+01 TEDE 1. 3693E-17 2. 5940E-01 TEDE 3. 1401E-14 2.9362E+00 TEDE 1.3788E-48 2.7093E+00 TEDE 1. 3201E-49 2. 5940E-01 TEDE 9. 5166E-45 2.9362E+00 TEDE 9.5828-193 2.7093E+00 TEDE 9.1750-194
: 2. 5940E-01 TEDE 1.6609-181 2.9362E+00 Exclusion Area Boundary Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4965-193 8.0083E-01 Low Population Zone Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4328-194 7.6675E-02 Whole Body 5.4332-184
: 3. 2219E-02 360003 1-131 Summary####################################################################
Time (hr)24.000 24.250 24 .498 24.746 24.994 25.242 Refuel Floor Airspace 1-131 (Curies)1.0470E+02 3.3080E+01 1.0549E+01 3.3638E+00 1.0727E+00 3.4205E-01 Environment 1-131 (Curies)2.4107E-04 7.1562E+01 9.4076E+01 1.0125E+02 1.0354E+02 1.0427E+02 Control Room 1-131 (Curies)4. 8921E-07 7.9665E-02 5.2165E-02 2.5695E-02 1.1261E-02 4.6294E-03 ICALCULATION NO. C-1302-822-E310-082 I REV. No. I I PAGE NO.42 25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 27.722 27.970 28.218 28.466 28.714 28.962 29.210 29.458 29.706 29.954 30.202 30.450 30. 698 30. 946 31.194 31.442 31.690 31. 938 32.000 32.248*32.496 32.744 32.992 33.240 33.488 33.736 33.984 34.232 48.000 120.000 744.000 1.0908E-01 3.4782E-02 1.1091E-02 3.5369E-03
: 1. 1278E-03 3. 5965E-04 1 .14 69E-04 3. 6572E-05 1. 1662E-05 3. 7188E-06 1. 1859E-06 3. 7816E-07 1. 2059E-07 3. 8453E-08 1. 2262E-08 3. 9102E-09 1 .2469E-09 3. 9761E-10 1. 2679E-10 4. 0432E-11 1 .2893E-11 4. 1114E-12 1. 3110E-12 4 1807E-13 1. 3332E-13 4 .2512E-14 1. 3556E-14 1. 0187E-14 3. 2485E-15 1. 0359E-15 3. 3033E-16 1. 0534E-16 3. 3590E-17 1. 0711E-17 3 4156E-18 1. 0892E-18 3. 4732E-19 9. 6443E-47 7.5382-191 0 OOOOE+00 1. 0451E+02 1. 0458E+02 1 .04 61E+02 1 .04 61E+02 1. 0461E+02 1. 0462E+02 1. 0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.8278E-03
: 7. 0189E-04 2. 6412E-04 9.7866E-05 3.5827E-05
: 1. 2988E-05 4. 6711E-06 1. 6688E-06 5. 9282E-07 2. 0958E-07 7. 3788E-08 2. 5884E-08 9. 0512E-09 3. 1562E-09 1. 0978E-09 3. 8101E-10 1. 3197E-10 4. 5629E-11 1. 5751E-11 5 4290E-12 1. 8688E-12 6. 4251E-13 2 .2065E-13 7. 5702E-14 2. 5948E-14 8 8862E-15 3. 0408E-15 2. 3255E-15 7 .9506E-16 2. 7164E-16 9. 2755E-17 3. 1654E-17 1. 0797E-17 3. 6809E-18 1 .2543E-18 4.2726E-19
: 1. 4548E-19 1.2207E-45 3.3743-182 0.0000E+00
####################################################################
Cumulative Dose Summary####################################################################
Exclusion Area Bounda Low Populatio Time Thyroid TEDE Thyroid (hr)24.000 24.250 24.498 24.746 24.994 25.242 25.490 25.738 25.986 26.234 26.482 26.730 26. 978 27.226 27 .474 (rem)0. 0000E+00 4.2432E+01 5 .5767E+01 6. 0015E+01 6 .1369E+01 6. 1800E+01 6.1937E+01
: 6. 1981E+01 6. 1995E+01 6. 1999E+01 6. 2001E+01 6. 2001E+01 6 .2001E+01 6. 2001E+01 6 .2001E+01 (rem)0.OOOOE+00 1.8604E+00 2.4405E+00
: 2. 6241E+00 2.6823E+00 2.7007E+00 2 7065E+00 2.7084E+00
: 2. 7090E+00 2. 7092E+00 2. 7092E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2.7093E+00 (rem)0.0000E+00 4.0626E+00 5.3394E+00 5.7461E+00 5.8757E+00
: 5. 9170E+00 5. 9301E+00 5.9343E+00 5.9357E+00 5.9361E+00 5.9362E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 0.0 1.7 2.3 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5)n Zone Control Room TEDE Thyroid TEDE (rem) (rem) (rem)0OOOE+00 0.0000E+00 0.0000E+00 813E-01 2.9178E+01 9.0842E-01 366E-01 6.1722E+01 1.9211E+00 124E-01 7.9952E+01 2.4881E+00 681E-01 8.8419E+01 2.7513E+00 858E-01 9.2016E+01 2.8630E+00 914E-01 9.3466E+01 2.9081E+00 932E-01 9.4031E+01 2.9256E+00 5937E-01 9.4246E+01 2.9323E+00 5939E-01 9.4326E+01 2.9348E+00 5940E-01 9.4355E+01 2.9357E+00 5940E-01 9.4366E+01 2.9360E+00 5940E-01 9.4370E+01 2.9361E+00 5940E-01 9.4371E+01 2.9362E+00 5940E-01 9.4372E+01 2.9362E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 43 27.722 27.970 28.218 28.466 28. 714 28.962 29.210 29.458 29.706 29. 954 30.202 30.450 30. 698 30.946 31.194 31.442 31. 690 31 938 32.000 32,248 32.496 32.744 32.992 33.240 33.488 33.736 33.984 34 .232 48.000 120.000 744 .000 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6 .2001E+01 6. 2001E+01 6.2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 2.7093E+00
: 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5.9363E+00
: 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E&#xf7;00 5. 9363E+00 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 9.4372E+01
: 9. 4372E+01 9. 4372E+01 9.4372E+01
: 9. 4372E+01 9. 4372E+01 9.4372E+01
: 9. 4372E+01 9. 4372E+01 9. 4372E+01 9. 4372E+01 9. 4372E+01 9. 4372E+01 9 .4372E+01 9.4372E+01
: 9. 4372E+01 9. 4372E+01 9.4372E+01 9.4372E+01
: 9. 4372E+01 9. 4372E+01 9. 4372E+01 9. 4372E+01 9.4372E+01
: 9. 4372E+01 9.4372E+01
: 9. 4372E+01 9. 4372E+01 9. 4372E+01 9.4372E+01 9.4372E+01
: 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 2. 9362E+00 Worst Two-Hour Doses####################################################################
Exclusion Time (hr)24.0 Area Boundary Whole Body Thyroid (rem) (rem)8.0076E-01 6.1995E+01 TEDE (rem)2.7090E+00
....L .U.. ... N. N.... ..... ... .... ... ....' N... 1 I PA E N .4 I I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 44 1 ATTACHMENT C ocfhaikr.nif FILE Nuclide Inventory Name: OC general Power Level: 0.1000E+01 Nuclides: 60 Nuclide 001: Kr-83m 1 0.6696E+04 0.8300E+02 0.4150E+04 none 0.0000E+00 none 0.OOOOE+00 none 0.0000E+00 Nuclide 002: Kr-85m 1 0.1612800000E+05 0.8500E+02
: 6. 94E+03 Kr-85 0.2100E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 003: Kr-85 1 0.338613048E+09 0.8500E+02
: 8. 06E+02 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 004: Kr-87 1 0.45780 0.8700E 1 .29E+0 Rb-87 none none Nuclide Kr-88 1'00000E+04
+02'4 0. 1000E+01 0.0000E+00 0.0000E+00 005: 0.1022400000E+05 0.8800E+02 1.83E+04 Rb-88 0.1000E+none 0.OOOOE+none 0.OOOOE+Nuclide 006: Kr-89 1 0.1896E+03 0.8900E+02 01 00 00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.45 3. 98E+04 Sr-89 none none Nuclide 0 Rb-86 3 0. 1000E+01 0.0000E+00 0.0000E+00 07: 0.1612224000E+07 0.8600E+02 0.403E+02 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 008: Sr-89 5 0.4363200000E+07 0.8900E+02 3.99E+03 none 0.0000E+00 none 0.0000E+00 none 0.OOOOE+00 Nuclide 009: Sr-90 5 0.9189573120E+09 0.9000E+02 6.12E+02 Y-90 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 010: Sr-91 5 0.3420000000E+05
: 0. 9100E+02 1.75E+04 Y-91m 0.5800E+00 Y-91 0.4200E+00 none 0.0000E+00 Nuclide 011: Sr-92 5 0.9756000000E+04 0.9200E+02
: 2. 61E+04 Y-92 0.1000E+01 none 0.OOOOE+00 none 0.0OOOE+00 Nuclide 012: Y-90 9 0.2304000000E+06 0.9000E+02 3.42E+03 none 0.0000.E00 none o.ooo0E+00 none 0.0000E+00 Nuclide 013: Y-91 9 0.5055264000E+07
: 0. 9100E+02 I CALCULATION NO. C-1302-822-E310-082 9 REV. No. 1 1 PAGE NO. 46 3 .27E+04 none none none Nuclide 0 Y-92 9 o.0000E+00 o.OOOOE+00 o.OOOOE+00 14: 0.1274400000E+05 0.9200E+02
: 3. 37E+04 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 015: Y-93 9 0.3636000000E+05 0.9300E+02 3.87E+04 Zr-93 0.1000E+01 none 0.OOOOE+00 none 0.0000E+00 Nuclide 016: Zr-95 9 0.5527872000E+07 0.9500E+02 4 .42E+04 Nb-95m 0.7000E-Nb-95 0.9900E+02 00 none Nuclide Zr-97 9 0.0000E+00 017: 0.6084000000E+05 0.9700E+02 4.37E+04 Nb-97m 0.9500E+00 Nb-97 0.5300E-01 none 0.0000E+00 Nuclide 018: Nb-95 9 0.3036960000E+07 0.9500E+02
: 4. 46E+04 none 0.0000E+00 none 0.OOOOE+00 none 0.0000E+00 Nuclide 019: Mo-99 7 0.2376000000E+06 0.9900E+02 4.70E+04 Tc-99m 0.8800E+00 Tc-99 0.1200E+00 none 0.OOOOE+00 Nuclide 020: Tc-99m 7 0.2167200000E+05 0.9900E+02 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 47 4. 11E+04 Tc-99 none none Nuclide 0 Ru-103-7 0.1000E+01 0.OOOOE+00 0.0000E+00 21: 0.3393792000E+07 0.1030E+03
: 3. 98E+04 Rh-103m 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 022: Ru-105 7 0.1598400000E+05
: 0. 1050E+03 2.57E+04 Rh-105 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 023: Ru-106-7 0.3181248000E+08
: 0. 1060E+03 1.41E+04 Rh-106 0.1000E+01 none 0.OOOOE+00 none 0.0000E+00 Nuclide 024: Rh-105 7 0.1272960000E+06
: 0. 1050E+03 2.49E+04 none 0.0000E+00 none 0.0000E+00 none 0.OOOOE+00 Nuclide 025: Sb-127 4 0.3326400000E+06
: 0. 1270E+03 2.33E+03 Te-127m 0.1800E+00 Te-127 0.8200E+00 none 0.0000E+00 Nuclide 026: Sb-129 4 0.1555200000E+05 0.1290E+03
: 0. 803E+04 Te-129m 0.2200E+00 Te-129 0.7700E+00 none 0.OOOOE+00 Nuclide 027: Te-127 4 0.3366000000E+05 0.1270E+03 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 48 1 2. 32E+03 none none none Nuclide Te-127m 4 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 28: 0.9417600000E+07 0 .1270E+03 3. 12E+02 Te-127 0.9800E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 029: Te-129 4 0.4176000000E+04
: 0. 1290E+03 7. 93E+03 1-129 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 030: Te-129m 4 0 *2903040000E+07
: 0. 1290E+03 1. 21E+03 Te-129 0.6500E+00 1-129 0.3500E+00 none 0.0000E+00 Nuclide 031: Te-131m 4 0.1080000000E+06
: 0. 1310E+03 3. 77E+03 Te-131 0.2200E+(1-131 0.7800E+(00 00 none Nuclide Te-132 0.O0OOE+00 032: 4 0.2815200000E+06 0 .1320E+03 3.60E+04 1-132 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 033: 1-131 2 0.6946560000E+06 0.1310E+03 4.016E+04 Xe-131m 0.1100E-01 none 0.OOOOE+00 none 0.OOOOE00 Nuclide 034: 1-132 2 0.8280000000E+04
: 0. 1320E+03 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 49 1 3. 66E+04 none 0.OOOOE+-none O.OOOOE+'none 0.OOOOE+'Nuclide 035: 1-133 2 0.7488000000E+05 0.1330E+03 5.18E+04 Xe-133m 0.2900E-4 Xe-133 0.9700E+none 0.0000E+'Nuclide 036: 1-134 00 00 00 01 00 00 2 0.3156000000E+04
: 0. 1340E+03 5. 60E+04 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 037: 1-135 2 0.2379600000E+05
: 0. 1350E+03 4. 82E+04 Xe-135m 0.1500E+00 Xe-135 0.8500E+00 none 0.0000E+00 Nuclide 038: Xe-133 1 0,4531680000E+06
: 0. 1330E+03 5.23E+04 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 039: Xe-133m 1 0.1926720000E+06 0.1330E+03 1.38E+03 Xe-133 0.1000E+01 none 0.OOOOE+00 none 0.OOOOE+00 Nuclide 040: Xe-135 1 0.3272400000E+05
: 0. 1350E+03 1.81E+04 Cs-135 0.1000E+/-01 none 0.ooo0E+00 none 0.OOOOE+00 Nuclide 041: Xe-135m 1 0.91800000E+03
: 0. 1350E+03 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 50 1. 56E+04 Xe-135 0.9940E+00 Cs-135 0.6000E-03 none 0.0000E+00 Nuclide 042: Xe-137 1 0.230400000E+03
: 0. 1370E+03 5. 10E+04 Cs-137 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 043: Xe-138 1 0.85200000E+03
: 0. 1380E+03 4. 78E+04 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 044: Cs-134 3 0.6507177120E+08
: 0. 1340E+03 4.83E+03 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 045: Cs-136 3 0.1131840000E+07
: 0. 1360E+03 1.39E+03 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 046: Cs-137 3 0.9467280000E+09
: 0. 1370E+03 4.56E+03 Ba-137m 0.9500E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 047: Ba-137m 3 0.15300000E+03
: 0. 1370E+03 1.81E+03 none 0.OOOOE+00 none 0.0000E+00 none U.UUUU0I+Nuclide 048: Ba-139 6 0.4962000000E+04 0.1390E+03 0U CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 51 4. 61E+04 none none none Nuclide 0 Ba-140 6 o.0000E+00 o.0000E+00 o.0000E+00 49: 0.1100736000E+07 0.1400E+03 4 .51E+04 La-140 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 050: La-140 9 0.1449792000E+06 0 .1400E+03 4. 63E+04 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 051: La-141 9 0.1414800000E+05 0 .1410E+03 4. 26E+04 Ce-141 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 052: La-142 9 0.5550000000E+04
: 0. 1420E+03 4. 12E+04 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 053: Ce-141 8 0.2808086400E+07
: 0. 1410E+03 4 .31E+04 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 054: Ce-143 8 0.1188000000E+06 0 .1430E+03 3.98E+04 Pr-143 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 055: Ce-144 8 0. 2456352000E+08
: 0. 1440E+03 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 52 3.48E+04 Pr-144m Pr-144 none Nuclide 0 Pr-143 9 0. 1800E-01 0.9800E+00 0.0000E+00 56: 0,1171584000E+07 0 1430E+03 3. 97E+04 none 0.0000E+00 none 0.0000E+00 none 0.0000E+00 Nuclide 057: Nd-147 9 0.9486720000E+06
: 0. 1470E+03 1.68E+04 Pm-147 0.1000E+01 none 0.0000E+00 none 0.0000E+00 Nuclide 058: Np-239 8 0 '2034720000E+06 0.2390E+03 5.07E+05 Pu-239 0.1000E+01 none 0.OOOOE+00 none 0.OOOOE+00 Nuclice 059: Pu-238 8 0.2768863824E+10 0.2380E+03
: 1. 04E+02 U-234 0.1000E+01 none 0.OOOOE+00 none 0.0000E+00 Nuclide 060: Pu-239 8 0.7594336440E+12 0.2390E+03 1.43E+01 U-235 0.1000E+01 none 0.0000E+00 none 0.OOOOE+00 End of Nuclear Inventory File I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 53 ATTACHMENT D oc fha.rft File Release Fraction and Timing Name: oc fha.rft Duration (h) : Design Basis Accident 0.10O0E-05 O.OOOOE+00 0.OOOE+00 Noble Gases: 5.OOOE-02 Iodine: 2.5000E-04 Cesium: o.OOOE+00 Tellurium:
o.OOOE+00 Strontium:
0.OOOE+00 Barium: o.OOOOE+00 Ruthenium:
o.OOOE+00 Cerium: o.OOOOE+00 Lanthanum:
O.OOOOE+00 o.0000E+00 o .COOOOE-i-O o .OO0OE+00 o .O0OE+/-00 o .OOOOE+O0 o .O0O0OOE0 0 .OOOE+/-00 o .OO0E+00 o.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.0000E+00 o.OOOOE+00 o.OOOOE+00 o.OOOOE+00 0.0000E+00 0.OOOOE+00 o.OOOOE+00 0.0000E+00 o.OOOOE+00 0.0000E+00 o.OOOOE+00 o.OOOOE+00 0.0000E+00 o.0000E+00 o.OOOOE+00 0.OOOOE+00 Non-Radioactive Aerosols (kg): 0.OOOOE+00 0.OOOOE+00 End of Release File 0.OOOOE+00 CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 PAGE NO. 54 ATTACHMENT E Control Room vs. HVAC Flow Sensitivity Study and associated RADTRAD output The purpose of this attachment is to demonstrate the most limiting Control Room dose as a function of CR flow rate. Values were chosen to bound all modes of control room operation from the expected 2,000 cfm for the partial recirculation mode to the maximum 28,000 cfm for the purge mode with 2 fans operating.
Values beyond 28,000 cfm are not reasonable as 28,000 cfm is the maximum flow rate possible within the CR in the unlikely event 2 fans are operating.
RADTRAD supplemental time steps were chosen to ensure the accuracy over periods of rapid release. High air change rates cause the activity to move quicker between compartments and greater integrational accuracy is needed to determine the mathematically determined Control Room dose. As such, CR flow rates over 1,000 cfm were treated with greater accuracy.Supplemental CR flow Supplemental time steps from CR TEDE rate time ses 26-end of dose 24-26 hrs acdn accident 50 0.01 0.1 2.69E+00 100 0.01 0.1 2.83E+00 200 0.01 0.1 2.89E+00 300 0.01 0.1 2.90E+00 400 0.01 0.1 2.91 E+00 500 0.01 0.1 2.92E+00 600 0.01 0.1 2.92E+00 700 0.01 0.1 2.93E+00 800 0.01 0.1 2.93E+00 900 .0.01 0.1 2.93E+00 1000 0.002 0.002 2.93E+00 2000 0.002 0.002 2.94E+00 5000 0.002 0.002 2.94E+00 10000 0.002 0.002 2.94E+00 14000 0.002 0.002 2.94E+00 15000 0.002 0.002 2.94E+00 20000 0.002 0.002 2.94E+00 25000 0.002 0.002 2.94E+00 28000 0.002 0.002 2.94E+00 CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 55 CR TEDE Dose vs. CR HVAC Flow Rate E 0)0 03 C-, 3.OOE+00 2.95E+00 2.90E+00 2.85E+00 2.80E+00 2.75E+00 2.70E+00 2.65E+00 2.60E+00 2.55E+00 Co C 00 00 00 00 00 00 00 00 0-CN C ) C 0 0 0 O C O0 00 0 00 0 0 0 0D C14 co. 't LO Co t1- 00 0) C) C C)D. C) CO C C C) CD-- (N L' O " It ) LO IC ) C C- IIF- C4 wN (N CR HVAC Flow Rate The above graph and table demonstrates the most bounding Control Room dose first occurs at 2,000 cfm. After.2,000 cfm, no significantly greater control room dose occurs for increased Control Room HVAC flows. The Control Room dose at 2,000 cfm is used in the analysis as the conservative bounding dose value. The above graph indicates many points of evaluation, however, additional .RADTRAD runs are included for only the following CR intake and exhaust flow rates of 50 cfm, 200 cfm, 1,000 cfm,. 5,000 cfm, 10,000 cfm, 14,000 cfm, 20,000 cfm, and 28,000 cfm. The sensitivity study shows that any increase in flow beyond 2,000 cfm does not cause an increase in total calculated Control Room operator dose for this Fuel Handling Accident analysis (calculated at 2,000 cfm in Attachment B).
I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE No. 56 1 50 cfm Case##########################################4############################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:43:58#######################################################################
t######################################################################
File information
#######################################################################
Plant file = C:\Program Files\radtrad3.03\OC AST\FHA 2007\FHA source release modified flow rates fixed inp file diffuse source xq less conservative iodine fractions 50 cfm time steps.psf Inventory file = c:\program files\radtrad3.03\defaults\ocfhaikr.nif Release file = c:\program files\radtrad3.03\oc ast\oc fha.rft Dose Conversion file = c:\program files\radtrad3.03\oc ast\oc60.inp
## ## # ## # # # #Radtrad 3.03 4/15/2001 50 cfm Nuclide Inventory File: c:\program files\radtrad3.03\defaults\ocfhaikr.nif Plant Power Level: 1.1310E+01 Compartments:
3 Compartment 1: Refuel Floor Airspace 3 1.0000E+02 0 0 0 0 0 Compartment 2: Environment 2 0.000OE+00 0 0 0 0 0 Compartment 3: Control Room 1 2.7500E+04 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 57 1 0 0 0 0 0 Pathways: 3 Pathway 1: Refuel Floor Airspace to Environment 1 2 2 Pathway 2: Environment to Control Room 2 3 2 Pathway 3: Control Room to Environment 3 2 2 End of Plant Model File Scenario Description Name: Plant Model Filename: Source Term: 1 i 1.OOOOE+00 c:\program files\radtrad3.03\oc ast\oc60.inp c:\program files\radtrad3.03\cc ast\oc fha.rft 2.4000E+01 1 0.OOOOE+00 5.7000E-01 4.3000E-01 1.OO0E+00 Overlying Pool: 0 0.0000E+00 0 0 0 0 Compartments:
3 Compartment 1: 0 1 0 0 0 0 0 0 0 Compartment 2: 0 1 0 0 0 0 0 0 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 58 1 0 Compartment 3: 0 1 0 0 0 0 0 0 0 Pathways: 3 Pathway 1: 0 0 0 0 0 1 2 2.4000E+01 7.6750E+00 7.4400E+02 0.OOOOE+00 0 0 0 0 0 0 Pathway 2: 0 0 0 0 0 1 2 2.4000E+01 5.0000E+01 7.4400E+02 0.OOOOE+00 0 0 0 0 0 0 Pathway 3: 0 0 0 0 0 1 2 2.4000E+01 5.OOOOE+01 7.4400E+02 0.OOOOE+00 0 0 0 0 0 0 Dose Locations:
3 o .OOOOE+00 o .OOOOE+00 o .OOOOE+/-00 o.OOOOE+00
: 0. OOOOE+/-00 O.OOOOE+/-00 o.OOOOE+00 o.OOOOE+/-00 o .OOOOE+/-00 o .OOOOE+/-00 o .OOOOE+00 o.OOOOE+0O
: 0. OOOOE&#xf7;00 0. OOOOE+00 0. OOOOE+00 0. 0000E--00 0. OOOOE+/-00 0. OOOOE+/-00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 59 Location 1: Exclusion Area Boundary 2 1 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 0 1. 4100E-03 0.0ooOE+00 3.5000E-04 1.8000E-04 2.3000E-04 O.OOOOE+00 Location 2: Low Population Zone 2 1 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01
: 3. 2000E+01 4.8000E+01 7.4400E+02 0 Location 3: Control Room 3 0 1.3500E-04 0.OOOOE+00 3.5000E-04 1.80OOE-04 2.3000E-04 0.0000E+00 1 2 2.4000E+01 3.5000E-04 7.4400E+02 0.OOOOE+00 1 4 2.4000E+01 1.0000E+00 4.8000E+01 6.OOOOE-01 1.2000E+02 4.OOOOE-01 7.4400E+02 0.OOOOE+00 Effective Volume Location: 1 2 2.4000E+01 2.1500E-03 7.4400E+02 0.OOOOE+00 Simulation Parameters:
3 2.4000E+01 1.OOOOE-02 2.6000E+01 1.OOOOE-01 7.4400E+02 0.OOOOE+00 Output Filename: C:\Program Files\radtrad3.o762 1 1 1 0 0 End of Scenario File CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 60###f####################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:43:58########################################################4###############
#############################4##########################################
Plant Description
#################################################i######################
Number of Nuclides = 60 Inventory Power = 1.0000E+00 MWth Plant Power Level = 1.1310E+01 MWth Number of compartments
= 3 Compartment information Compartment number 1 (Source term fraction = 1.0000E+00 Name: Refuel Floor Airspace Compartment volume = 1.0000E+02 (Cubic feet)Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Refuel Floor Airspace to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: Refuel Floor Airspace to Environment Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 2.7500E+04 (Cubic feet)Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Total number of pathways 3 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO.61############4#############~#####f################4#####
#############4(4#####
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:43:58#######################################################################
Scenario Description Time between shutdown and first release Radioactive Decay is enabled Calculation of Daughters is enabled 2.4000E+01 (Hours)Release Fractions and Timings NOBLES IODINE CESIUM TELLURIUM STRONTIUM BARIUM RUTHENIUM CERIUM LANTHANUM GAP 0.000001 hr 5. 0000E-02 2. 5000E-04 0 OOOOE+00 0.0000E+00
: 0. 0000E+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 EARLY IN-VESSEL 0.0000 hrs 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 LATE RELEASE 0.0000 hrs 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 RELEASE MASS (gm)1.329E+00 1. lOOE-03 0.OOOE+00 0 .OOOE+00 0.OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 Inventory-Power
: 11. MWt Nuclide Namp Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 1-131 1-132 1-133 1-134 1-135 Xe-133 Xe-133m Xe-135 Xe-135m Xe-137 Xe-138 Nuclide Kr-85m Kr-87 Kr-88 Kr-89 Sr-90 Sr-91 Sr-92 Y-93 Zr-95 Zr-97 Mo-99 Group Specific 1 1 1 1 1 1 2 2 2 2 2 1 1 1 1 1 1 Inventory (Ci/MWt)4. 150E+03 6. 940E+03 8. 060E+02 1.290E+04 1. 830E+04 3. 980E+04 4.016E+04 3. 660E+04 5. 180E+04 5. 600E+04 4. 820E+04 5.230E+04 1.380E+03 1. 810E+04 1. 560E+04 5. 100E+04 4. 780E+04 half Whole Body life DCF (s) (Sv-m3/Bq-s) 6.696E+03 7.480E-15 1.613E+04 7.480E-15 3.386E+08 1.190E-16 4.578E+03 4.120E-14 1.022E+04 1.020E-13 1.896E+02 i.020E-13 6.947E+05 1.820E-14 8.280E+03
.1.120E-13 7.488E+04 2.940E-14 3.156E+03 1.300E-13 2.380E+04 8.294E-14 4.532E+05 1.560E-15 1.927E+05 1.560E-15 3.272E+04 1.190E-14 9.180E+02 1.190E-14 2.304E+02 1.190E-14 8.520E+02 1.190E-14 Inhaled Thyroid (Sv/Bq)0 OOOE+00 0 OOOE+00 0 OOOE+00 0 OO0E+00 0 OOOE+00 0 .OOOE+00 2. 920E-07 1. 740E-09 4. 860E-08 2. 880E-10 8. 460E-09 0. OOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 Inhaled Effective (Sv/Bq)0. OOOE+00 0;000E+00 0.OOOE+00 0.OOOE+00 0.OOOE+00 0.OOOE+00 8. 890E-09 1.030E-10 1.580E-09 3.550E-11 3.320E-10 0.OOOE+00 0.OOOE+00 0.OOOE+00 0.OOOE+00 0. OOOE+00 0. 0OOE+00 Fraction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Daughter Kr-85 Rb-87 Rb-88 Sr-89 Y-90 Y-91m Y-92 Zr-93 Nb-95m Nb-97m Tc-99m Fraction Daughter Fraction Daughter 0.21 none 0.00 none 1.00 none 0.00 none 1.00 none 0.00 none 1.00 none 0.00 none 1.00 0.58 1.00 1.00 0.01 0.95 0.88 none Y-91 none none Nb-95 Nb-97 Tc-99 0.00 0.42 0.00 0.00 0.99 0.05 0.12 none none none none none none none CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 62 Tc-99m Ru-103 Ru-105 Ru-106 Sb-127 Sb-129 Te-127m Te-129 Te-129m Te-131m Te-132 1-131 1-133 1-135 Xe-133m Xe-135 Xe-135m Xe-137 Cs-137 Ba-140 La-141 Ce-143 Ce-144 Nd-147 Np-239 Pu-238 Pu-239 Tc-99 Rh-103m Rh-105 Rh-106 Te-127m Te-129m Te-127 1-129 Te-129 Te-131 1-132 Xe-131m Xe-133m Xe-135m Xe-133 Cs-135 Xe-135 Cs-137 Ba-137m La-140 Ce-141 Pr-143 Pr-144m Pm-147 Pu-239 U-234 U-235 1.00 1.00 1.00 1.00 0.18 0.22 0.98 1.00 0.65 0.22 1.00 0.01 0.03 0.15 1.00 1.00 0.99 1.00 0.95 1.00 1.00 1.00 0.02 1.00 1.00 1.00 1.00 none none none none Te-127 Te-129 none none 1-129 1-131 none none Xe-133 Xe-135 none none Cs-135 none none none none none Pr-144 none none none none 0.00 0.00 0.00 0.00 0.82 0.77 0.00 0.00 0.35 0.78 0.00 0.00 0.97 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.98 0.00 0.00 0.00 0.00 none none none none none none none none none none none none none none none none none none none none none none none none none none none 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Iodine fractions Aerosol =Elemental
=Organic =COMPARTMENT DATA Compartment number Compartment number Compartment number 0.OOOOE+00 5.7000E-01 4.3000E-01 1: Refuel Floor Airspace 2: Environment 3: Control Room PATHWAY DATA Pathway number 1: Refuel Floor Airspace to Environment Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)7.6750E+00 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)5. OOOOE+01 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 O.OOOOE+00 Pathway number 3: Control Room to Environment I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 63 1 Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)5. OOOE+01 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.O000E+00 0.0000E+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1. 4100E-03 0.OOOOE+00 Location BreaJ Time (hr)2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 thing Rate Data Breathing Rate (m^3
* sec^-l)3.5000E-04 1.80OOE-04 2.3000E-04 0.00OOE+00 is in compartment 2 Location Low Population Zone Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1.3500E-04 0.0000E+00 Location Breathing Rate DE Time (hr) Breathi 2.4000E+01
: 3. 2000E+01 4.8000E+01 7.4400E+02 Location Control Room ing Rate (m^3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 0.0000E+00 is in compartment 3 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 Location Breathing Time (hr)2.4000E+01 7.4400E+02 Location Occupancy Time (hr)2.4000E+01 4.8000E+01 1.2000E+02 7.4400E+02 X/Q (s
* m^-3)2.1500E-03 0.0000E+00 Rate Data Breathing Rate (m^3
* sec^-l)3.5000E-04 0.0000E+00 Factor Data Occupancy Factor 1.0000E+00
: 6. 0OOOE-01 4.0O00E-01 C.0000E+00 USER SPECIFIED TIME STEP DATA -SUPPLEMENTAL TIME STEPS Time C.0000E+00 2.0000E+00 7.2000E+02 Time step 1.0000E-02
: 1. COOOE-01 C.0000E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 64#####A#################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:43:58#######################################################################
itititit it it ititititit it it it it it it it it it it it it it it it it it it it it it it itj.it it ititititit it it it it it it it ititititit it it it it it it #####iti it it it .it it it######################################################W##############
Dose Output####################################################################
Exclusion Area Boundary Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8911E-06 1.8911E-06 Low Population Zone Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8107E-07 1.8107E-07 Whole Body 4.2450E-15 4 .2450E-15 Exclusion Area Boundary Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 8.0120E-01 8.0120E-01 Thyroid 1.4300E-04 1.4300E-04 Thyroid 1.3692E-05 1.3692E-05 Thyroid 1.1894E-11 1.1894E-11 Thyroid 6. 2003E+01 6.2003E+01 Thyroid 5.9365E+00 5.9365E+00 Thyroid 5. 2829E+01 5.2829E+01 Thyroid 3.0257E-15
: 6. 2003E+01 TEDE 6.2941E-06
: 6. 2941E-06 TEDE 6.0262E-07 6.0262E-07 TEDE 3. 7045E-13 3. 7045E-13 TEDE 2.7097E+00 2.7097E+00 TEDE 2. 5944E-01 2. 5944E-01 TEDE 1.6369E+00 1.6369E+00 TEDE 1.4314E-16 2.7097E+00 Low Population Zone Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 7.6711E-02
: 7. 6711E-02 Whole Body 1.5269E-02 1.5269E-02 Exclusion Area Boundary Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 5.0483E-17 8.0120E-01 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.65 Low Population Zone Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 4.8335E-18 7.6711E-02 Whole Body 5.9942E-03 2.1263E-02 Exclusion Area Boundary Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.9705E-49 8.0120E-01 Low Population Zone Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.8441E-50
: 7. 6711E-02 Whole Body 4.6984E-04 2.1733E-02 Thyroid 2. 8969E-16 5.9365E+00 Thyroid 3. 0663E+01 8. 3493E+01 Thyroid 3.5502E-47
: 6. 2003E+01 Thyroid 3.3991E-48 5.9365E+00 Thyroid 3.5264E+00 8.7019E+01 Thyroid 2.6554-191
: 6. 2003E+01 Thyroid 2.5424-192 5.9365E+00 Thyroid 6.8009E-04 8 .7020E+01 TEDE 1.3705E-17 2.5944E-01 TEDE 9.4403E-01 2.5809E+00 TEDE 1.3816E-48.
2.7097E+00 TEDE 1.3228E-49 2.5944E-01 TEDE 1.0812E-01 2.6890E+00 TEDE 9.5846-193 2.7097E+00 TEDE 9.1767-194
: 2. 5944E-01 TEDE 2.0779E-05 2.6890E+00 Excli'3ion Area Boundary Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4969-193 8.0120E-01 Low Population Zone Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4332-194 7.6711E-02 Whole Body 6.6927E-08
: 2. 1733E-02 7383 1-131 Summary 4################4#######4######4#4#i
#4#############4fn(Time (hr)24.000 24.260 24.510 24.760 25.010 25.260 Refuel Floor Airspace 1-131 (Curies)1. 0470E+02 3. 1590E+01 9. 9812E+00.3 1536E+00 9.9641E-01
: 3. 1482E-01 Environment 1-131 (Curies)2.4107E-04 7.3050E+01 9.4641E+01 1.0146E+02 1.0362E+02 1.0430E+02 Control Room 1-131 (Curies)1.2230E-08 3.6420E-03 4.6181E-03 4.8303E-03 4.8036E-03 4.7042E-03 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 66 25.510 25.760 26.100 26.400 26.700 27.000 27.300 27.600 27.900 28.200 28.500 28.800 29.100 29.400 29.700 30.000 30.300 30.600 30.900 31.200 31.500 31.800 32.000 32.300 32.600 32.900 33.200 33.500 33.800 34.100 34.400 48.000 120.000 744.000 9. 9471E-02 3.1429E-02 6.5587E-03 1.6458E-03 4.1298E-04 1.0363E-04 2.6004E-05
: 6. 5251E-06 1.6374E-06 4.1086E-07
: 1. 0310E-07 2. 5871E-08 6. 4917E-09 1.6290E-09
: 4. 0876E-10 1.0257E-10 2.5738E-11 6.4585E-12
: 1. 6206E-12 4.0667E-13
: 1. 0205E-13 2 .5606E-14 1. 0187E-14 2. 5563E-15 6. 4144E-16 1. 6096E-16 4.0389E-17
: 1. 0135E-17 2.5432E-18
: 6. 3816E-19 1. 6013E-19 9.6443E-47 7.5382-191 0.0000E+00 1.0452E+02 1.0458E+02
: 1. 0461E+02 1. 0461E+02 1. 04 61E+02 1. 0461E+02 1. 0461E+02 1. 0461E+02 1 .04 61E+02 1. 0461E+02 1.04 61E+02 1. 0461E+02 1 .04 61E+02 1. 0461E+02 1. 0461E+02 1. 04 61E+02 1. 04 61E+02 1. 0461E+02 1. 0461E+02 1. 0461E+02 1. 04 61E+02 1 .04 61E+02 1. 0461E+02 1. 04 61E+02 1 .04 61E+02 1. 0461E+02 1. 0461E+02 1. 0461E+02 1. 0461E+02 1. 04 61E+02 1.04 61E+02 1. 0461E+02 1.0461E+02
: 1. 0461E+02 4.5842E-03 4.4603E-03 4.2939E-03 4.1514E-03
: 4. 0135E-03 3.8801E-03 3.7511E-03 3.6264E-03 3.5059E-03 3.3893E-03 3.2767E-03
: 3. 1678E-03 3.0625E-03 2.9607E-03 2.8623E-03
: 2. 7671E-03 2. 6751E-03 2.5862E-03 2.5002E-03 2.4171E-03 2.3368E-03 2.2591E-03 2.2088E-03 2.1354E-03 2.0644E-03 1.9958E-03 1.9294E-03 1.8653E-03 1.8033E-03 1.7433E-03 1.6854E-03 3.6404E-04 1.0905E-07 3.1663E-38
##################################C#################################
Cumulative Dose Summary########0############################################################
Exclusion Area Bounda Low Populatio Time Thyroid TEDE Thyroid (hr)24.000 24.260 24.510 24.760 25.010 25.260 25.510 25.760 26.100 26.400 26.700 27.000 27.300 27.600 27.900 28.200 28.500 28.800 29.100 29.400 29.700 (rem)0.0000E+00 4.3316E+01
: 5. 6105E+01 6.0141E+01 6.1415E+01
: 6. 1818E+01 6. 1945E+01 6. 1985E+01 6. 1999E+01 6. 2002E+01 6.2003E+01
: 6. 2003E+01 6. 2003E+01 6. 2003E+01 6. 2003E+01 6.2003E+01
: 6. 2003E+01 6. 2003E+01 6. 2003E+01 6.2003E+01
: 6. 2003E+01 (rem)0.0000E+00 1.8993E+00 2.4554E+00 2.6299E+00 2.6846E+00
: 2. 7018E+00 2.7072E+00
: 2. 7089E+00 2. 7096E+00 2. 7097E+00 2. 7097E+00 2.7097E+00 2.7097E+00
: 2. 7097E+00 2.7097E+00
: 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 (rem)0.OOOOE+00
: 4. 1472E+00 5. 3717E+00 5.7582E+00 5.8802E+00
: 5. 9187E+00 5.9309E+00 5.9347E+00 5.9361E+00 5.9364E+00 5.9364E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 0.0 1.8 2.3 2.5 2.'5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.2.5 2.5 2.5 2.5 n Zone Control Room TEDE Thyroid TEDE (rem) (rem) (rem)(000E+00 0.OOOOE+00 0.0000E+00 184E-01 1.1070E+00 3.4464E-02 3509E-01 3.1629E+00 9.8435E-02 179E-01 5.4698E+00 1.7018E-01 704E-01 7.8084E+00 2.4287E-01 869E-01 1.0111E+01 3.1440E-01 920E-01 1.2357E+01 3.8415E-01 5937E-01 1.4541E+01 4.5197E-01 5943E-01 1.7414E+01 5.4111E-01 944E-01 1.9856E+01 6.1689E-01 944E-01 2.2216E+01 6.9004E-01 5944E-01 2.4494E+01 7.6066E-01 5944E-01 2.6695E+01 8.2884E-01 5944E-01 2.8820E+01 8.9467E-01 5944E-01 3.0873E+01 9.5823E-01 5944E-01 3.2855E+01 1.0196E+00 5944E-01 3.4770E+01 1.0789E+00 5944E-01 3.6620E+01 1.1361E+00 5944E-01 3.8406E+01 1.1913E+00 5944E-01 4.0132E+01 1.2447E+00 5944E-01 4.1799E+01 1.2962E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.67 30.000 30.300 30. 600 30. 900 31.200 31.500 31.800 32.000 32.300 32.600 32.900 33.200 33.500 33.800 34.100 34.400 48.000 120.000 744.000 6. 2003E+01 6. 2003E+01 6.2003E+01 6.2003E+01
: 6. 2003E+01 6. 2003E+01 6.2003E+01
: 6. 2003E+01 6.2003E+01 6.2003E+01 6.2003E+01 6.2003E+01 6.2003E+01
: 6. 2003E+01 6.2003E+01 6.2003E+01
: 6. 2003E+01 6.2003E+01 6.2003E+01 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 2.7097E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00
: 5. 9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 2.5944E-01 4.3409E+01 4.4964E+01 4.6467E+01 4.7918E+01 4.9320E+01 5.0674E+01 5.1982E+01 5.2829E+01 5.4064E+01 5.5257E+01 5.6410E+01 5.7523E+01 5.8599E+01 5.9638E+01
: 6. 0642E+01 6.1612E+01 8.3493E+01 8.7019E+01 8.7020E+01 1.3460E+00 1.3940E+00 1.4404E+00 1.4852E+00 1.5285E+00 1.5703E+00 1.6107E+00 1.6369E+00
: 1. 6750E+00 1.7118E+00 1.7473E+00 1.7817E+00 1.8148E+00 1.8469E+00 1.8778E+00 1.9077E+00 2.5809E+00 2.6890E+00 2.6890E+00
#44#########################################################4 Worst Two-Hour Doses###.4###44#44#4#######
############
###################
#################
Exclusion Time (hr)24.0 Area Boundary Whole Body Thyroid (rem) (rem)8.0111E-01 6.1995E+01 TEDE (rem)2.7094E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO.68 ]200 cfm Case#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:46:21#######################################################################
#######################################################################
File information
##############4#########################################################
Plant file = C:\Program Files\radtrad3.03\OC AST\FHA 2007\FHA source release modified flow rates fixed inp file diffuse source xq less conservative iodine fractions 200 cfm time steps.psf Inventory file = c:\program files\radtrad3.03\defaults\ocfhaikr.nif Release file = c:\program files\radtrad3.03\oc ast\oc fha.rft Dose Conversion file = c:\program files\radtrad3.03\oc ast\oc60.inp t t t t t ii i .it i Radtrad 3.03 4/15/2001 200 cfm Nuclide Inventory File: c:\program files\radtrad3.03\defaults\ocfhaikr.nif Plant Power Level: 1. 1310E+01 Compartments:
3 Compartment 1: Refuel Floor Airspace 3 1.0000E+02 0 0 0 0 0 Compartment 2: Environment 2 0.0000E+00 0 0 0 0 0 Compartment 3: Control Room 1 2.7500E+04 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 [ PAGE NO. 69:]0 0 0 0 0 Pathways: 3 Pathway 1: Refuel Floor Airspace to Environment 1 2 2 Pathway 2:.Environment to Control Room 2 3 2 Pathway 3: Control Room to Environment 3 2 2 End of Plant Model File Scenario Description Name: Plant Model Filename: Source Term: 1 1 1.0OOOE+00 c:\program files\radtrad3.03\oc ast\oc60.inp c:\program files\radtrad3.03\oc ast\oc fha.rft 2.4000E+01 1 0.OOOOE+00 5.7000E-01 4.3000E-01 1.0000E+00 Overlying Pool: 0 o.0000E+00 0 0 0 0 Compartments:
3 Compartment 1: 0 1 0 0 0 0 0 0 0 Compartment 2: 0 1 0 0 0 0 0 0 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO.70 0 Compartment 3: 0 1 0 0 0 Pathways: 3 Pathway 1: C 0 0 0 0 1 2 2 .4000E+01 7. 4400E+02 0 0 0 0 0 0 Pathway 2: 0 0 0 0 0 1 2 2 .4000E+01 7. 4400E+02 0 0 0 C 0 0 Pathway 3: 0 0 0 0 0 1 2 2. 4000E+01 7.4400E+02 0 0 0 0 0 Dose Locations 3 7.6750E+00 o.0000E+00 2.0000E+02 0.0000E+00 2.0O00E+02 o.0000E+00 o .CCCE+CC o .CCOCE+/-C o .CCCE+CC o .CCCE+CC o .CCCE+CC o .CCOE+CC o .0000E+00 C.0O00E+00 o.0000E+00 0.0000E+00 o.O000E+00 6.O000E+O0 o .CCCE+CC C. CCCCE+/-CC C. CCCCE+CO C. CCOCE+/-CC C. CCCCE+CC C. CCCCE+CC I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 71 ]Location 1: Exclusion Area Boundary 2 1 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 0 1. 4100E-03 0.0000E+00 3.5000E-04 1.8000E-04 2.3000E-04 o.OOOOE+00 Location 2: Low Population Zone 2 1 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01 3.2000E+01
: 4. 8000E+01 7.4400E+02 0 Location 3: Control Room 3 0 1 2 2.4000E+01 7.4400E+02 1 1.3500E-04 0.OOOE+00 3.5000E-04 1.8000E-04 2.3000E-04 O.OOOE+00 3.5000E-04 0.OOOOE+00 4 2.4000E+01 1.OOOOE+00 4.8000E+01 6.0000E-01 1.2000E+02 4.0000E-01 7.4400E+02 O.OOOOE+00 Effective Volume Location: 1 2 2.4000E+01 2.1500E-03 7.4400E+02 0.0000E+00 Simulation Parameters:
3 2.4000E+01 1.OOOOE-02 2.6000E+01 1.0000E-01 7.4400E+02 O.OOOOE+00 Output Filename: C:\Program Files\radtrad3.o763 1 1 1 0 0 End of Scenario File CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 72#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:46:21###########0############################################################
Plant Description
#######################################################################
Number of Nuclides = 60 Inventory Power = 1.0000E+00 MWth Plant Power Level = 1.1310E+01 MWth Number of compartments
= 3 Compartment information Compartment number 1 (Source term fraction = 1.0000E+00 Name: Refuel Floor Airspace Compartment volume = 1.0000E+02 (Cubic feet)Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Refuel Floor Airspace to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: Refuel Floor Airspace to Environment Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume= 2.7500E+04 (Cubic feet)Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Total number of pathways = 3 CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.73 RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:46:21#######################################################################
Scenario Description
##################################################0#####################
Time between shutdown and first release =Radioactive Decay is enabled Calculation of Daughters is enabled Release Fractions and Timings GAP EARLY IN-VESSEL 0.000001 hr 0.0000 hrs NOBLES 5.0000E-02 0.OOOOE+00 IODINE 2.5000E-04 0.OOOOE+00 CESIUM 0.0000E+00 0.0000E+00 TELLURIUM 0.OOOOE+00 0.0000E+00 STRONTIUM 0.0000E+00 0.OOOOE+00 BARIUM 0.OOOOE+00 0.OOOOE+00 RUTHENIUM 0.OOOOE+00 0o0000E+00 CERIUM 0.0000E+00 0.0000E+00 LANTHANUM 0.0000E+00 0.OOOOE+00 2.4000E+01 (Hours)LATE RELEASE 0.0000 hrs 0.OOOOE+00 0.0000+E00 O.OOOOE+00 0.0000E+00 0.OOOOE+00 0.0O00E+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 RELEASE MASS (gm)1. 329E+00 1 .100E-03 0. OOOE+00 0. OOOE+00 0. OOOE+00 0 .000E+00 0 .OOOE+00 0 .000E+00 0. OOOE+00 Inventory Power 11. MWt Nuclide Name Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 1-131 1-132 1-133 1-134 1-135 Xe-133 Xe-133m Xe-135 Xe-135m Xe-137 Xe-138 Nuclide Kr-85m Kr-87 Kr-88 Kr-89 Sr-90 Sr-91 Sr-92 Y-93 Zr-95 Zr-97 Mo-99 Group Specific Inventory (Ci/MWt)1 4.150E+03 1 6.940E+03 1 8.060E+02 1 l.290E+04 1 l.830E+04 1 3. 980E+04 2 4. 016E+04 2 3.660E+04 2 5. 180E+04 2 5.600E+04 2 4. 820E+04 1 5.230E+04 1 1.380E+03 1 1.810E+04 1 .560E+04 1 5.100E+04 1 4-780E+04 half life (s)6. 696E+03 1. 613E+04 3. 386E+08 4. 578E+03 1. 022E+04 1. 896E+02 6. 947E+05 8. 280E+03 7 488E+04 3. 156E+03 2. 380E+04 4. 532E+05 1 927E+05 3. 272E+04 9. 180E+02 2. 304E+02 8. 520E+02 Whole Body DCF (Sv-m3/Bq-s) 7.480E-15 7.480E-15 1.190E-16 4.120E-14 1.020E-13 1.020E-13 1.820E-14 1.120E-13 2. 940E-14 1.300E-13 8.294E-14 1. 560E-15 1.560E-15 1.190E-14 1.190E-14 1.190E-14 1.190E-14 Inhaled Thyroid (Sv/Bq)0. OOOE+00 0. 000E+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 2. 920E-07 1. 740E-09 4.860E-08 2. 880E-10 8.4 60E-09 0. OOOE+00 0. OOOE+00 0. 000E+00 0. OOOE+00 0. 000E+00 0. OOOE+00 Daughter none none none none none none none none none none none Inhaled Effective (Sv/Bq)0 OOOE+00 0 OOOE+00 0. 0OE+00 0 000E+00 0. OOOE+00 0. OOOE+00 8. 890E-09 1. 030E-10 1. 580E-09 3. 550E-11 3. 320E-10 0 .OQE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0 .OOOE&#xf7;00 Fraction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Daughter Kr-85 Rb-87 Rb-88 Sr-89 Y-90 Y-91m Y-92 Zr-93 Nb-95m Nb-97m Tc-99m Fraction 0.21 1.00 1.00 1.00 1.00 0.58 1.00 1.00 0.01 0.95 0.88 Daughter none none none none none Y-91 none none Nb-95 Nb-97 Tc-99 Fraction 0.00 0.00 0.00 0.00 0.00 0.42 0.00 0.00 0.99 0.05 0.12 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 74 Tc-99m Ru-103 Ru-105 Ru-106 Sb-127 Sb-129 Te-127m Te-129 Te-129m Te-l131m Te-132 1-131 1-133 1-135 Xe-133m Xe-135 Xe-135m Xe-137 Cs-137 Ba-140 La-141 Ce-143 Ce-144 Nd-147 Np-239 Pu-238 Pu-239 Tc-99 Rh-103m Rh-105 Rh-106 Te-127m Te-129m Te-127 1-129 Te-129 Te-131 1-132 Xe-131m Xe-133m Xe-135m Xe-133 Cs-135 Xe-135 Cs-137 Ba-137m La-140 Ce-141 Pr-143 Pr-144m Pm-147 Pu-239 U-234 U-235 1.00 1.00 1.00 1.00 0.18 0.22 0.98 1.00 0.65 0.22 1.00 0.01 0.03 0.15 1.00 1.00 0.99 1.00 0.95 1.00 1.00 1.00 0.02 1.00 1.00 1.00 1.00 none none none none Te-127 Te-129 none none 1-129 1-131 none none Xe-133 Xe-135 none none Cs-135 none none none none none Pr-144 none none none none 0.00 0.00 0.00 0.00 0.82 0.77 0.00 0.00 0.35 0.78 0.00 0.00 0.97 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.98 0.00 0.00 0.00 0.00 none none none none none none none none none none none none none none none.none none none none none none none none none none none none 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Iodine fractions Aerosol Elemental Organic COMPARTMENT DATA= 0.OOOOE+00
-5.7000E-01 S4. 3000E-01 Compartment number Compartment number Compartment number 1: Refuel Floor Airspace 2: Environment 3: Control Room PATHWAY DATA Pathway number 1: Refuel Floor Airspace to Environment Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)7.6750E+00 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)2.OOOOE+02 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOOOE+00 "0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 3: Control Room to Environment I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 75 Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)2.0000E+02 C.0000E+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.C000E+00 0.OC00E+00 0.O000E+00 0.0000E+00 0.0000E+00 D.0000E+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr)2. 4000E+01 7.4400E+02 X/Q (s
* m^-3)1.410CE-03 C.0000E+00 Location Breathing Rate Data Time (hr) Breathing 2.4000E+01 3.2000E+01
: 4. 8000E+01 7.4400E+02 Location Low Population Zone Rate (m^3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 C.C000E+00 is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1.3500E-04 C.0000E+00 Location Breathing Rate Data Time (hr) Breathing 2. 4000E+01 3. 2000E+01 4. 8000E+01 7.4400E+02 Location Control Room is Rate (mW3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 C.0CCCE+00 in compartment 3 Location X/Q Data Time (hr) X/Q (s
* m^-3)2.4000E+01 2.15CDE-03 7.4400E+02 C.0000E+00 Location Breathing Rate Data Time (hr) Breathing Rate (mW3
* sec^-l)2.4000E+01 3.5000E-04 7.4400E+02 C.00C0E+00 Location Occupancy Factor Data Time (hr) Occupancy Factor 2.4000E+01 1.COCE+00 4.8000E+01 6.C000E-01 1.2000E+02 4.0000E-01 7.4400E+02 0.CC0CE+00 USER SPECIFIED TIME STEP DATA -SUPPLEMENTAL TIME STEPS Time Time step 0.0C0CE+00 1.00C0E-02 2.0000E+00 1.0000E-01 7.2000E+02 C.CCC0E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 [ PAGE NO. 76#############################################################1#########
RADTEAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:46:21#######################################################################
#### #it it it ititititit it it it it it it it it it it it it it it it it it it it it it #####################################################################
Dose Output###################################################a################
Exclusion Area Boundary Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8911E-06 1.8911E-06 LOw Population Zone Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8107E-07
: 1. 8107E-07 Whole Body 1.6980E-14
: 1. 6980E-14 Exclusion Area Boundary Doses: Time (h) = 32.0000 Whole Body Delta dose (rem) 8.0120E-01 Accumulated dose (rem) 8.0120E-01 Thyroid 1.4300E-04 1.4300E-04 Thyroid 1.3692E-05 1.3692E-05 Thyroid 4. 7575E-11 4.7575E-11 Thyroid 6. 2003E+01 6. 2003E+01 Thyroid 5.9365E+00 5.9365E+00 Thyroid 9. 0051E+01 9. 0051E+01 Thyroid 3. 0257E-15 6. 2003E+01 TEDE 6. 2941E-06 6.2941E-06 TEDE 6.0262E-07 6.0262E-07 TEDE 1.4818E-12 1.4818E-12 TEDE 2.7097E+00 2.7097E+00 TEDE 2.5944E-01
: 2. 5944E-01 TEDE 2.7944E+00 2.7944E+00 TEDE 1.4314E-16 2.7097E+00 Low Population Zone Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 7.6711E-02
: 7. 6711E-02 Whole Body 2.7787E-02 2.7787E-02 Exclusion Area Boundary Doses: Time (h) = 48.0000 Whole Body Delta dose (rem) 5.0483E-17 Accumulated dose (rem) 8.0120E-01 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 77 1 Low Population Zone Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 4. 8335E-18 7.6711E-02 Whole Body 6.4322E-04 2.8430E-02 Exclusion Area Boundary Doses: Time (h) = 120.0000 Whole Body Delta dose (rem) 2.9705E-49 Accumulated dose (rem) 8.0120E-01 Low Population Zone Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.8441E-50 7.6711E-02 Whole Body 2.1853E-07 2.8430E-02 Thyroid 2. 8969E-16 5.9365E+00 Thyroid 2.9774E+00
: 9. 3028E+01 Thyroid 3.5502E-47
: 6. 2003E+01 Thyroid 3. 3991E-48 5.9365E+00 Thyroid 1.5234E-03
: 9. 3030E+01 Thyroid 2.6554-191 6.2003E+01 Thyroid 2.5424-192 5.9365E+00 Thyroid 1.7045E-17 9.3030E+01 TEDE 1. 3705E-17 2.594 4E-01 TEDE 9. 1782E-02 2. 886iE+00 TEDE 1.3816E-48 2.7097E+00 TEDE 1.3228E-49 2.5944E-01 TEDE 4.6745E-05 2.8862E+00 TEDE 9.5846-193 2.7097E+00 TEDE 9.1767-194
: 2. 5944E-01 TEDE 5.2084E-19 2.8862E+00 Exclusion Area Boundary Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4969-193 8.0120E-01 Low Population Zone Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4332-194
: 7. 6711E-02 Whole Body 1. 6976E-21 2.8430E-02 7383 1-131 Summary#######################h#####i#i#i(i#i#i####il(#4###4###
####)(i###i(Time (hr)24.000 24.260 24.510 24.760 25.010 25.260 Refuel Floor Airspace 1-131 (Curies)1.0470E+02 3.1590E+01
: 9. 9812E+00 3.1536E+00 9.9641E-01 3.1482E-01 Environment 1-131 (Curies)2.4107E-04 7.3050E+01 9.4641E+01
: 1. 0146E+02 1.0362E+02 1.0430E+02 Control Room 1-131 (Curies)4.8921E-08 1.3852E-02
: 1. 6516E-02 1.6094E-02 1.4827E-02
: 1. 3412E-02 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 78 1 25.510 25.760 26.100 26.400 26.700 27.000 27.300 27. 600 27 .900 28.200 28.500 28.800 29.100 29. 400 29.700 30.000 30.300 30.600 30. 900 31.200 31.500 31.800 32.000 32.300 32. 600 32. 900 33.200 33.500 33.800 34.100 34 .400 48.000 120.000 744.000 9.9471E-02
: 3. 1429E-02 6.5587E-03 1.6458E-03 4.1298E-04 1.0363E-04 2.6004E-05
: 6. 5251E-06 1.6374E-06 4.1086E-07 1.0310E-07
: 2. 5871E-08 6. 4917E-09 1.6290E-09
: 4. 0876E-10 1. 0257E-10 2.5738E-11
: 6. 4585E-12 1. 6206E-12 4.0667E-13
: 1. 0205E-13 2. 5606E-14 1. 0187E-14 2. 5563E-15 6. 4144E-16 1. 6096E-16 4. 0389E-17 1. 0135E-17 2.5432E-18
: 6. 3816E-19 1. 6013E-19 9.6443E-47 7.5382-191 0.0000E+00 1.0452E+02 1.0458E+02
: 1. 0461E+02 1 .04 61E+02 1. 0461E+02 1. 04 61E+02 1 .04 61E+02 1. 0461E+02 1. 0461E+02 1 .04 61E+02 1. 0461E+02 1.04 61E+02 1 .04 61E+02 1. 0461E+02 1. 0461E+02 1. 0461E+02 1. 0461E+02 1. 0461E+02 1. 04 61E+02 1. 0461E+02 1. 0461E+02 1. 0461E+02 1.0461E+02
: 1. 0461E+02 1. 0461E+02 1 .04 61E+02 1. 0461E+02 1. 0461E+02 1 .04 61E+02 1. 0461E+02 1. 0461E+02 1. 04 6iE+02 1 .04 61E+02 1. 0461E+02 1.2056E-02
: 1. 0814E-02 9. 3158E-03 8. 1648E-03 7.1555E-03 6.2708E-03 5.4955E-03
: 4. 8160E-03 4.2205E-03 3.6986E-03
: 3. 2413E-03 2.8405E-03 2.4893E-03 2.1815E-03
: 1. 9118E-03 1.6754E-03 1.4682E-03 1.2867E-03
: 1. 1276E-03 9. 8817E-04 8.6598E-04 7.5891E-04 6.9498E-04 6.0905E-04 5.3374E-04 4.6775E-04 4.0991E-04 3.5923E-04
: 3. 1481E-04 2.7588E-04 2.4177E-04 6.0932E-07 1.0661E-20 6.3075-140
###########################################C########################
Cumulative Dose Summary####################################################################
Exclusion Area Bounda Low Populatio Time Thyroid TEDE Thyroid (hr)24.000 24.260 24.510 24.760 25.010 25.260 25.510 25.760 26.100 26.400 26.700 27.000 27 .300 27.600 27.900 28.200 28.500 28.800 29.100 29.400 29.700 (rem)0.0000E+00 4 3316E+01 5. 6105E+01 6. 0141E+01 6. 1415E+01 6. 1818E+01 6. 1945E+01 6. 1985E+01 6.1999E+01
: 6. 2002E+01 6. 2003E+01 6.2003E+01
: 6. 2003E+/-01 6. 2003E+01 6. 2003E+01 6.2003E+01
: 6. 2003E+01 6. 2003E+01 6. 2003E+01 6.2003E+01 6.2003E+01 (rem)0.OOOE+00 1.8993E+00 2.4554E+00 2.6299E+00 2.6846E+00 2.7018E+00 2.7072E+00 2.7089E+00 2.7096E+00 2.7097E+00 2.7097E+00 2.'7097E+00 2.7097E+00
: 2. 7097E+00 2.7097E+00
: 2. 7097E+00 2.7097E+00 2.7097E+00
: 2. 7097E+00 2. 7097E+00 2. 7097E+00 (rem)0.OOOOE+00
: 4. 1472E+00 5.3717E+00 5.7582E+00 5.8802E+00 5.9187E+00 5.9309E+00 5.9347E+00
: 5. 9361E+00 5.9364E+00 5.9364E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 0.0 1.8 2.3 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5)n Zone Control Room TEDE Thyroid TEDE (rem) (rem) (rem)000E+00 0.0000E+00 0.0000E+00 184E-01 4.2946E+00 1.3370E-01 509E-01 1.1877E+01 3.6962E-01 179E-01 1.9845E+01 6.1742E-01 704E-01 2.7349E+01 8.5069E-01 869E-01 3.4183E+01 1.0630E+00 920E-01 4.0336E+01 1.2541E+00 937E-01 4.5855E+01 1.4255E+00 943E-01 5.2449E+01 1.6301E+00 5944E-01 5.7499E+01 1.7867E+00 5944E-01 6.1921E+01 1.9238E+00 944E-01 6.5792E+01 2.0438E+00 5944E-01 6.9181E+01 2.1488E+00 5944E-01 7.2148E+01 2.2407E+00 944E-01 7.4745E+01 2.3211E+00 944E-01 7.7019E+01 2.3915E+00 5944E-01 7.9011E+01 2.4532E+00 5944E-01 8.0754E+01 2.5071E+00 944E-01 8.2281E+01 2.5543E+00 5944E-01 8.3617E+01 2.5956E+00 5944E-01 8.4788E+01 2.6318E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.79 30.000 30.300 30. 600 30.900 31.200 31.500 31.800 32 .000 32.300 32. 600 32. 900 33.200 33.500 33.800 34.100 34. 400 48.000 120.000 744 .000 6. 2003E+01 6. 2003E+01 6.2003E+01 6 .2003E+01 6. 2003E+01 6. 2003E+01 6.2003E+01 6.2003E+01 6 .2003E+01 6. 2003E+01 6. 2003E+01 6. 2003E+01 6. 2003E+01 6.2003E+01 6* 2003E+01 6. 2003E+01 6.2003E+01
: 6. 2003E+01 6. 2003E+01 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 2. 7097E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00 5.9365E+00
: 5. 9365E+00 5. 9365E+00 5. 9365E+00 5. 9365E+00 5. 9365E+00 5. 9365E+00 5. 9365E+00 5. 9365E+00 2.5944E-01
: 2. 5944E-01 2. 5944E-01 2. 5944E-01 2.5944E-01 2.5944E-01
: 2. 5944E-0I 2. 5944E-01 2.5944E-01 2.5944E-01
: 2. 5944E-01 2. 5944E-01 2. 5944E-01 2. 5944E-01 2.5944E-01 2.5944E-01
: 2. 5944E-01 2. 5944E-01 2. 5944E-01 8. 5812E+01 8.6710E+01 8.74 95E+01 8. 8183E+01 8. 8786E+01 8. 9313E+01 8. 9775E+01 9. 0051E+01 9. 0421E+01 9.0745E+01
: 9. 1029E+01 9. 1278E+01 9.1496E+01 9: 1686E+01 9. 1853E+01 9. 2000E+01 9. 3028E+01 9. 3030E+01 9. 3030E+01 2. 6635E+00 2. 6912E+00 2 7155E+00 2. 7367E+00 2. 7553E+00 2 7716E+00 2. 7859E+00 2. 7944E+00 2. 8058E+00 2 8158E+00 2. 8246E+00 2. 8322E+00 2. 8389E+00 2. 8448E+00 2. 8500E+00 2. 8545E+00 2 8861E+00 2. 8862E+00 2. 8862E+00####################################################################
Worst Two-Hour Doses########################V###
########################################
Exclusion Time (hr)24.0 Area Boundary Whole Body Thyroid (rem) (rem)8.0111E-01 6.1995E+01 TEDE (rem)2.7094E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 80-1,000 cfm Case#4####################################
###############################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:54:33##4#############################4############
#4#####################
#######################################4#####4####################
File information
#######################################################################
Plant file = C:\Program Files\radtrad3.03\OC AST\FHA 2007\FHA source release modified flow rates fixed inp file diffuse source xq less conservative iodine fractions 1000 cfm increased time steps.psf Inventory file = c:\program files\radtrad3.03\defaults\ocfhaikr.nif Release file = c:\program files\radtrad3.03\oc ast\oc fha.rft Dose Conversion file = c:\program files\radtrad3.03\oc ast\oc6O.inp
#4 # # # # 4 # # # # # # #4 4 4 *# # # 4 4 4 4 4 4*##### W### #### # # # # ##### # # ##44 4444 #44# 4# 4*4 4 4 4# #### # # # # #### #Radtrad 3.03 4/15/2001 1000 cfm Nuclide Inventory File: c:\program files\radtrad3.03\defaults\ocfhaikr.nif Plant Power Level: 1.1310E+01 Compartments:
3 Compartment 1: Refuel Floor Airspace 3 1.0000E+02 0 0 0 0 0 Compartment 2: Environment 2 0.0000E+00 0 0 0 0 0 Compartment 3: Control Room 1 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 81 2.7500E+04 0 0 0 0 0 Pathways: 3 Pathway 1: Refuel Floor Airspace to Environment 1 2 2 Pathway 2: Environment to Control Room 2 3 2 Pathway 3: Control Room to Environment 3 2 2 End of Plant Model File Scenario Description Name: Plant Model Filename: Source Term: 1.1 1.0000E+00 c:\prcgram files\radtrad3.03\oc ast\oc60.inp c:\program files\radtrad3.03\oc ast\oc fha.rft 2.4000E+01 1 0.0000E+00 5.7000E-01 4.3000E-01 1.0000E+00 Overlying Pool: 0 0.0000E+00 0 0 0 0 Compartments:
3 Compartment 1: 0 1 0 0 0 0 0 0 0 Compartment 2: 0 1 0 0 0 0 0 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 P PAGE NO. 82 0 Compartment 3: 0 1 0 0 0 0 o 0 0 Pathways: 3 Pathway 1:*0 0 0 0 0 1 2 2.4000E+01 7.4400E+02 0 0 0 0 0.0 Pathway 2: 0 0 0 0 0 1 2 2 .4000E+01 7.4400E+02 0 0 0 0 0 0 Pathway 3: 0 0 0 0 0 1 2 2 .4000E+01 7.4400E+02 7.6750E+00 o.0000E+00 1.0000E+03 C.0000E+00 o.0000E+00 0.0000E+00 C.0000E+00 0.0000E+00 o .CCCE+CC o .CCCCE+/-C o .CCCE+0C o .CCCCE+/-C 0.0000E+00 0.0000E+00 o.0000E+00 0.0000E+00 1.0000E+03 C.0000E+00 0.0000E+00 o.0000E+00 o .OOCOE+CC o .CCCE+CC O .CCCE+/-CC o .CCCCE+/-C 0 0 0 0 0 0 Dose Locations:
CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 83 3 Location 1: Exclusion Area Boundary 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01 3.2000E+01
: 4. 8000E+01 7.4400E+02 1.41OOE-03 o.OOOE+00 3.5000E-04 1.8000E-04 2.3000E-04 0.OOOOE+00 Location 2: Low Population Zone 2 1 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01 3.2000E+01
: 4. 8000E+01 7.4400E+02 0 Location 3: Control Room 3 0 1 2 2.4000E+01 7.4400E+02 1 1.3500E-04 0.0000E+00 3.5000E-04 1.8000E-04 2.3000E-04 O.O0005E00 3.5000E-04 0.0000E+00 4 2.4000E+01 1.O000E+00 4.8000E+01 6.0000E-01 1.2000E+02 4.0000E-01 7.4400E+02 0.OOOOE+00 Effective Volume Location: 1 2 2.4000E+01 2.1500E-03 7.4400E+02 0.0000E+00 Simulation Parameters:
2 2.4000E+01 2.OOOOE-03 7.4400E+02 0.0000E+00 Output Filename: C:\Program Files\radtrad3.o772 1 1 1 0 0 End of Scenario File CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO.84#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:54:33#############################i##########################################
#######################################################################
Plant Description
#######################################################################
Number of Nuclides = 60 Inventory Power 1.0000E+00 MWth Plant Power Level = 1.1310E+01 MWth Number of compartments
= 3 Compartment information Compartment number 1 (Source term fraction = 1.OOOOE+00 Name: Refuel Floor Airspace Compartment volume = 1.0000E+02 (Cubic feet)Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Refuel Floor Airspace to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: Refuel Floor Airspace to Environment Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 2.7500E+04 (Cubic feet)Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Total number of pathways 3 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO.85 RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:54:33#######################################################################
#############.##########################################################
Scenario Description
#######################################################################
Time between shutdown and first release = 2.4000E+01 (Hours)Radioactive Decay is enabled Calculation of Daughters is enabled Release Fractions and Timings NOBLES IODINE CESIUM TELLURIUM STRONTIUM BARIUM RUTHENIUM CERIUM LANTHANUM GAP 0.000001 hr 5. OOOOE-02 2. 5000E-04 0 OOOOE+00 0 .0000E+00 0 OOOOE+00.0OOOE+00 0. 0000E+00 0 .OOOOE+00 0 OOOOE+00 EARLY IN-VESSEL 0.0000 hrs 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 LATE RELEASE 0.0000 hrs 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 RELEASE MASS (gm)1. 329E+00 1.100E-03 0. OOOE+00.0.OOOE+00
: 0. OOOE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 0.OOOE+00 Inventory Power 11. MWt Nuclide Name Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 1-131 1-132 1-133 1-134 1-135 Xe-133 Xe-133m Xe-135 Xe-135m Xe-137 Xe-138 Nuclide Kr-85m Kr-87 Kr-88 Kr-89 Sr-90 Sr-91 Sr-92 Y-93 Zr-95 Zr-97 Mo-99 Group Specific Inventory (Ci/MWt)1 4.150E+03 1 6.940E+03 1 8.060E+02 1 .290E+04 1 1.830E+04 1 3 .980E+04 2 4. 016E+04 2 3 .660E+04 2 5.180E+04 2 5. 600E+04 2 4.820E+04 1 5.230E+04 1 1.380E+03 1 1.810E+04 1 1.560E+04 1 5.100E+04 1 4.780E+04 half life (s).696E+03 1. 613E+04 3. 386E+08 4.578E+03 1 .022E+04 1. 896E+02 6 947E+05 8 280E+03 7 488E+04 3. 156E+03 2. 380E+04 4. 532E+05 1. 927E+05 3.272E+04 9. 180E+02 2 .304E+02 8. 520E+02 Whole Body DCF (Sv-m3/Bq-s) 7.480E-15 7.480E-15 1.190E-16 4.120E-14 1.020E-13 1.020E-13 1.820E-14 1.120E-13 2. 940E-14 1.300E-13 8.294E-14 1.560E-15 1.560E-15 1.190E-14 1.190E-14 1.190E-14 1.190E-14 Inhaled Thyroid (Sv/Bq)0. OOOE+00 0. OOOE+00 0.OOOE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 2. 920E-07 1. 740E-09 4.860E-08 2. 880E-10 8.460E-09 0. OOOE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 0. OOOE+00 0. OOOE+00 Daughter none none none none none none none none none none none Inhaled Effective (Sv/Bq)0. OOOE+00 0.OOOE+00 0. OOOE+00 0.OOOE+00 0.OOOE+00 0. OOOE+00 8.890E-09 1.030E-10 1.580E-09 3.550E-11 3.320E-10 0.OOOE+00 0.OOOE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 0. OOOE+00 Fraction 0.00 0.00 0.00.0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Daughter Kr-85 Rb-87 Rb-88 Sr-89 Y-90 Y-91m Y-92 Zr-93 Nb-95m Nb-97m Tc-99m Fraction 0.21 1.00 1.00 1.00 1.00 0.58 1.00 1.00 0.01 0.95 0.88 Daughter none none none none none Y-91 none none Nb-95 Nb-97 Tc-99 Fraction 0.00 0.00 0.00 0.00 0.00 0.42 0.00 0.00 0.99 0.05 0.12 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 PAGE NO.86 1 Tc-99m Ru-103 Ru-105 Ru-106 Sb-127 Sb-129 Te-127m Te-129 Te-129m Te-131m Te-132 1-131 1-133 1-135 Xe-133m Xe-135 Xe-135m Xe-137 Cs-137 Ba-140 La-141 Ce-143 Ce-144 Nd-147 Np-239 Pu-238 Pu-239 Tc-99 Rh-103m Rh-105 Rh-106 Te-127m Te-129m Te-127 1-129 Te-129 Te-131 1-132 Xe-131m Xe-133m Xe-135m Xe-133 Cs-135 Xe-135 Cs-137 Ba-137m La-140 Ce-141 Pr-143 Pr-144m Pm-147 Pu-239 U-234 U-235 1.00 1.00 1.00 1.00 0.18 0.22 0.98 1.00 0.65 0.22 1.00 0.01 0.03 0.15 1.00 1.00 0.99 1.00 0.95 1.00 1.00 1.00 0.02 1.00 1.00 1.00 1.00 none none none none Te-127 Te-129 none none 1-129 1-131 none none Xe-133 Xe-135 none none Cs-135 none none none none none Pr-144 none none none none 0.00 0.00 0.00 0.00 0.82 0.77 0.00 0.00 0.35 0.78 0.00 0.00 0. 97 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.98 0.00 0.00 0.00 0.00 none none none none none none none none none none none none none none none none none none none none none none none none none none none 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Iodine fractions Aerosol Elemental
=Organic -COMPARTMENT DATA Compartment number Compartment number Compartment number 0.0000E+00 5.7000E-01
: 4. 3000E-01 1: Refuel Floor Airspace 2: Environment 3: Control Room PATHWAY DATA Pathway number 1: Refuel Floor Airspace to Environment Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)7.6750E+00 0.OOOOE+00 Aeros 0.0000E 0.0000E Filter Efficiencies sol Elemental>+00 0.OOOOE+00
+00 0.OOOOE+00
(%)Organic 0.OOOOE+00 0.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)1.0000E+03 0.0000E+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOOOE+00 0.0000E+00 O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 3: Control Room to Environment I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 87 1 Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)1.OOOOE+03 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOE+00 O.OOOOE+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr)2.4000E+0i 7.4400E+02 X/Q (s
* m^-3)1. 4100E-03 0.OOD0E+00 Location Breathing Rate Data Time (hr) Breathing 2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 Location Low Population Zone Rate (m^3
* sec^-l)3.5000E-04 1.80OOE-04 2.3000E-04 C.OODOE+00 is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1.3500E-04 C.OOOOE+00 Location Breathing Rate Data Time (hr) Breathing 2.4000E+01 3.2000E+01
: 4. 8000E+01 7.4400E+02 Location Control Room is Rate (m^3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 D.ODODE+00 in compartment 3 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 Location Breathing Time (hr)2.4000E+01 7.4400E+02 Location Occupancy Time (hr)2.4000E+01
: 4. 8000E+0l 1.2000E+02 7.4400E+02 X/Q (s
* m^-3)2.1500E-03 D.OOODE+00 Rate Data Breathing Rate (mW3
* sec^-l)3.5000E-04 C.00ODE+00 Factor Data Occupancy Factor 1.DOOOE+00
: 6. DODOE-01 4. DODOE-01 0.00O0E+00 USER SPECIFIED TIME Time C.00D0E+00 7.2000E+02 STEP DATA- SUPPLEMENTAL TIME STEPS Time step 2.00OOE-03 C.OOC0E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO.88#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 10:54:33#######################################################################
4444 4#4 44 44 44 4.~ 4 4 4 4 4 4 4 44444 4 4 4 4 4 44444 4 4 4 4 44444 4#f 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4444 4 4444 4444 4####################################################################
Dose Output########################################4########################4##
Exclusion Area Boundary Doses: Time (h) = 24.0000 Whole Body Delta dose (rem) 1.8911E-06 Accumulated dose (rem) 1.8911E-06 Low Population Zone Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8107E-07 1.8107E-07 Whole Body 8.4900E-14 8.4900E-14 Exclusion Area Boundary Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 8.0083E-01 8.0083E-01 Thyroid 1.4300E-04 1.4300E-04 Thyroid 1.3692E-05 1.3692E-05 Thyroid 2. 3787E-10 2. 3787E-10 Thyroid 6. 2001E+01 6.2001E+01 Thyroid 5.9363E+00 5.9363E+00 Thyroid 9. 4209E+01 9.4209E+01 Thyroid 3. 0249E-15 6. 2001E+01 TEDE 6.2941E-06 6.2941E-06 TEDE 6.0262E-07 6.0262E-07 TEDE 7.4090E-12 7.4090E-12 TEDE 2.7093E+00 2.7093E+00 TEDE 2. 5940E-01 2.5940E-01 TEDE 2.9298E+00 2.9298E+00 TEDE 1.4301E-16 2.7093E+00 Low Population Zone Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 7.6675E-02 7.6675E-02 Whole Body 3.1640E-02 3.1640E-02 Exclusion Area Boundary Doses: Time (h) = 48.0000 Whole Body Delta dose (rem) 5.0380E-17 Accumulated dose (rem) 8.0083E-01 I CALCULATION NO. C-1 302-822-E310-082 I REV. No. 1 1 PAGE NO. 89 Low Population Zone Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 4. 8236E-18 7.6675E-02 Whole Body 1.0231E-09 3.1640E-02 Exclusion Area Boundary Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.9673E-49 8.0083E-01 Low Population Zone Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.8411E-50 7.6675E-02 Whole Body 2.5095E-25
: 3. 1640E-02 Thyroid 2. 8961E-16 5.9363E+00 Thyroid 4.4661E-06 9.4209E+01 Thyroid 3.5423E-47
: 6. 2001E+01 Thyroid 3. 3916E-48 5.9363E+00 Thyroid 1. 6999E-21 9.4209E+01 Thyroid 2.6550-191
: 6. 2001E+01 Thyroid 2.5420-192 5.9363E+00 Thyroid 4.9897E-90
: 9. 4209E+01 TEDE 1. 3693E-17 2.5940E-01 TEDE 1.3778E-07 2.9298E+00 TEDE 1.3788E-48 2.7093E+00 TEDE 1.3201E-49
: 2. 5940E-01 TEDE 5. 2178E-23 2.9298E+00 TEDE 9.5828-193 2.7093E+00 TEDE 9.1750-194
: 2. 5940E-01 TEDE 1.5247E-91 2.9298E+00 Exclusion Area Boundary Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4965-193 8.0083E-01 Low Population Zone Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4328-194 7.6675E-02 Whole Body 4.9858E-94 3.1640E-02 360003 1-131 Summary Time (hr)24.000 24.250 24. 498 24 .746 24. 994 25.242 Refuel Floor Airspace 1-131 (Curies)1.0470E+02 3.3080E+01 1.0549E+01 3.3638E+00 1.0727E+00 3.4205E-01 Environment 1-131 (Curies)2 4107E-04 7 1562E+01 9. 4076E+01 1. 0125E+02 1. 0354E+02 1. 0427E+02 Control Room 1-131 (Curies)2 .44 61E-07 5.3117E-02
: 4. 7651E-02 3.3057E-02 2.0930E-02 1.2716E-02 CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.90 25.490 25.738 25.986 26. 234 26.482 26.730 26. 978 2.7.226 27.474 27.722 27. 970 28.218 28.466 28.714 28.962 29. 210 29. 458 29.706 29. 954 30.202 30.450 30.698 30. 946 31.194 31 .442 31. 690 31. 938 32.000 32.248 32.496 32.744 32.992 33.240 33.488 33.736 33. 984 34.232 48.000 120.000 744 .000 1. 0908E-01 3.4782E-02
: 1. 1091E-02 3.5369E-03 1 .1278E-03 3.5965E-04
: 1. 1469E-04 3.6572E-05
: 1. 1662E-05 3.7188E-06
: 1. 1859E-06 3. 7816E-07 1.2059E-07 3.8453E-08 1.12262E-08 3.9102E-09 1.2469E-09
: 3. 9761E-10 1.2 679E-10 4.0432E-11 1 .2893E-11 4.1114E-12
: 1. 3110E-12 4.1807E-13 1.3332E-13 4.2512E-14
: 1. 3556E-14 1.0187E-14 3.2485E-15 1.0359E-15 3.3033E-16 1.0534E-16 3.3590E-17
.1.0711E-17 3.4156E-18 1.0892E-18 3.4732E-19 9.6443E-47 7.5382-191 0.0000E+00
: 1. 0451E+02 1.0458E+02 1.0461E+02
: 1. 0461E+02 1 .04 61E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 7.5689E-03 4.4573E-03
: 2. 6100E-03 1.5236E-03 8.8789E-04
: 5. 1696E-04 3.0084E-04 1.7503E-04
: 1. 0181E-04 5.9220E-05 3.4444E-05 2.0033E-05 1.1651E-05 6.7764E-06
: 3. 9411E-06 2.2921E-06 1.3331E-06 7.7532E-07 4.5092E-07 2.6226E-07 1.5253E-07 8.8708E-08 5.1592E-08 3.0006E-08 1.7451E-08
: 1. 0150E-08 5.9029E-09 5.1549E-09
: 2. 9981E-09 1.743,7E-09 1.0141E-09
: 5. 8980E-10 3.4302E-10
: 1. 9950E-10 1. 1603E-10 6. 7481E-11 3. 9247E-11 3.3607E-24 1.5502E-92 0.0000E+00 Cumulative Dose Summary####################################################################
Exclusion Area Bounda Low Populatio Time Thyroid TEDE Thyroid (hr)24 .000 24.250 24.498 24.746 24.994 25.242 25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 (rem)0.0000E+00 4 .2432E+01 5 .5767E+01 6. 0015E+01 6. 1369E+01 6. 1800E+01 6. 1937E+01 6.1981E+01.
: 6. 1995E+01 6. 1999E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 (rem)0.0000E+00
: 1. 8604E+00 2. 4405E+00 2. 6241E+00 2. 6823E+00 2. 7007E+00 2.7065E+00
: 2. 7084E+00 2. 7090E+00 2. 7092E+00 2. 7092E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 (rem)0.OOOOE+00 4.0626E+00 5.3394E+00
: 5. 7461E+00 5.8757E+00
: 5. 9170E+00 5.9301E+00 5.9343E+00 5.9357E+00
: 5. 9361E+00 5.9362E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 0.0 1.7 2.3 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5)n Zone Control Room TEDE Thyroid TEDE (rem) (rem) (rem)OOOE+00 O.OOOOE+00 0.O000E+00 813E-01 1.7339E+01 5.3981E-01 366E-01 4.2495E+01 1.3226E+00 124E-01 6.1915E+01 1.9266E+00 5681E-01 7.4729E+01 2.3249E+00 5858E-01 8.2662E+01 2.5714E+00 5914E-01 8.7427E+01 2.7194E+00 932E-01 9.0245E+01 2.8069E+00 5937E-01 9.1898E+01 2.8582E+00 5939E-01 9.2864E+01 2.8881E+00 5940E-01 9.3426E+01 2.9056E+00 5940E-01 9.3754E+01 2.9157E+00 5940E-01 9.3944E+01 2.9216E+00 5940E-01 9.4055E+01 2.9251E+00 5940E-01 9.4119E+01 2 .9271E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.91 27.722 27. 970 28.218 28. 466 28 714 28. 962 29.210 29.458 29.706 29.954 30.202 30.450 30. 698 30. 946 31.194 31. 442 31.690 31.938 32. 000 32.248 32.496 32.744 32.992 33.240 33.488 33.736 33. 984 34 .232 48.000 120.000 744.000 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6.2001E+01 6..2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6.2001E+01
: 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01 2.5940E-01 2.5940E-01
: 9. 4157E+01 9. 4178E+01 9. 4191E+01 9. 4198E+01 9. 4203E+01 9. 4205E+01 9. 4207E+01 9. 4207E+01 9. 4208E+01 9. 4208E+01 9. 4208E+01 9. 4209E+01 9. 4209E+01 9 4209E+01 9. 4209E+01 9. 4209E+01 9. 4209E+01 9. 4209E+01 9 4209E+01 9. 4209E+01 9. 4209E+01 9. 4209E+01 9. 4209E+01 9. 4209E+01 9 4209E+01 9. 4209E+01 9. 4209E+01 9. 4209E+01 9. 4209E+01 9. 4209E+01 9. 4209E+01 2.9282E+00 2.9289E+00 2.9293E+00 2.9295E+00 2.9296E+00 2.9297E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00
: 2. 9298E+00 2. 9298E+00 2. 9298E+00 2. 9298E+00 2. 9298E+00 2. 9298E+00 2. 9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 2.9298E+00 Worst Two-Hour Doses####################################################################
Exclusion Area Boundary Time Whole Body Thyroid TEDE (hr) (rem)24.0 8.0076E-01 (rem) (rem)6.1995E+01 2.7090E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 92 5000 cfm Case#####.################################################444###############
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:25:09#######################################################################
File information
#######################################################################
Plant file = C:\Pro modified flow rates fixed inp 5000 cfm increased time steps.Inventory file = c:\pro Release file = c:\pro Dose Conversion file = c:\pro)gram Files\radtrad3.03\OC AST\FHA 2007\FHA source release file diffuse source xq less conservative iodine fractions psf)gram files\radtrad3.03\defaults\ocfhaikr.nif)gram files\radtrad3.03\oc ast\oc fha.rft)gram files\radtrad3.03\oc ast\oc60.inp
# ## # # ## # #44444 4 4 4 4 44444 4 4 4 4444 44444 4 4 4 4 4444 4444 4. 4 44#444 4 4 44 4 4 4 4 4 4 4 4 4 44444 4 4 4 4 44 4 4 4 4 4 44 4 4 4 4 4 4 4 4444 4 4 4 4 4 Radtrad 3.03 4/15/2001 5000 cfm Nuclide Inventory File: c:\program files\radtrad3.03\defaults\ocfhaikr.nif Plant Power Level: 1.1310E+01 Compartments:
3 Compartment 1: Refuel Floor Airspace 3 1.0000E+02 0 0 0 0 0 Compartment 2: Environment 2 O.O000E+00 0 0.0 0 0 Compartment 3: Control Room 1 2.7500E+04 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.93 0 0 0 0 Pathways: 3 Pathway 1: Refuel Floor.1 2 2 Airspace to Environment Pathway 2: Environment to Control Room 2 3 2 Pathway 3: Control Room to Environment 3 2 2 End of Plant Model File Scenario Description Name: Plant Model Filename: Source Term: 1 1 1.0000E+00 c:\program files\radtrad3.03\oc ast\oc60.inp c:\program files\radtrad3.03\oc ast\oc fha.rft 2. 4000E+01 1 0.OOOE+00 5.7000E-01 4.3000E-01 1.0OOOE+00 Overlying Pool: 0 o.O0O0E+00 0 0 0 0 Compartments:
3 Compartment 1: 1 0 0 0 0 0 0 0 0 Compartment 2: 0 1 0 0 0 0 0 0 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 94 0 Compartment 3: 0 1 0 0 0 0 0 0 0 Pathways: Pathway 1: 0 0 0 0 0 1 2 2.4000E+01 7.4400E+02 0 0 0 0 0 0 Pathway 2: 0 0 0 0 0 1 2 2.4000E+01 7.4400E+02 0 0 0 0 0 0 Pathway 3: 0 0 0 0 0 1 7.6750E+00 0.0000E+00 5.0000E+03 0.0000E+00 0.OOOOE+00 O.OOOOE+00 0.0000E+00 o.OOOOE+00 o .OOOOE+00 0. OOOOE+00 O.OOOOE+00 O.O000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 2 2.4000E+01 5.OOOOE+03 7.4400E+02 0.OOOOE+00 0 0 0 0 0 0 Dose Locations:
3 0. OOOOE+00 0. OOOOE+/-00 0. OOOOE+00 0. OOOOE+00 0. OOOOE+00 0. OOCOE+/-00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO.95 Location 1: Exclusion Area Boundary 2 1 2 2.4000E+01 7.4400E+02
: 1. 4100E-03 0.OOOOE+00 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 0.OOO0E+00 0 Location 2: Low Population Zone 2 1 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01 3.2000E+01
: 4. 8000E+01 7.4400E+02 0 Location 3: Control Room 3 0 1 2 2.4000E+01 7.4400E+02 i 1.3500E-04 0.0000E+00 3.5000E-04 1.8000E-04 2.3000E-04 o.0OO0E+00 3.5000E-04 0.0000E+00 4 2.4000E+01 1.0OOOE+00 4.8000E+01 6.OOOOE-01 1.2000E+02 4.OOOOE-01 7.4400E+02 O.OOOOE+00 Effective Volume Location: 1 2 2.4000E+01 2.1500E-03 7.4400E+02 O.OOOOE+00 Simulation Parameters:
2 2.4000E+01 2.OOOOE-03 7.4400E+02 0.0OO0E+00 Output Filename: C:\Program Files\radtrad3.o776 1 1 1 0 0 End of Scenario File CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 96=#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:25:09###########################################################i############
Plant Description
#######################################################################
Number of Nuclides = 60 Inventory Power = 1.0000E+00 MWth Plant Power Level = 1.1310E+01 MWth Number of compartments
= 3 Compartment information Compartment number 1 (Source term fraction = 1.0000E+00 Name: Refuel Floor Airspace Compartment volume = 1.OOOOE+02 (Cubic feet)Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Refuel Floor Airspace to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: Refuel Floor Airspace to Environment Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 2.7500E+04 (Cubic feet)Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Total number of pathways 3 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 97#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:25:09##################4#####################################################
#######################################################################
Scenario Description
#####################t######i##########################################
Time between shutdown and first release Radioactive Decay is enabled Calculation of Daughters is enabled 2.4000E+01 (Hours)Release Fractions and Timings NOBLES IODINE CESIUM TELLURIUM STRONTIUM BARIUM RUTHENIUM CERIUM LANTHANUM GAP 0.000001 hr 5. OOOOE-02 2. 5000E-04 0 OOOOE+00 0. 0000E+00 0 OOOOE+00 0. 0000E+00 0 OOOOE+00 0 OOOOE+00 0. 0000E+00 EARLY IN-VESSEL 0.0000 hrs 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE&#xf7;00 0.OOOOE+00 LATE RELEASE 0.0000 hrs 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 0.OOOOE+00 RELEASE MASS (gm)1.329E+00 1.100E-03 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 Inventory Power 11. MWt Nuclide Name Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 1-131 1-132 1-133 1-134 1-135 Xe-133 Xe-133m Xe-135 Xe-135m Xe-137 Xe-138 Nuclide Kr-85m Kr-87 Kr-88 Kr-89 Sr-90 Sr-91 Sr-92 Y-93 Zr-95 Zr-97 Group Specific Inventory (Ci/MWt)1 4.150E+03 1 6.940E+03 1 8.060E+02 1 1.290E+04 1 1.830E+04 1 3.980E+04 2 4.016E+04 2 3.660E+04 2 5.180E+04 2 5.600E+04 2 4.820E+04 1 5.230E+04 1 1.380E+03 1 1.810E+04 1 1.560E+04 1 5.100E+04 1 4.780E+04 Daughter Fra Kr-85 0.Rb-87 1.'Rb-88 1.(Sr-89 1.'Y-90 1.Y-91m 0.Y-92 1.Zr-93 1.(Nb-95m 0.(Nb-97m 0.half life (s)*6. 696E+03 1 613E+04 3 386E+08 4 578E+03 1 022E+04 1 896E+02 6 947E+05 8 280E+03 7 488E+04 3 156E+03 2. 380E+04 4 .532E+05 1. 927E+05 3. 272E+04 9 180E+02 2. 304E+02 8.520E+02 Whole Body DCF (Sv-m3/Bq-s) 7.480E-15 7.480E-15 1.190E-16 4.120E-14 1.020E-13 1.020E-13 1.820E-14 1.120E-13 2. 940E-14 1.300E-13 8.294E-14 1.560E-15 1.560E-15 1.190E-14 1.190E-14 1.190E-14 1.190E-14 Inhaled Thyroid (Sv/Bq)0.OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 2. 920E-07 1. 740E-09 4. 860E-08 2. 880E-10 8.460E-09 0.OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 Inhaled Effective (Sv/Bq)0. OOOE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 0.OOOE+00 0. OOOE+00 8.890E-09 1.030E-10 1.580E-09 3.550E-11 3.320E-10 0. OOOE+00 0. OOOE+00 0.OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 Fraction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ction Daughter Fraction Daughter 21 none 0.00 none 00 none 0.00 none 00 none 0.00 none 00 none 0.00 none 00 none 0.00 none 58 Y-91 0.42 none 00 none 0.00 none 00 none 0.00 none 01 Nb-95 0.99 none 95 Nb-97 0.05 none Mo-99 Tc-99m 0.88 Tc-99 0.12 none I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 98 Tc-99m Ru-103 Ru-105 Ru-106 Sb-127 Sb-129 Te-127m Te-129 Te-129m Te-131m Te-132 1-131 1-133 1-135 Xe-133m Xe-135 Xe-135m Xe-137 Cs-137 Ba-140 La-141 Ce-143 Ce-144 Nd-147 Np-239 Pu-238 Pu-239 Tc-99 Rh-103m Rh-105 Rh-106 Te-127m Te-129m Te-127 1-129 Te-129 Te-131 1-132 Xe-131m Xe-133m Xe-135m Xe-133 Cs-135 Xe-135 Cs-137 Ba-137m La-140 Ce-141 Pr-143 Pr-144m Pm-147 Pu-239 U-234 U-235 1.00 1.00 1.00 1.00 0.18 0.22 0.98 1.00 0.65 0.22 1.00 0.01 0.03 0.15 1.00 1.00 0.99 1.00 0.95 1.00 1.00 1.00 0.02 1.00 1.00 1.00 1.00 none none none none Te-127 Te-129 none none 1-129 1-131 none none Xe-133 Xe-135 none none Cs-135 none none none none none Pr-144 none none none none 0.00 0.00 0.00 0.00 0.82 0.77 0.00 0.00 0.35 0.78 0.00 0.00 0. 97 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0. 98 0.00 0.00 0.00 0.00 none none none none none none none none none none none none none none none none none none none none none none none none none none none 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Iodine fractions Aerosol Elemental Organic COMPARTMENT DATA-0.OOOOE+00
.5.7000E-01
-4.3000E-01 Compartment number Compartment number Compartment number 1: Refuel Floor Airspace 2: Environment 3: Control Room PATHWAY DATA Pathway number 1: Refuel Floor Airspace to Environment Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (c fm)7.6750E+00 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway.number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr).2.4000E+01 7.4400E+02 Flow Rate (cfm)5.0O00E+03 C.0000E+00 I Filter Efficiencies
(%)Aerosol Elemental Organic 0.0000E+00 0.000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.000E+00 Pathway number 3: Control Room to Environment CALCULATION NO. C-1 302-822-E310-082 REV. No. 1 I PAGE NO. 99 Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)5.OOOOE+03 0.OOO0E+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OCO0E+00 O.OOOOE+00 O.OOOE+00 O.000E+00 O.OOOOE+00 0.OOOE+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr) X/&#xfd;2.4000E+01 7;4400E+02 Location Breathing Rat Time (hr) BrE 2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 Location Low Populati Location X/Q Data Time (hr) X/2.4000E+01 7.4400E+02 Location Breathing Rat Time (hr) BrE 2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 Location Control Room Location X/Q Data Time (hr) X/2 .4000E+/-01 7.4400E+02 Location Breathing Rat Time (hr) Br 2.4000E+01 7.4400E+02 Location Occupancy Fa Time (hr) Occ 2.4000E+01
: 4. 8000E+01 1.2000E+02 7.4400E+02 (s
* m^-3)1. 4100E-03 0.OOOOE+00 te Data eathing Rate (m^3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 0.OOOOE+00 is in compartment 2 on Zone Q (s
* m^-3)1.3500E-04 0.0000E+00 te Da eathi ta ng Rate (m^3
* se 3.5000E-04 1.8000E-04 2.3000E-04 0.OOOOE+00 is in compartment c^-l)3 Q (s
* m^-3)2.1500E-03 0.OOOOE+00 te Data eathing Rate (mW3
* sec^-l)3.5000E-04 0.OOOOE+00 ctor Data cupancy Factor 1.0000E+00 6.OOG0E-01
: 4. 0000E-01 0.OOOOE+00 USER SPECIFIED TIME Time 0.OOOOE+00 7.2000E+02 STEP DATA -SUPPLEMENTAL TIME STEPS Time step 2.0000E-03 0.OOOOE+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGENO. 100#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:25:09############
##### ##########
#################################
4 4 4 4 4 4 4 4 44 4 4 4 4 4 44 4 it 4 4 #4444 It It I)4 4 4 4 4 4 It It 4 It 4 It* It #41(4 1)It It 4444 4441 Dose Output#######44###t#########################################################
Exclusion Area Boundary Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8911E-06 1.8911E-06 Low Population Zone Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8107E-07 1.8107E-07 Whole Body 4.2450E-13 4.2450E-13 Exclusion Area Boundary Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body.8.0083E-01 8.0083E-01 Thyroid 1.4300E-04 1.4300E-04 Thyroid 1.3692E-05 1.3692E-05 Thyroid 1.1894E-09 1.1894E-09 Thyroid 6.2001E+01
: 6. 2001E+01 Thyroid 5.9363E+00 5.9363E+00 Thyroid 9. 4471E+01 9. 4471E+01 Thyroid 3. 0249E-15 6. 2001E+01 TEDE 6.2941E-06 6.2941E-06 TEDE 6.0262E-07 6.0262E-07 TEDE 3.7045E-11 3.7045E-11 TEDE 2.7093E+00 2.7093E+00 TEDE 2.5940E-01
: 2. 5940E-01 TEDE 2.9402E+00 2.9402E+00 TEDE 1.4301E-16 2.7093E+00 Low Population Zone Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 7.6675E-02 7.6675E-02 Whole Body 3.2630E-02 3.2630E-02 Exclusion Area Boundary Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 5.0380E-17 8.0083E-01 CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 101 1 Low Population Zone Doses: Time (h) = 48.0000 Whole Body Delta dose (rem) 4.8236E-18 Accumulated dose (rem) 7.6675E-02 Control Room Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 3.5877E-18 3.2630E-02 Exclusion Area Boundary Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.9673E-49
: 8. 0083E-01 Low Population Zone Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.8411E-50 7.6675E-02 Whole Body 1.2757E-50 3.2630E-02 Thyroid 2. 8961E-16 5.9363E+00 Thyroid 1. 5520E-14 9. 4471E+01 Thyroid 3.5423E-47 6.2001E+01 Thyroid 3. 3916E-48 5.9363E+00 Thyroid 8.6036E-47 9.4471E+01 Thyroid 2.6550-191 6 .2001E+0l Thyroid 2.5420-192 5.9363E+00 Thyroid 4.2643-191 9.4471E+01 TEDE 1. 3693E-17 2.5940E-01 TEDE 4.7886E-16 2.9402E+00 TEDE 1.3788E-48 2.7093E+00 TEDE 1.3201E-49 2.5940E-01 TEDE 2. 6410E-48 2.9402E+00 TEDE 9.5828-193 2.7093E+00 TEDE 9.1750-194
: 2. 5940E-01 TEDE 1.3031-192 2.9402E+00 Exclrsion Area Boundary Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4965-193
: 8. 0083E-01 Low Population Zone Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4328-194 7.6675E-02 Whole Body 4.2628-195 3.2630E-02 360003####################################################################
1-131 Summary####################%################################################
Time (hr)24.000 24.250 24.498 24.746 24.994 25.242 Refuel Floor Airspace 1-131 (Curies)1.0470E+02 3.3080E+01 1.0549E+01
.3.3638E+00 1.0727E+00 3.4205E-01 Environment 1-131 (Curies)2.4107E-04 7.1562E+01 9.4076E+01
: 1. 0125E+02 1.0354E+02 1.0427E+02 Control Room 1-131 (Curies)1.2230E-06 9.7244E-02 3.7401E-02 1.2353E-02 3.9678E-03 1.2672E-03 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 102 25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 27.722 27.970 28.218 28.466 28.714 28.962 29.210 29.458 29.706 29.954 30.202 30.450 30.698 30.946 31.194 31.442 31. 690 31.938 32.000 32.248 32.496 32.744 32.992 33.240 33.488 33.736 33.984 34.232 48.000 120.000 744.000 1. 0908E-01 3.4782E-02
: 1. 1091E-02 3. 5369E-03 1. 1278E-03 3.5965E-04 1 .1469E-04 3.6572E-05
: 1. 1662E-05 3. 7188E-06 1. 1859E-06 3 .7816E-07 1. 2059E-07 3.8453E-08 1.2262E-08
: 3. 9102E-09 1.2469E-09
: 3. 9761E-10 1 .2679E-10 4. 0432E-11 1. 2893E-11 4. 1114E-12 1. 3110E-12 4. 1807E-13 1. 3332E-13 4. 2512E-14 1. 3556E-14 1. 0187E-14 3. 2485E-15 1. 0359E-15 3. 3033E-1 6 1. 0534E-16 3. 3590E-17 1. 0711E-17 3. 4156E-18 1. 0892E-18 3. 4732E-19 9. 6443E-47 7.5382-191
: 0. 0000E+00 1. 0451E+02 1.0458E+02
: 1. 04 61E+02 1. 0461E+02 1. 0461E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 4.0420E-04 1.2890E-04 4 1105E-05 1. 3108E-05 4 1798E-06 1.3329E-06
: 4. 2503E-07 1.3554E-07 4.3220E-08 1.3782E-08 4.3949E-09
: 1. 4015E-09 4 .4 690E-10 1. 4251E-10 4. 5444E-11 1. 4491E-11 4. 6210E-12 1. 4736E-12 4. 6989E-13 1. 4984E-13 4. 7782E-14 1. 5237E-14 4 8588E-15 1. 5494E-15 4 9407E-16 1. 5755E-16 5. 0240E-17 3. 7754E-17 1. 2039E-17 3 8390E-18 1. 2242E-18 3. 9038E-19 1. 2448E-19 3. 9696E-20 1.2658E-20
: 4. 0366E-21 1. 2872E-21 3.5742E-49 2.7937-193
: 0. 0000E+00 Cumulative Dose Summary Exclusion Area Bounda Low Population Zone Time (hrY 24.000 24.250 24 .498 24.746 24.994 25.242 25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 Thyroid (rem)0.0000E+00 4.2432E+01
: 5. 5767E+01 6.0015E+01
: 6. 1369E+01 6.1800E+01 6.1937E+01 6.1981E+01 6.1995E+01 6.1999E+01 6.2001E+01
: 6. 2001E+01 6.2001E+01 6.2001E+01 6.2001E+01 TEDE (rem)0.0000E+00 1.8604E+00 2.4405E+00 2.6241E+00 2.6823E+00 2.7.007E+00 2.7065E+00 2.7084E+00 2.7090E+00 2.7092E+00 2.7092E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 Thyroid (rem)0.0000E+00 4.0626E+00 5.3394E+00 5.7461E+00 5.8757E+00 5.9170E+00 5.9301E+00 5.9343E+00 5.9357E+00 5.9361E+00 5.9362E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00
* TEDE (rem)0.0000E+00 1 .7813E-01 2 .3366E-01 2. 5124E-01 2 .5681E-01 2 .5858E-01 2.5914E-01 2.5932E-01 2.5937E-01 2 .5939E-01 2 .5940E-01 2 .5940E-01 2 .5940E-01 2.5940E-01 2.5940E-01 Control Thyroid (rem)0.0000E+00 4.7347E+01 7.8323E+01 8.9251E+01 9.2803E+01 9 .3940E+01 9.4302E+01
: 9. 4417E+01 9. 4454E+01 9. 4466E+01 9. 4470E+01 9 .4471E+01 9. 4471E+01 9.4471E+01 9.4471E+01
-Room TEDE (rem)0.0000E+00 1.4741E+00 2.4380E+00 2;7779E+00 2.8883E+00 2.9237E+00 2.9349E+00 2.9385E+00 2.9396E+00 2.9400E+00
: 2. 9401E+00 2.9402E+00 2.9402E+00 2.9402E+00 2.9402E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGENO. 103 27.722 27. 970 28.218 28.466 28. 714 28. 962 29.210 29.458 29.706 29.954 30.202 30.450 30.698 30. 946 31.194 31.442 31.690 31. 938 32.000 32 .248 32.496 32.744 32.992 33.240 33.488 33.736 33.984 34.232 48.000 120.000 744 .000 6. 2001E+01 6.2001E+01 6.2001E+01 6 .2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6.2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.20 01E+01 6. 2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E*00 5.9363E+00 5.9363E+00 5.9363E+00
: 5. 9363E+00 5. 9363E+00 5. 9363E&#xf7;00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5.9363E+00
: 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01 2 .5940E-01 2.5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01 2.5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01 9.4471E+01
: 9. 4471E+01 9.4471E+01
: 9. 4471E+01 9. 4471E+01 9.4471E+01 9.4471E+01 9.4471E+01
: 9. 4471E+01 9. 4471E+01 9. 4471E+01 9.4471E+01 9.4471E+01 9.4471E+01
: 9. 4471E+01 9. 4471E+01 9. 4471E+01 9. 4471E+01 9.4471E+01
: 9. 4471E+01 9. 4471E+01 9. 4471E+01 9. 4471E+01 9. 4471W-E+01 9.4471E+01
: 9. 4471E+01 9.4471E+01
: 9. 4471E+01 9. 4471E+01 9. 4471E+01 9. 4471E+01 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 21 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00 2. 9402E+00####################################################################
Worst Two-Hour Doses####################################################################
Exclusion Time (hr)24.0 Area Boundary Whole Body Thyroid (rem) (rem)8.0076E-01 6.1995E+01 TEDE (rem)2.7090E+00 CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 104 I 10,000 cfm Case RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:15:53#######################################################################
###################################################################0####
File information
############################################%###########################
Plant file = C:\Program Files\radtrad3.03\OC AST\FHA 2007\FHA source release modified flow rates fixed inp file diffuse source xq less conservative iodine fractions 10000 cfm increased time steps.psf Inventory file = c:\program files\radtrad3.03\defaults\ocfhaikr.nif Release file = c:\program files\radtrad3.03\oc ast\oc fha.rft Dose Conversion file = c:\program files\radtrad3.03\oc ast\oc60.inp
##### #### ##### ## ### # ####itiitti # #0 #00 i it#t #i # 0 it it it t it # 0.0 000 it it it#t itii it it it
* 0 #0 # it Radtrad 3.03 4/15/2001 10000 cfm Nuclide Inventory File: c:\program files\radtrad3.03\defaults\ocfhaikr.nif Plant Power Level: 1.1310E+01 Compartments:
3 Compartment 1: Refuel Floor Airspace 3 1.OOOOE+02 0 0 0 0 0 Compartment 2: Environment 2.0.0000E+00 0 0 0 0 0 Compartment 3: Control Room I CALCULATION NO. C-1302-822-E310-082 REV. No. 1 I PAGE NO. 105 I 1 2.7500E+04 0 0 0 0 0 Pathways: 3 Pathway 1: Refuel Floor Airspace to Environment 1 2 2 Pathway 2: Environment to Control Room 2 3 2 Pathway 3: Control Room to Environment 3 2 2 End of Plant Model File Scenario Description Name: Plant Model Filename: Source Term: 1 1 1.0000E+00 c:\program files\radtrad3.03\oc ast\oc60.inp c:\program files\radtrad3.03\oc ast\6c fha.rft 2.4000E+01 1 0.0000E+00 5.7000E-01 4.3000E-01 1.0O00E+00 Overlying Pool: 0 o.0O00E+00 0 0 0 0 Compartments:
3 Compartment 1: 0 1 0 0 0 0 0 0 0 Compartment 2: 0 0 1 0 0 0 0 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 106 0 0 0 Compartment 3: 0 1 0 0 C 0 0 0 0 Pathways: 3 Pathway 1: 0 0 0 0 0 1 2 2.4000E+01 7.4400E+02 0 0 0 0 0 0 Pathway 2: 0 0 0 0 0 1 2 2 '4000E+01 7.4400E+02, 0 0 0 0 0 0 Pathway 3: 0 0 0 0 0 1 2 2 .4000E+01 7.4400E+02 0 0 0 0 0 0 7.6750E+00 O.0000E+00 1.0O00E+04 o.0000E+00 1.0000E+04 O.OOCE+00 0.0000E+00 0.0000E+00 o.0000E+00 o.0000E+00 o.0000E+00 o.0000E+00 O .CCOE+CC O .CCCE+0C o .CCCCE+/-C o .OOCOE+CC o .ooooE+o 0. CCCCE+CC C. CCCCE+0C C. CCCCE+00 C. CCCCE+00 0. CCCCE+CC C. CCCCE+CC C. CCOCE+CC I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGENO. 107 Dose Locations:
3 Location 1: Exclusion Area Boundary 2 1 2 2.4000E+01 l.4l00E-03 7.4400E+02 O.0OO0E+00 1 4 2.4000E+01 3.5000E-04 3.2000E+01 1.80OOE-04 4.8000E+01 2.3000E-04 7.4400E+02 O.0OO0E+00 0 Location 2: Low Population Zone 2 1 2 2.4000E+01 1.3500E-04 7.4400E+02 0.OOOE+00 1 4 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 0.OOOOE+00 0 Location 3: Control Room 3 0 1 2 2.4000E+01 3.5000E-04 7.4400E+02 0.O000E+o0 1 4 2.4000E+01 1.0000E+00 4.8000E+01 6.0000E-01 1.2000E+02 4.0OO0E-01 7.4400E+02 0.OOO0E+00 Effective Volume Location: 1 2 2.4000E+01 2.1500E-03 7.4400E+02 0.0000E+00 Simulation Parameters:
2 2.4000E+01 2.0000E-03 7.4400E+02 0.0000E+00 Output Filename: C:\Program Files\radtrad3.o775 1 1 1 0 0 End of Scenario File
[ CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 PAGE NO. 108 ]RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:15:53###4##########################t########################t##################
Plant Description
#######################################################################
Number of Nuclides 60 Inventory Power = 1.0000E+00 MWth Plant Power Level = 1.1310E+01 MWth Number of compartments
= 3 Compartment information Compartment number 1 (Source term fraction = 1.OOOE+00 Name: Refuel Floor Airspace Compartment volume = 1.0000E+02 (Cubic feet)Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Refuel Floor Airspace to Environment Compartment number 2 Name: Environment Compartment type is Environment
*Pathways into and out of compartment 2 Inlet Pathway Number 1: Refuel Floor Airspace to Environment Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume 2.7500E+04 (Cubic feet)Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number. 3: Control Room to Environment Total number of pathways 3 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 109######################################################A#################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:15:53##4##4#4##4###################################################
#######################################################################
Scenario Description
#######################################################################
Time between shutdown and first release Radioactive Decay is enabled Calculation of Daughters is enabled 2.4000E+01 (Hours)Release Fractions and NOBLES IODINE CESIUM TELLURIUM STRONTIUM BARIUM RUTHENIUM CERIUM LANTHANUM GAP 0.000001 5. OOOOE-C 2 50OOE-0 0. OOOOE+0 0. OOOOE+0 0. OOOOE+0 0. OOOE+O 0. OOOOE+0 0 .0000E+0 0. OOOOE+0 Timings EARLY IN-VESSEL hr 0.0000 hrs 2 0.OOOOE+00 4 0.OOOOE+00 0 0.OOOE+00 0 0.OOOOE+00 0 0.OOOOE+00 0 0.OOOOE+00 0 0.OOOOE+/-00 0 0.OOOOE+00 0 O.OOOOE+00 LATE RELEASE 0.0000 hrs 0. OOOE+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 0. 00OE+00 0 OOOOE+00 RELEASE MASS (gm)1.329E+00 1.100E-03 0. 000E+00 0.OO0E+00 0. OOOE+00 0. 000E400 0. OOOE+00 0. OOOE+00 0. 000E+00 Inventory Power =11. MWt Nuclide Name Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 1-131 1-132 1-133 1-134 1-135 Xe-133 Xe-133m Xe-135 Xe-135m Xe.-137 Xe-138 Nuclide Kr-85m Kr-87 Kr-88 Kr-89 Sr-90 Sr-91 Sr-92 Y-93 Zr-95 Zr-97 Mo-99 Group Specific Inventory (Ci/MWt)1 4.150E+03 1 6.940E+03 1 8.060E+02 1 1.290E+04 1 1.830E+04 1 3.980E+04 2 4.016E+04 2 3.660E+04 2 5.180E+04 2 5.600E+04 2 4.820E+04 1 5.230E+04 1 1.380E+03 1 1.810E+04 1 1.560E+04 1 5.l100E+04 1 4.780E+04 half life (s)6. 696E+03 1. 613E+04 3.386E+08 4.578E+03 1 .022E+04 1. 896E+02 6. 947E+05 8. 280E+03 7 .488E+04 3.156E+03 2. 380E+04 4. 532E+05 1. 927E+05 3. 272E+04 9.180E+02 2. 304E+02 8. 520E+02 Whole Body DCF (Sv-m3/Bq-s) 7.480E-15 7.480E-15 1.190E-16 4. 120E-14 1.020E-13 1.020E-13 1.820E-14 1.120E-13 2. 940E-14 1.300E-13 8.294E-14 1.560E-15 1.560E-15 1.190E-14 1.190E-14 1.190E-14 1.190E-14 Inhaled Thyroid (Sv/Bq)0 OOOE+00 0 OOOE+00 0OOOE+00 0OOOE+00 OOOE+00 OOOE+00.920E-07 1.740E-09.860E-08.880E-10 8.460E-09 0OOOE+00 0OOOE+00 0OOOE+00 OOOE+00 OOOE+00 0.OOOE+00 Daughter none none none none none none none none none none none Inhaled Effective (Sv/Bq)0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 0. OOOE+00 8. 890E-09 1.030E-10 1.580E-09 3.550E-11 3.320E-10 0. OOOE+00 0. OOOE+00 0.OOOE+00 0.OOOE+00 0.OOOE+00 0. OOOE+00 Fraction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Daughter Kr-85 Rb-87 Rb-88 Sr-89 Y-90 Y-91m Y-92 Zr-93 Nb-95m Nb-97m Tc-99m Fraction 0.21 1.00 1.00 1.00 1.00 0.58 1.00 1.00 0.01 0.95 0.88 Daughter none none none none none Y-91 none none Nb-95 Nb-97 Tc-99 Fraction 0.00 0.00 0.00 0.00 0.00 0_.42 0.00 0.00 0.99 0.05 0.12 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 110 Tc-99m Ru-103 Ru-105 Ru-106 Sb-127 Sb-129 Te-127m Te-129 Te-129m Te-131m Te-132 1-131 1-133 1-135 Xe-133m Xe-135 Xe-135m Xe-137 Cs-137 Ba-140 La-141 Ce-143 Ce-144 Nd-147 Np-239 Pu-238 Pu-239 Tc-99 Rh-103m Rh-105 Rh-106 Te-127m Te-129m Te-127 1-129 Te-129 Te-131 1-132 Xe-131m Xe-133m Xe-135m Xe-133 Cs-135 Xe-135 Cs-137 Ba-137m La-140 Ce-141 Pr-143 Pr-144m Pm-147 Pu-239 U-234 U-235 1.00 1.00 1.00 1.00 0.18 0.22 0.98 1.00 0.65 0.22 1.00 0.01 0.03 0.15 1.00 1.00 0.99 1.00 0..95 1.00 1.00 1.00 0.02 1.00 1.00 1.00 1.00 none none none none Te-127 Te-129 none none 1-129 1-131 none none Xe-133 Xe-135 none none Cs-135 none none none none none Pr-144 none none none none 0.00 0.00 0.00 0.00 0.82 0.77 0.00 0.00 0.35 0.78 0.00 0.00 0.97 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.98 0.00 0.00 0.00 0.00 none none none none none none none none none none none none none none none none none none none none none none none none none none none 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Iodine fractions Aerosol -Elemental
=Organic =COMPARTMENT DATA Compartment number Compartment number Compartment number 0.0000E+00
: 5. 7000E-01 4. 3000E-01 1: Refuel Floor Airspace 2: Environment 3: Control Room PATHWAY DATA Pathway number 1:.Refuel Floor Airspace to Environment Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)7.6750E+00 0.OOOOE+00 Aeros 0.00OOE 0.0000E Filter Efficiencies sol Elemental E+00 0.0000E+00
(;+00 0.0000E+00
((%)Organic).OOOOE+00.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)1.0000E+04 C.0000E+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.0000E+00 0.0000E+00 0.0000E+00 0.0O00E+00 0.0000E+00 0.0000E+00 Pathway number 3: Control Room to Environment
[-CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGENO. Ill I Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)1.0000E+04 0.00OOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic O.OOOOE+00 0.0000E+00 0.0000E+00 D.0000E+00 O.OO0E+00 0.0000E+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02.
X/Q (s
* m^-3)1. 4100E-03 0.0000E+00 Location Breathing Rate Data Time (hr) Breathing 2.4000E+01 3.2000E+01
: 4. 8000E+01 7.4400E+02 Location Low Population Zone Rate (m^3
* sec^-l)3.5000E-04 1.8000E-04 2.300OE-04 0.0000E+00 is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1.3500E-04 0.0600E+00 Location Breathing Rate Data Time (hr) Breathing Rate (mW3
* sec^-l)2.4000E+01 3.5000E 7 04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 0.0000E+00 Location Control Room is in compartment 3 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 Location Breathing Time (hr)2.4000E+01 714400E+02 Location Occupancy Time (hr)2.4000E+01 4.8000E+01 1.2000E+02 7.4400E+02 X/Q (s
* m^-3)2.1500E-03 0.0000E+00 Rate Data Breathing Rate (m^3
* sec^-l)3.5000E-04 0.0000E+00 Factor Data Occupancy Factor 1.0000E+00
: 6. OOOE-01 4.0000E-01 0.0000E+00 USER SPECIFIED TIME Time D.0000E+00 7.2000E+02 STEP DATA -SUPPLEMENTAL TIME STEPS Time step 2.000DE-03 0.0000E+00
[ CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. II2 1######################e################################################
RADTRAD Version 3.03 .(Spring 2001) run on 7/01/2008 at 11:15:53##############################################4#########################
itititit it it it it it it it it it it it it it it it it it ititititit ititititit it it it it it it it it it it* it it it ititititit it it it it it it it it it it ititititit it it it it it it it it it it itititit itititit it it####################################################################
Dose Output####################################################################
Exclusion Area Boundary Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8911E-06 1.8911E-06 LOw Population Zone Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1. 8107E-07 1. 8107E-07 Whole Body 8.4899E-13
: 8. 4899E-13 Exclusion Area Boundary Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 8.0083E-01 8;0083E-01 Thyroid 1.4300E-04 1.4300E-04 Thyroid 1.3692E-05 1.3692E-05 Thyroid 2.3787E-09 2.3787E-09 Thyroid 6.2001E+01
: 6. 2001E+01 Thyroid 5.9363E+00 5.9363E+00 Thyroid 9.4504E+01
: 9. 4504E+01 Thyroid 3.0249E-15 6.2001E+01 TEDE 6.2941E-06
: 6. 2941E-06 TEDE 6.0262E-07 6.0262E-07 TEDE 7.4089E-11 7.4089E-11 TEDE 2.7093E+00 2.7093E+00 TEDE 2.5940E-01
: 2. 5940E-01 TEDE 2; 9415E+00 2. 9415E+00 TEDE 1.4301E-16 2.7093E+00 Low Population Zone Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 7.6675E-02 7.6675E-02 Whole Body 3.2785E-02 3.2785E-02 Exclusion Area Boundary Doses: Time (h) = 48.0000 Whole Body Delta dose (rem) 5.0380E-17 Accumulated dose (rem) 8.0083E-01 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE No.113 I Low Population Zone Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 4.8236E-18 7.6675E-02 Whole Body 2.6279E-18 3.2785E-02 Exclusion Area Boundary Doses: Time (h) = 120.0000 Whole Body Delta dose (rem) 2.9673E-49 Accumulated dose (rem) 8.0083E-01 Low Population Zone Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.8411E-50 7.6675E-02 Whole Body 9. 3440E-51 3.2785E-02 Thyroid 2. 8961E-16 5.9363E+00 Thyroid 1. 1368E-14 9.4504E+01 Thyroid 3.5423E-47
: 6. 2001E+01 Thyroid 3 3916E-48 5.9363E+00 Thyroid 6. 3019E-47 9.4504E+01 Thyroid 2.6550-191 6.2001E+01 Thyroid 2.5420-192 5.9363E+00 Thyroid 3.1235-191 9.4504E+01 TEDE 1. 3693E-17 2. 5940E-01 TEDE 3. 5075E-16 2. 9415E+00 TEDE 1.3788E-48 2.7093E+00 TEDE 1.3201E-49
: 2. 5940E-01 TEDE 1.9344E-48
: 2. 9415E+00 TEDE 9.5828-193 2.7093E+00 TEDE 9.1750-194 2.5940E-01 TEDE 9.5445-193
: 2. 9415E+00 Exclusion Area Boundary Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4965-193 8.0083E-01 Low Population Zone Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4328-194 7.6675E-02 Whole Body 3.1224-195 3.2785E-02 360003####################################################################
1-131 Summary Time (hr)24 .000 24.250 24.498 24 .746 24. 994 25.242 Refuel Floor Airspace 1-131 (Curies)1.0470E+02 3.3080E+01 1.0549E+01 3.3638E+00 1.0727E+00 3.4205E-01 Environment 1-131 (Curies)2.4107E-04 7.1562E+01 9.4076E+01 1.0125E+02 1.0354E+02 1.0427E+02 Control Room 1-131 (Curies)2.4461E-06 8.8584E-02 2.8630E-02 9.1313E-03 2.9118E-03 9.2853E-04 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 114 25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 27.722 27.970 28.218 28.466 28.714 28.962 29.210 29.458 29.706 29.954 30.202 30.450 30 '698 30.946 31.194 31.442 31.690 31.938 32.000 32.248 32.496 32.744 32,992 33.240 33.488 33.736 33.984 34.232 48.000 120.000 744.000 1.0908E-01 3.4782E-02 1.1091E-02 3.5369E-03
: 1. 1278E-03 3.5965E-04
: 1. 1469E-04 3.6572E-05 1.1 662E-05 3. 7188E-06 1. 1859E-06 3. 7816E-07 1.2059E-07 3.8453E-08 1.2262E-08
: 3. 9102E-09 1.2469E-09
: 3. 9761E-10 1.2679E-10
: 4. 0432E-11 1. 2893E-11 4. 1114E-12 1. 3110E-12 4. 1807E-13 1. 3332E-13 4. 2512E-14 1. 3556E-14 1. 0187E-14 3. 2485E-15 1. 0359E-15 3. 3033E-16.1 0534E-16 3. 3590E-17 1. 0711E-17 3. 4156E-18 1. 0892E-18 3. 4732E-19 9. 6443E-47 7.5382-191
: 0. 0000E+00 1. 0451E+02 1.0458E+02
: 1. 0461E+02 1.0461E+02
: 1. 0461E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 2.9609E-04
: 9. 4419E-05 3.0108E-05
: 9. 6011E-06.3.0616E-06 9.7630E-07
: 3. 1133E-07 9.9276E-08
: 3. 1658E-08 1.0095E-08 3.2191E-09
: 1. 0265E-09 3. 2734E-10 1. 0438E-10 3. 3286E-11 1. 0614E-11 3. 3848E-12 1. 0793E-12 3. 4418E-13 1 .0975E-13 3. 4999E-14 1. 1161E-14 3 .5589E-15 1 .1349E-15 3. 6189E-16 1. 1540E-16 3. 6800E-17 2. 7654E-17 8. 8183E-18 2 8120E-18 8. 9670E-19 2. 8594E-19 9. 1182E-20 2.9076E-20
: 9. 2720E-21 2.9567E-21 9.4283E-22
: 2. 6180E-49 2.0463-193 0.OOOOE+00 Cumulative Dose Summary Exclusion Area Bounda Low Population Zone Time (hr)24.000 24.250 24.498 24.746 24.994 25.242 25.490 25.738 25.986 26.234 26.482.26.730 26.978 27.226 27.474 Thyroid (rem)0.OOOOE+00
: 4. 2432E+01 5. 5767E+01 6. 0015E+01 6. 1369E+01 6.1800E+01 6.1937E+01
: 6. 1981E+01 6. 1995E+01 6.1999E+01 6.2001E+01 6.2001E+01 6.2001E+01 6.2001E+01 6.2001E+01 TEDE (rem)0.0000E+00 1.8604E+00 2.4405E+00
: 2. 6241E+00 2.6823E+00 2.7007E+00 2.7065E+00 2.7084E+00 2.7090E+00 2.7092E+00 2.7092E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 Thyroid (rem)0.0000E+00 4.0626E+00 5.3394E+00 5.7461E+00 5.8757E+00 5.9170E+00 5.9301E+00 5.9343E+00 5.9357E+00 5.9361E+00 5.9362E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 TEDE (rem)0.OOOOE+00
: 1. 7813E-01 2. 3366E-01 2. 5124E-01 2. 5681E-01 2. 5858E-01 2. 5914E-01 2. 5932E-01 2. 5937E-01 2. 5939E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 Control Thyroid (rem)0.OOOOE+00
: 5. 6789E+01 8.2456E+01
: 9. 0665E+01 9. 3281E+01 9. 4114E+01 9. 4380E+01 9. 4464E+01.9.4491E+01
: 9. 4500E+01 9. 4502E+01 9. 4503E+01 9. 4504E+01 9. 4504E+01 9. 4504E+01 Room TEDE (rem)0.0000E+00 1.7682E+00 2.5669E+00 2.8222E+00 2.9035E+00 2.9294E+00 2.9376E+00 2.9403E+00
: 2. 9411E+00 2.9414E+00
: 2. 9415E+00 2. 9415E+00 2. 9415E+00 2. 9415E+00 2. 9415E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 115 27.722 27.970 28.218 28.466 28.714 28. 962 29. 210 29.458 29.706 29.954 30 .202 30.450 30. 698 30. 946 31.194 31. 442 31. 690 31.938 32.000 32.248 32.496 32.744 32. 992 33.240 33.488 33.736 33. 984 34.232 48.000 120.000 744 .000 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01 6 .2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+/-01 6. 2001E+01 6.2001E+01 6 .2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00
: 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00
: 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 9. 4504E+01 9. 4504E+01 9 4504E+01 9. 4504E+01 9. 4504E+01 9. 4504E+01 9. 4504E+01 9. 4504E+01 9. 4504E+01 9. 4504E+01 9. 4504E+01 9 4504E+01 9. 4504E+01 9 4504E+01 9. 4504E+01 9. 4504E+01 9. 4504E+01 9 4504E+01 9.4504E+01
: 9. 4504E+01 9. 4504E+01 9. 4504E+01 9.4504E+01 9.4504E+01
: 9. 4504E+01 9. 4504E+01 9. 4504E+01 9. 4504E+01 9.4504E+01 9.4504E+01
: 9. 4504E+01 2 9415E+00 2 9415E+00 2 9415E+00 2 9415E+00 2 9415E+00 2 9415E+00 2 9415E+00 2 9415E+00 2. 9415E+00 2. 9415E+00 2 9415E+00 2 9415E+00 2. 9415E+00 2. 9415E+00 2 9415E+00 2 9415E+00 2 9415E+00 2. 9415E+00 2. 9415E+00 2 9415E+00 2. 9415E+00 2. 9415E+00 2. 9415E+00 2. 9415E+00 2 9415E+00 2. 9415E+00 2. 9415E+00 2. 9415E+00 2. 9415E+00 2. 9415E+00 2 9415E+00 Worst Two-Hour Doses####################################################################
Exclusion Time (hr)24.0 Area Boundary Whole Body Thyroid (rem) (rem)8.0076E-01 6.1995E+01 TEDE (rem)2.7090E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 116.14,000 cfm Case RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:31:42###4444######444#4#4#4####444#######4###
4#######4###############
######444#######4#4####44###4################.###4###########4##44##4 4 File information
######4###4#####4#####44##4#####4#######4################4
##########
Plant file = C:\Program Files\radtrad3.03\OC AST\FHA 2007\FHA source release modified flow rates fixed inp file diffuse source xq less conservative iodine fractions 14000 cfm increased time steps.psf Inventory file = c:\program files\radtrad3.03\defaults\ocfhaikr.nif Release file = c:\program files\radtrad3.03\oc ast\oc fha.rft Dose Conversion file = c:\program files\radtrad3.03\oc ast\oc60.inp 44444 4444 44444 4 4 4 #4#44 4 4 44444 4 44# #4# 44 4 4 4 4###44# 44# 444# 4## 4 4 Radtrad 3.03.4/15/2001 14000 cfm Nuclide Inventory File: c:\program files\radtrad3.03\defaults\ocfhaikr.nif Plant Power Level: 1.1310E+01 Compartments:
3 Compartment 1: Refuel Floor Airspace 3 1.OOOOE+02 0 0 0 0 0 Compartment 2: Environment 2 0. 0000E00 0 0 0 0 0 Compartment 3: Control Room 1 2.7500E+04 0 0 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 117 0 0 0 Pathways: 3 Pathway 1: Refuel Floor Airspace to Environment 1 2 2 Pathway 2: Environment to Control Room 2 3 2 Pathway 3: Control Room to Environment 3 2 2 End of Plant Model File Scenario Description Name: Plant Model Filename: Source Term: 1 1 1.OOO0E+00 c:\program files\radtrad3.03\oc ast\oc60.inp c:\program files\radtrad3.03\oc ast\oc fha.rft 2.4000E+01 1 0.OO00E+00 5.7000E-01 4.3000E-01 1.OOOOE+00 Overlying Pool: 0 0.0000E+00 0 0 0 0 Compartments:
3 Compartment 1: 0 1 0 0 0 0 0 0 0 Compartment 2: 0 1 0 0 0 0 0 0 0 Compartment 3:
[CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 1187]0 1 0 0 0 0 0 0 0 Pathways: 3 Pathway 1: 0 0 0 0 0 1 2 2. 4000E+/-01 7. 4400E+02 0 0 0 0 0 0 Pathway 2: 0 0 0 0 1 2 2. 4000E+01 7. 4400E+02 0 0 0 0 0 0 Pathway 3: 0 0 0 0 0 1 7.6750E+00 o.0000E+00 1.4000E+04 0.0000E+00 o .CCCE+CC C. CCCCE+CC o .CCCE+CC o .CCCE+CC o .CCCE+CC o .CCCE+CC o .CCCE+CC o.CCCCE+0C o .COCCOEtC O .CCCE+CC o .CCCE+CC C. CCCCE-i-O 2 2.4000E+01 1.4000E+04 7.4400E+02 0.0000E+00 0 0 0 0 0 0 Dose Locations:
3 Location 1: Exclusion Area Boundary C. CCCCE+00 C. CCCCE+0C C CCCCE+/-CC C. CCCCE+/-CC 0.0000E+00 C.0000E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 1 &#xfd;19 2 1 2 2.4000E+01 7.4400E+02 1 1. 4100E-03 C. CCOQE+/-OC 4 2.4000E+01 3.5000E-04 3.2000E++/-1 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 O.OOOOE+00 0 Location 2: Low Population Zone 2 1 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 0 Location 3: Control Room 3 0 1 2 2.4000E+01 7.4400E+02 1.3500E-04 o.0000E+00 3.5000E-04 1.8000E-04 2.3000E-04 o.0000E+00 3.5000E-04 0.0000E+00 1 4 2.4000E+01 1.0000E+00 4.8000E+01 6.0000E-01 1.2000E+02 4.0000E-01 7.4400E+02 0.0000E+00 Effective Volume Location: 1 2 2.4000E+01 2.1500E-03 7.4400E+02 O.OOOOE+00 Simulation Parameters:
2 2.4000E+01 2.0000E-03 7.4400E+02 0.OOOOE+00 Output Filename: C:\Program Files\radtrad3.o777 1 1 1 0 0 End of Scenario File CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 120#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:31:42#######################################################################
#######################################################################
Plant Description
#######################################################################
Number of Nuclides=
60 Inventory Power = 1.0000E+00 MWth Plant Power Level = 1.1310E+01 MWth Number of compartments
= 3 Compartment information Compartment number 1 (Source term fraction = I.0000E+00 Name: Refuel Floor Airspace Compartment volume = 1.OOOOE+02 (Cubic feet)Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Refuel Floor Airspace to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: Refuel Floor Airspace to Environment Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 2.7500E+04 (Cubic feet)Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Total number of pathways I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 121 J RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:31:42#######################################################################
Scenario Description
################4###4######4###########4########4########4#######4#4####4 Time between shutdown and first release Radioactive Decay is enabled Calculation of Daughters is enabled 2.4000E+01 (Hours)Release Fractions and Timings NOBLES IODINE CESIUM TELLURIUM STRONTIUM BARIUM RUTHENIUM CERIUM LANTHANUM GAP 0.000001 hr 5. OOOOE-02 2. 50OOE-04 0. 0000E+00 0 OOOOE+00 0. 0OOE+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 EARLY IN-VESSEL 0.0000 hrs 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.0000E+00 0.0000E+00 LATE RELEASE 0.0000 hrs 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 RELEASE MASS (gm)1.329E+00 1. IOOE-03 0. OOOE+00 0. OOOE+00 0.OOOE+00 0. OOOE+00 0. OOOE+00 0. OOE+00 0. OOOE+00 Inventory Power 11. MWt Nuclide Name Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 1-131 1-132 1-133 1-134 1-135 Xe-133 Xe-133m Xe-135 Xe-135m Xe-137 Xe-138 Nuclide Kr-85m Kr-87 Kr-88 Kr-89 Sr-90 Sr-91 Sr-92 Y-93 Zr-95 Zr-97 Mo-99 Group Specific Inventory (Ci/MWL)1 4I15OE+03 1 6. 940E+03 1 8.060E+02 1 1.290E+04 1 1.830E+04 I 3.980E+04 2 4. 016E+04 2 3 .660E+04 2 5 .180E+04 2 5 .600E+04 2 4 .820E+04 1 5.230E+04 1 1.380E+03 1 1.810E+04 1 1.560E+04 1 5.100E+04 1 4.780E+04 Daughter Fra Kr-85 0.Rb-87 1.Rb-88 1.'Sr-89 1.'Y-90 1.'Y-91m 0..Y-92 1.(Zr-93 1.Nb-95m 0.'Nb-97m 0.Tc-99m 0.: half life (s)6. 696E+03 1. 613E+04 3 386E+08 4. 578E+03 1. 022E+04 1 896E+02 6 947E+05 8. 280E+03 7. 488E+04 3 156E+03 2. 380E+04 4 532F+05 1 927E+05 3. 272E+04 9. 180E+02 2. 304E+02 8. 520E+02 Whole Body DCF (Sv-m3/Bq-s) 7.480E-15 7.480E-15 1.190E-16 4.120E-14 1.020E-13 1. 020E-13 1.820E-14 1.120E-13 2. 940E-14 1. 300E-13 8.294E-14 1.560E-15 1.560E-15 1.190E-14 1.190E-14 1.190E-14 1.190E-14 Inhaled Thyroid (Sv/Bq)0. OOOE+00 0. OOOE+00 0. 000E+00 0. OOOE+00 0. OOOE+00 0. ODE+00 2.920E-07 1.740E-09 4.8 60E-08 2 .880E-10 8. 460E-09 0 .OOOE+00 0. CODE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 0 .000E+00 Daughter none none none none none none none none none none none Inhaled Effective (Sv/Bq)0. OOOE+00 0. 000E+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 8. 890E-09 1.030E-10 1.580E-09 3.550E-11 3.320E-10 0. O00E+00 0. OOOE+O0 0. OOOE+O0 0. 0OOE+-0O 0. OOOE+00 0.000E+00 Fraction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ction Daughter Fractior 21 none 0.00 00 none 0.00 00 none 0.00 00 none 0.00 00 none 0.00 58 Y-91 0.42 00 none 0.00 00 none 0.00 01 Nb-95 0.99 95 Nb-97 0.05 88 Tc-99 0.12 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 122 1 Tc-99m Ru-103 Ru-105 Ru-106 Sb-127 Sb-129 Te-127m Te-129 Te-129m Te-131m Te-132 1-131 1-133 1-135 Xe-133m Xe-135 Xe-135m Xe-137 Cs-137 Ba-140 La-141 Ce-143 Ce-144 Nd-147 Np-239 Pu-238 Pu-239 Tc-99 Rh-103m Rh-105 Rh-106 Te-127m Te-129m Te-127 1-129 Te-129 Te-131 1-132 Xe-131m Xe-1333m Xe-13 5m Xe-133 Cs-135 Xe-135 Cs-137 Ba-137m La-140 Ce-141 Pr-143 Pr-144m Pm-147 Pu-239 U-234 U-235 1.00 1.00 1.00 1.00 0.18 0.22 0.98 1.00 0.65 0.22 1.00 0.01 0.03 0.15 1.00 1.00 0.99 1.00 0.95 1.00 1.00 1.00 0.02 1.00 1.00 1.00 1.00 none none none none Te-127 Te-129 none none 1-129 1-131 none none Xe-133 Xe-135 none none Cs-135 none none none none none Pr-144 none none none none 0.00 0.00 0.00 0.00 0.82 0 .77 0.00 0.00 0.35 0.78 0.00 0.00 0. 97 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.98 0.00 0.00 0.00 0.00 none none none none none none none none none none none none none none none none none none none none none none none none none none none 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Iodine fractions Aerosol -Elemental Organic -COMPARTMENT DATA Compartment number Compartment number Compartment number 0.OOOE+00 5.7000E-01
: 4. 3000E-01 1: Refuel Floor Airspace 2: Environment 3: Control Room PATHWAY DATA Pathway number 1: Refuel Floor Airspace to Environment Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)7.6750E+00 0.OOOOE+00 Filter Efficiencies M%)Aerosol Elemental Organic 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.0000E+00 0.0000E+00 0.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)1.4000E+04 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 Pathway number 3: Control Room to Environment I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 123 1 ICLCULANN.C30-2E3082 IRVNo1 I PAEN. J2 Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)1.4000E+04 0.0000E+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OO0E+00 0.O0OOE+00 0.0000E+00 0.0000E+00 0.0000E+00 D.O00E+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr).2. 4000E+01 7.4400E+02 X/Q (s
* m^-3)1. 4100E-03 0.OOOE+00 Location Breathing Rate Data Time (hr) Breathing 2 4000E+01 3.2000E+01
: 4. 8000E+01 7.4400E+02 Location Low Population Zone Rate (mW3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 0.0000E+00 is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1.3500E-04 0.OOOOE+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3
* sec^-l)2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 0.0000E+00 Location Control Room is in compartment 3 Location X/Q Data Time (hr) X/Q (s
* m^-3)2.4000E+01 2.1500E-03 7.4400E+02 0.0000E+00 Location Breathing Rate Data Time (hr) Breathing Rate (mW3
* sec'-l)2.4000E+01 3.50OOE-04 7.4400E+02 0.0000E+00 Location Occupancy Factor Data Time (hr) Occupancy Factor 2.4000E+01
 
==1.0 000ED00==
4.8000E+01 6.0000E-01 1.2000E+02 4.0000E-01 7.4400E+02 0.0000E+00 USER SPECIFIED TIME STEP DATA -SUPPLEMENTAL TIME STEPS Time Time step 0.0000E+00 2.0000E-03 7.2000E+02 0.0000E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 1247 RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:31:42####.#################################i#################################
itti# it it #iti # #ttti it# ## # # # #t it i # i # i it # t# i it it it it# #it itttii it it it it it Dose Output##########################################################c#########
Exclusion Area Boundary Doses:.Time (h) = 24.0000 Whole Body Delta dose (rem) 1.8911E-06 Accumulated dose (rem) 1.8911E-06 Low Population Zone Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8107E-07 1.8107E-07 Whole Body 1.1886E-12 1.1886E-12 Exclusion Area Boundary Doses: Time (h) = 32.0000 Whole Body Delta dose (rem) 8.0083E-01 Accumulated dose (rem) 8.0083E-01 Thyroid 1.4300E-04 1.4300E-04 Thyroid 1.3692E-05 1.3692E-05 Thyroid 3.3302E-09 3.3302E-09 Thyroid 6.2001E+01 6.2001E+01 Thyroid 5.9363E+00 5.9363E+00 Thyroid 9. 4512E+01 9. 4512E+01 Thyroid 3. 0249E-15 6. 2001E+01* TEDE 6.2941E-06 6.2941E-06 TEDE 6.0262E-07 6.0262E-07 TEDE 1.0372E-10 1.0372E-10 TEDE 2.7093E+00 2.7093E+00 TEDE 2.5940E-01 2.5940E-01 TEDE 2.9419E+00 2.9419E+00 TEDE 1.4301E-16 2.7093E+00 Low Population Zone Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 7.6675E-02 7..6675E-02 Whole Body 3.2831E-02 3.2831E-02 Exclusion Area Boundary Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 5.0380E-17
: 8. 0083E-01 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 125 Low Population Zone Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 4.8236E-18 7.6675E-02 Whole Body 2.4413E-18 3.2831E-02 Exclusion Area Boundary Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.9673E-49 8.0083E-01 Low Population Zone Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.8411E-50 7.6675E-02 Whole Body 8.6805E-51 3.2831F-02 Thyroid 2. 8961E-16 5.9363E+00 Thyroid 1.0561E-14
: 9. 4512E+01 Thyroid 3.5423E-47
: 6. 2001E+01 Thyroid 3.3916E-48 5.9363E+00 Thyroid 5.8544E-47
: 9. 4512E+01 Thyroid 2.6550-191
: 6. 2001E+01 Thyroid 2.5420-192 5.9363E+00 Thyroid 2.9017-191
: 9. 4512E+01 TEDE 1.3693E-17
: 2. 5940E-01 TEDE 3.2584E-16
: 2. 9419E+00 TEDE 1.3788E-48 2.7093E+00 TEDE 1.3201E-49
: 2. 5940E-01 TEDE 1.7971E-48
: 2. 9419E+00 TEDE 9.5828-193 2.7093E+00 TEDE 9.1750-194
: 2. 5940E-01 TEDE 8.8668-193
: 2. 9419E+00 Exclusion Area Boundary Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4965-193 8.0083E-01 Low Population Zone Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4328-194 7.6675E-02 Whole Body 2.9007-195 3.2831E-02 360003 1-131 Summary###################'#################################################
Time (hr)24.000 24.250 24 .498 24.746 24.994 25.242 Refuel Floor Airspace 1-131 (Curies)1.0470E+02 3.3080E+01 1.0549E+01 3.3638E+00 1.0727E+00 3.4205E-01 Environment 1-131 (Curies)2 4107E-04 7. 1562E+01 9. 4076E+01 1. 0125E+02 1. 0354E+02 1. 0427E+02 Control Room 1-131 (Curies)3: 4245E-06 8.3295E-02 2.6602E-02 8.4829E-03 2.7050E-03 8.6259E-04 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGENO. 126 -25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 27.722 27.970 28.218 28.466 28.714 28.962 29.210 29.458 29.706 29.954 30.202 30.450 30. 698 30. 946 31.194 31.442 31.690 31. 938 32.000 32.248 32.496 32.744 32.992 33.240 33.488 33.736 33.984 34.232 48.000 120.000 744.000 1. 0908E-01 3. 4782E-02 1. 1091E-02 3. 5369E-03 1. 1278E-03 3 .5965E-04 1. 1469E-04 3. 6572E-05 1 .1 662E-05 3. 7188E-06 1 .1859E-06 3. 7816E-07 1. 2059E-07 3. 8453E-08 1. 2262E-08 3. 9102E-09 1. 2469E-09 3. 9761E-10 1. 2679E-10 4. 0432E-11 1. 2893E-11 4 1114E-12 1. 3110E-12 4. 1807E-13 1. 3332E-13 4. 2512E-14 1. 3556E-14 1. 0187E-14 3. 2485E-15 1. 0359E-15 3. 3033E-16 1. 0534E-16 3. 3590E-17 1. 0711E-17 3. 4156E-18 1. 0892E-18 3.4732E-19 9.6443E-47 7.5382-191 0.OOOOE+00
: 1. 0451E+02 1.0458E+02 1.04 61E+02 1. 0461E+02 1. 0461E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02
: 2. 7507E-04 8. 7714E-05 2. 7971E-05 8. 9193E-06 2. 8442E-06 9 .0697E-07 2. 8922E-07 9. 2227E-08 2. 9410E-08 9. 3782E-09 2. 9906E-09 9. 5364E-10 3. 0410E-10 9.6972E-11
: 3. 0923E-11 9. 8607E-12 3.1444E-12
: 1. 0027E-12 3. 1974E-13 1. 0196E-13 3. 2514E-14 1. 0368E-14 3. 3062E-15 1. 0543E-15 3. 3620E-16 1. 0721E-16 3.4187E-17 2 .5690E-17 8. 1921E-18 2 6123E-18 8. 3302E-19 2. 6564E-19 8. 4707E-20 2 7012E-20 8 6136E-21 2. 7467E-21 8. 7588E-22 2. 4321E-49 1.9010-193
: 0. 0000E+00 Cumulative Dose Summary Exclusion Area Bounda Low Population Zone Time (hr)24.000 24.250 24.498 24.746 24.994 25.242 25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 Thyroid (rem)0.0000E+00 4.2432E+01
: 5. 5767E+01 6. 0015E+01 6. 1369E+01 6. 1800E+01 6. 1937E+01 6. 1981E+01 6.1995E+01
: 6. 1999E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 TEDE (rem)0.OOOOE+00 1.8604E+00 2.4405E+00
: 2. 6241E+00 2.6823E+00 2.7007E+00 2.7065E+00 2.7084E+00 2.7090E+00 2.7092E+00 2.7092E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 Thyroid (rem)0.OOOOE+00 4.0626E+00 5.3394E+00 5.7461E+00 5.8757E+00 5.9170E+00
: 5. 9301E+00 5.9343E+00 5.9357E+00
: 5. 9361E+00 5.9362E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 TEDE (rem)0.0000E+00 1.7813E-01
: 2. 3366E-01 2. 5124E-01 2.5681E-01 2.5858E-01 2.5914E-01 2.5932E-01
: 2. 5937E-01 2 .5939E-01 2 .5940E-01 2 .5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 Control Room Thyroid TEDE (rem) (rem)0.OOOOE+00 0.OOOOE+00 5.9384E+01 1.8490E+00 8.3319E+01 2.5938E+00 9.0947E+01 2.8310E+00 9.3376E+01 2.9066E+00 9.4150E+01 2.9306E+00 9.4397E+01 2.9383E+00 9.4476E+01 2.9407E+00 9.4501E+01 2.9415E+00 9.4509E+01 2.9417E+00 9.4511E+01 2.9418E+00 9.4512E+01 2.9418E+00 9.4512E+01 2.9419E+00 9.4512E+01 2.9419E+00 9.4512E+01 2.9419E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 127 27.722 27. 970 28.218 28. 466 28.714 28. 962 29.210 29. 458 29.706 29. 954 30.202 30.450 30. 698 30. 946 31.194 31. 442 31. 690 31. 938 32.000 32.248 32.496 32 .744 32.992 33.240 33. 488 33.736 33. 984 34 232 48.000 120.000 744 .000 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6..2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00
: 2. 7093E+00 2. 793E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2.7093B+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00
: 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363B+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 5. 9363E+00 2. 5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01 2.5940E-01 2.5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01 2.5940E-01 2 .5940E-01 2.5940E-01 2.5940E-01 2.5940E-01 2.5940E-01 2.5940E-01 2.5940E-01 2.5940E-01 9.4512E+01
: 9. 4512E+01 9. 4512E+01 9. 4512E+01 9. 4512E+01 9.4512E+01
: 9. 4512E+01 9.4512E+01
: 9. 4512E+01 9 ;4512E+01 9. 4512E+01 9. 4512E+01 9. 4512E+01 9. 4512E+01 9. 4512E+01 9.4 512E+01 9. 4512E+01 9.4512E+01
: 9. 4512E+01 9. 4512E+01 9.4512E+01
: 9. 4512E+01 9. 4512E+01 9.4512E+01
: 9. 4512E+01 9.4512E+01
: 9. 4512E+01 9. 4512E+01 9. 4512E+01 9.4512E+01
: 9. 4512E+01 2 9419E+00 2 9419E+00 2. 9419E+00 2 9419E+00 2 9419E+00 2 9419E+00 2 9419E+00 2 9419E+00 2 9419E+00 2. 9419E+00 2 9419E+00 2 9419E+00 2. 9419E+00 2. 9419E+00 2 9419E+00 2 9419E+00 2 9419E+00 2. 9419E+00 2. 9419E+00 2. 9419E+00 2. 9419E+00 2. 9419E+00 2. 9419E+00 2 9419E+00 2. 9419E+00 2. 9419E+00 2. 9419E+00 2. 9419E+00 2. 9419E+00 2. 9419E+00 2. 9419E+00 Worst Two-Hour Doses Exclusion Time (hr)24.0 Area Boundary Whole Body Thyroid (rem) (rem)8.0076E-01 6.1995E+01 TEDE (rem)2.7090E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE No. 1281 20,000 cfm Case######################################################################4 RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:45:14#####################################################.##################
File information
##########################################
##############################
Plant file = C:\Program Files\radtrad3.03\OC AST\FHA 2007\FHA source release modified flow rates fixed inp file diffuse source xq less conservative iodine fractions 20000 cfm increased time steps.psf Inventory file = c:\program files\radtrad3.03\defaults\ocfhaikr.nif Release file = c:\program files\radtrad3.03\oc ast\oc fha.rft Dose Conversion file = c:\program files\radtrad3.03\oc ast\oc60.inp
#4444 # #44##44 4 #44 4. 4 444 4 4 4. 4 4 #4# 4 4 4 4 4 4### #### ##### #### ## # # ###S# # # # #4# # # # #4 #444 4 4 4 4 4 4444 4 Radtrad 3.03 4/15/2001 20000 cfm Nuclide Inventory File: c:\program files\radtrad3.03\defaults\ocfhaikr.nif Plant Power Level: 1.1310E+01 Compartments:
3 Compartment 1: Refuel Floor Airspace 3 1.0000E+02 0 0 0.0 0 Compartment 2: Environment 2 0.OOOOE+00 0 0 0 0*0.Compartment 3: Control Room 1 2.7500E+04 0
I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 129 ]0 0 0 0 Pathways: 3 Pathway 1: Refuel Floor Airspace to Environment 1 2 2 Pathway 2: Environment to Control Room 2 3 2 Pathway 3: Control Room to Environment 3 2 2 End of Plant Model File Scenario Description Name: Plant Model Filename: Source Term: 1 1 1.0000E+00 c:\program files\radtrad3.03\oc ast\oc60.inp c:\program files\radtrad3.03\oc ast\oc fha.rft 2.4000E401 1 0.OOOOE+00 5.7000E-01 4.3000E-01 1.OOOOE+00 Overlying Pool: 0 o.OOOE00 0 0 0 0 Compartments:
.3 Compartment 1: 0 1 0 0 0 0 0 0 0 Compartment 2: 0 1 0 0 0 0 0 0 0 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 130 1 Compartment 3: 0 1 0 0 0 0 0 0 0 Pathways: 3 Pathway 1: 0 0 0 0 0 2 2.4000E+01 7.4400E+02 0 0 0 0 0 0 Pathway 2: 0 0 0 0 0 1 2 2.4000E+01 7.4400E+02 0 a 0 0 0 0 Pathway 3: 0 0 0 0 0 1 2 2.4000E+01 7.4400EC02 0 0 0 0 0 0 Dose Locations:
3 Location 1: 7.6750E+00 0.0000E+00 2.0000E+04 o.0000E+00 2.0000E+04 0.0000E+00 0.0000E+00 0.0000E+00 o.0000E+00 o.0000E+00 o.0000E+00 0.0000E+00 o .CCCE+CC o .CCCE+CC o .CCCE+CC C. CCCCE+/-CC o .CCCE+/-CC o .CCCCE+/-C C. CCCCE-i-C C. CCCCE+0C C. CCCCE+CC C. OCCOE+CC C. CCCCE+/-CC C. CCCCE+0C I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 131 1 Exclusion Area Boundary 2 1 2 2.4000E+01 7.4400E+02 1 4 2.4000E+01
: 3. 2000E+01 4.8000E+01 7.4400E+02 0 1. 4100E-03 0.0000E+00 3.5000E-04 1.8000E-04 2.3000E-04 o.0000E+00 Location 2: Low Population Zone 2 1 2 2.4000E+01 1.35 7.4400E+02 0.00(1 4 2.4000E+01 3.50C 3.2000E+01 1.80(4.8000E+01 2.30C 7.4400E+02 0.00C 0 OOE-04 00E+00 OOE-04 OOE-04 0OE-04 00E+00 Location 3: Control Room.3 0 1 2 2.4000E+01 3.5000E-04 7.4400E+02 0.0000E+00 1 4 2.4000E+01 1.0000E+00 4.8000E+01 6.000CE-01 1.2000E+02 4.0000E-01 7.4400E+02 0.0000E+00 Effective Volume Location: 1 2 2.4000E+01 2.1500E-03 7.4400E+02 0.CCCCE+00 Simulation Parameters:
2 2.4000E+01 2.0000E-03 7.4400E+02 0.0000E+00 Output Filename: C:\Program Files\radtrad3.o779 0 0 End of Scenario File CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 132#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:45:14#######################################################################
#######################################################################
Plant Description
#######################################################################
Number of Nuclides = 60 Inventory Power = 1.0000E+00 Mwth Plant Power Level = 1.1310E+01 MWth Number of compartments
= 3 Compartment information Compartment number 1 (Source term fraction = 1.OOOOE+00 Name: Refuel Floor Airspace Compartment volume = 1.0000E+02 (Cubic feet)Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Refuel Floor Airspace to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: Refuel Floor Airspace to Environment Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 2.7500E+04 (Cubic feet)Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Total number of pathways 3 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 133 1 I CLUAINN.C30-2E3002 i RV o IPAEO13 I RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:45:14########################i##4##
##4######i##44###############4##
Scenario Description
################1
###) ########4###1##1( #############4#i(4f(1#4##41(1(Time between shutdown and first release = 2.4000E+01 (Hours)Radioactive Decay is enabled Calculation of Daughters is enabled I Release Fractions and Timings NOBLES IODINE CESIUM TELLURIUM STRONTIUM BARIUM RUTHENIUM CERIUM LANTHANUM GAP 0.000001 hr 5.0000E-02 2.5000E-04 0.0000E+00 0.0000E+00 0.0000E+00 O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 EARLY IN-VESSEL 0.0000 hrs 0 OOOOE+00 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00 0 OOOOE+00.0 OOOE+00 0 OOOOE+00 0 OOOOE+00 LATE RELEASE 0.0000 hrs 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOO0E+00 0.OOOOE+00 0.OOOOE+00 RELEASE MASS (gm)1. 329E+00 1. 100E-03 0 .OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. 00E+00 0. OOOE+00 Inventory Power 11. MWt Nuclide Name Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 1-131 1-132 1-133 1-134 1-135 Xe-133 Xe-133m Xe-135 Xe-135m Xe-137 Xe-138 Nuclide Kr-85m Kr-87 Kr-88 Kr-89 Sr-90 Sr-91 Sr-92 Y-93 Zr-95 Zr-97 Mo-99 Group Specific Inventory (Ci/MWt)1 4.150E+03 1 6.940E+03 1 8 .060E+02 1 1.290E+04 1 1.830E+04 1 3 .980E+04 2 4. 016E+04 2 3.660E+04 2 5.180E+04 2 5.600E+04 2 4.820E+04 1 5.230E+04 1 1.380E+03 1 1.810E+04 1 1.560E+04 1 5.100E+04 1 4.780E+04 Daughter Fra Kr-85 0.Rb-87 Rb-88 11 Sr-89 11 Y-90 1.Y-91m 0.Y-92 11 Zr-93 11 Nb-95m 0.Nb-97m 02 Tc-99m 0.half life (s)6. 696E+03 1. 613E+04 3. 386E+08 4.578E+03 1. 022E+04 1. 896E+02 6. 947E+05 8 .280E+03 7. 488E+04 3. 156E+03 2. 380E+04 4.532E+05 1. 927E+05 3 .272E+04 9. 180E+02 2 .304E+02 8. 520E+02 Whole Body DCF (Sv-m3/Bq-s) 7.480E-15 7. 480E-15 1. 190E-16 4 120E-14 1. 020E-13 1. 020E-13 1. 820E-14 1. 120E-13 2. 940E-14 1. 300E-13 8 294E-14 1. 560E-15 1. 560E-15 1. 190E-14 1. 190E-14 1.190E-14 1.190E-14 Inhaled Thyroid (Sv/Bq)0. OOOE+00 0. OOOE+00 0.OOOE+00 0. OOOE+00 0. 0O0E+00 0. OOOE+00 2.920E-07 1.740E-09 4.860E-08 2.880E-10 8.460E-09 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 Daughter none none none none none none none none none none none Inhaled Effective (Sv/Bq)0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0 OOOE+00 0 OOOE+00 8 890E-09 1. 030E-10 1. 580E-09 3. 550E-11 3. 320E-10 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 Fraction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 ction Daughter Fraction 21 none 0.00 00 none 0.00 00 none 0.00 00 none 0.00 00 none 0.00 58 Y-91 0.42 00 none 0.00 00 none 0.00 01 Nb-95 0.99 95 Nb-97 0.05 88 Tc-99 0.12 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 134 ]Tc-99m Ru-103 Ru-105 Ru-106 Sb-127 Sb-129 Te-127m Te-129 Te-129m Te-131m Te-132 1-131 1-133 1-135 Xe-133m Xe-135 Xe-135m Xe-137 Cs-137 Ba-140 La-141 Ce-143 Ce7144 Nd-147 Np-239 Pu-238 Pu-239 Tc-99 Rh-103m Rh-105 Rh-106 Te-127m Te-129m Te-127 1-129 Te-129 Te-131 1-132 Xe-131m Xe-133m Xe-135m Xe-,133 Cs-135 Xe-135 Cs-137 Ba-137m La-140 Ce-141 Pr-143 Pr-144m Pm-147 Pu-239 U-234 U-235 1.00 1.00 1 .00 1.00 0.18 0.22 0. 98 1.00 0.65 0.22 1.00 0.01 0.03 0.15 1 .00 1.00 0.99 1.00 0. 95 1.00 1.00 1.00 0.02 1.00 1.00 1.00 1.00 none none none none Te-127 Te-129 none none 1-129 1-131 none none Xe-133 Xe-135 none none Cs-135 none none none none none Pr-144 none none none none 0.00 0.00 0.00 0.00 0.82 0.77 0.00 0.00 0.35 0.78 0.00 0.00 0.997 0.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.98 0.00 0.00 0.00 0.00 none none none none none none none none none none none none none none none none none none none none none none none none none none none 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0. 00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Iodine fractions Aerosol =Elemental
=Organic* =COMPARTMENT DATA Compartment number Compartment number Compartment number 0.OOOOE+00 5.7000E-01 4.3000E-01 1: Refuel Floor Airspace 2: Environment 3: Control Room PATHWAY DATA Pathway number 1: Refuel Floor Airspace to Environment Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)7.6750E+00 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathwaynumber 2: Environment to Control Room Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)2.OOOOE+04 0.OOOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 3: Control Room to Environment I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 135 1 Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)2.OOOE+04 0.OOOE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOO0E+00 0.0OOOE+00 0.0O00E+00 0.OOOE+00 0.OOOOE+00 0.0O00E+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m"-3)1. 41O0E-03 0.0000E+00 Location Breathing Rate Data Time (hr) Breathing 2.4000E+01
: 3. 2000E+01 4.8000E+01 7.4400E+02 Location Low Population Zone Rate (mW3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 0.0000E+00 is in compartment 2 Location X/Q Data Time (hr) X/(2.4000E+01 7.4400E+02 Location Breathing Rat Time (hr) BrE 2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 Location Control Room Location X/Q Data Time (hr) X/(2.4000E+01 7.4400E+02 Location Breathing Rat Time (hr) BrE 2 .4000E+01 7.4400E+02 Location Occupancy Fa(Time (hr) Occ 2.4000E+01
: 4. 8000E+01 1.2000E+02 7.4400E+02 (s
* m^-3)1.3500E-04 0.0000E+00 te Data eathing Rate (m^3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 0.0000E+00 is in compartment 3 (s
* m^-3)2.1500E-03 0.0000E+00 te Data eathing Rate (m^3 sec^-l)3.5000E-04 0.0000E+00 ctor Data cupancy Factor 1.0000E+00
: 6. OODE-01 4. OOOOE-01 0.0O00E+00 USER SPECIFIED TIME STEP DATA -SUPPLEMENTAL TIME STEPS Time Time step O.OOODE+00 2.0D00E-03 7.2000E+02 0.0O00E+00 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 136##################################D####################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:45:14#######################################################################
##iit# it#t t it it t it it it it it it it it it it it # it it it it it it it it it it itittiti it it it it it it it it #it itittiti it it it it it it it it it itiiti iiiti it it###################################################################D Dose Output Exclusion Area Boundary Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1. 8911E-06 1.8911E-06 Low Population Zone Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8107E-07 1.8107E-07 Whole Body 1. 6980E-12 1.6980E-12 Exclusion Area Boundary Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 8.0083E-01 8.0083E-01 Thyroid 1.4300E-04 1.4300E-04 Thyroid 1.3692E-05 1.3692E-05 Thyroid 4.7574E-09 4.7574E-09 Thyroid 6.2001E+01
: 6. 2001E+01 Thyroid 5.9363E+00 5.9363E+00 Thyroid 9. 4518E+01 9. 4518E+01 Thyroid 3. 0249E-15 6.2001E+01 TEDE 6.2941E-06
: 6. 2941E-06 TEDE 6.0262E-07 6.0262E-07 TEDE 1.4818E-10 1.4818E-10 TEDE 2.7093E+00 2.7093E+00 TEDE 2. 5940E-01 2. 5940E-01 TEDE 2. 9421E+00 2. 9421E+00 TEDE 1. 4301E-16 2.7093E+00 Low Population Zone Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Control RoomDoses:
Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 7.6675E-02 7.6675E-02 Whole Body 3:2867E-02 3.2867E-02 Exclusion Area Boundary Doses: Time (h) = 48.0000 Whole Body Delta dose (rem) 5.0380E-17 Accumulated dose (rem) 8.0083E-01 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 137 Low Population Zone Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 4. 8236E-18 7.6675E-02 Whole Body 2.3179E-18 3.2867E-02 Exclusion Area Boundary Doses: Time (h) = 120.0000 Whole Body Delta dose (rem) 2.9673E-49 Accumulated dose (rem) 8.0083E-01 Low Population Zone Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.8411E-50 7.6675E-02 Whole Body 8. 2416E-51 3.2867E-02 Thyroid 2. 8961E-16 5.9363E+00 Thyroid 1.0027E-14 9.4518E+01 Thyroid 3.5423E-47 6.2001E+01 Thyroid 3. 3916E-48 5.9363E+00 Thyroid 5.5584E-47
: 9. 4518E+01 Thyroid 2.6550-191
: 6. 2001E+01 Thyroid 2.5420-192 5.9363E+00 Thyroid 2.7550-191
: 9. 4518E+01 TEDE 1. 3693E-17 2.5940E-01 TEDE 3.0937E-16 2.9421E+00 TEDE 1.3788E-48 2.7093E+00 TEDE 1.3201E-49 2.5940E-01 TEDE 1.7062E-48
: 2. 9421E+00 TEDE 9.5828-193 2.7093E+00 TEDE 9.1750-194
: 2. 5940E-01 TEDE 8.4184-193
: 2. 9421E+00 Exclusion Area Boundary Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4965-193
: 8. 0083E-01 Low Population Zone Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose. (rem)Whole Body 1.4328-194 7.6675E-02 Whole Body 2.7540-195 3.2867E-02 360003##1#################################################################
1-131 Summary Time (hr)24.000 24.250 24.498 24.746 24.994 25.242 Refuel Floor Airspace 1-131 (Curies)1.0470E+02 3.3080E+01 1.0549E+01 3.3638E+00 1.0727E+00
: 3. 4205E-01 Environment 1-131 (Curies)2.4107E-04 7.1562E+01
: 9. 4076E+01 1.0125E+02 1.0354E+02 1.0427E+02 Control Room 1-131 (Curies)4.8921E-06 7.9199E-02 2.5257E-02 8.0540E-03 2.5683EL03 8.1898E-04 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGENO. 138N 25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 27.722 27.970 28.218 28.466 28.714 28.962 29.210 29.458 29.706 29.954 30.202 30.450 30.698 30.946 31.194 31.442 31.690 31.938 32.000 32.248 32.496 32.744 32. 992 33.240 33.488 33.736 33.984 34.232 48.000 120.000 744.000 1.0908E-01 3.4782E-02
: 1. 1091E-02 3.5369E-03 1.1278E-03 3.5965E-04
: 1. 1469E-04 3.6572E-05
: 1. 1662E-05 3. 7188E-06 1. 1859E-06 3. 7816E-07 1. 2059E-07 3. 8453E-08 1. 2262E-08 3. 9102E-09 1 .2469E-09 3. 9761E-10 1 .2679E-10 4. 0432E-11 1. 2893E-11 4 1114E-12 1. 3110E-12 4 1807E-13 1. 3332E-13 4. 2512E-14 1. 3556E-14 1. 0187E-14 3.2485E-15
: 1. 0359E-15 3. 3033E-16 1. 0534E-16 3. 3590E-17 1. 0711E-17 3 4156E-18 1. 0892E-18 3. 4732E-19 9. 6443E-47 7.5382-191
: 0. 0000E+00 1.0451E+02 1.0458E+02
: 1. 0461E+02 1.0461E+02
: 1. 04 61E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02
: 2. 6116E-04 8.3279E-05 2.6556E-05 8.4683E-06 2.7004E-06 8.6111E-07 2.7459E-07 8.7564E-08 2.7923E-08 8.9040E-09 2.8393E-09 9.0542E-10 2.8872E-10 9.2069E-11
: 2. 9359E-11 9. 3621E-12 2.9854E-12
: 9. 5200E-13 3. 0358E-13 9.6806E-14
: 3. 0870E-14 9. 8438E-15 3. 1390E-15 1.0010E-15
: 3. 1920E-16 1.0179E-16
: 3. 2458E-17 2.4391E-17 7 .7779E-18 2.4802E-18
: 7. 9090E-19 2 .5221E-19 8.0424E-20
: 2. 5646E-20 8 1780E-21 2 6078E-21 8. 3159E-22 2. 3091E-49 1.8049-193 0 OOOOE+00############################################################C#######
* Cumulative Dose Summary Exclusion Area Bounda Low Population Zone Time Thyroid (hr)24.000 24.250 24.498 24.746 24.994 25.242 25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 (rem)0.0O00E+00 4.2432E+01 5.5767E+01
: 6. 0015E+01 6. 1369E+01 6. 1800E+01 6. 1937E+01 6. 1981E+01 6. 1995E+01 6. 1999E+01 6.2001E+1l
: 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 TEDE (rem)0.0000E+00 1.8604E+00 2.4405E+00 2.6241E+00 2;6823E+00 2.7007E+00 2.7065E+00 2.7084E+00 2.7090E+00 2.7092E+00 2.7092E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 Thyroid (rem)0.OOOOE+00 4.0626E+00 5.3394E+00 5.7461E+00 5.8757E+00 5.9170E+00 5.9301E+00 5.9343E+00 5.9357E+00
: 5. 9361E+00 5.9362E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 TEDE (rem)0.OOOOE+00
: 1. 7813E-01 2.3366E-01
: 2. 5124E-01 2.5681E-01
: 2. 5858E-01 2.5914E-01
: 2. 5932E-01 2. 5937E-01 2.5939E-01
: 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01 Control Thyroid (rem)0.OOQ0E+00
: 6. 1158E+01 8 3891E+01 9. 1132E+01 9. 3439E+01 9.41374E+0i
: 9. 4408E+01 9 4483E+01 9. 4507E+01 9. 4514E+01 9. 4517E+01 9. 4517E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01-Room TEDE (rem)0.OOOOE+00 1.9042E+00
: 2. 6117E+00 2.8369E+00 2.9086E+00
: 2. 9314E+00 2.9387E+00
: 2. 9410E+00 2.9418E+00 2.9420E+00
: 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 139 1 27.722 6.2001E+01 27.970. 2001E+01 28.218 6.2001E+01 28.466 6.2001E+01 28.714 6.2001E+01 28.962 6.2001E+01 29.210 6.2001E+01 29.458 6.2001E+01 29.706 6.2001E+01 29.954 6.2001E+01 30.202 6.2001E+01 30.450 6.2001E+01 30.698 6.2001E+01 30.946 6.2001E+01 31.194 6.2001E+01 31.442 6.2001E+01 31.690 6.2001E+01 31.938 6 2001E+01 32.000 6.2001E+01 32.248 6.2001E+01 32.496 6.2001E+01 32.744 6.2001E+01 32.992 6.2001E+01 33.240 6.2001E+01 33.488 6.2001E+01 33.736 6.2001E+01 33.984 6.2001E+01 34.232 6.2001E+01 48.000 6.2001E+01 120.000 6.2001E+01 744.000 6.2001E+01 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00
: 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00
: 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00
: 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-0i 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2.5940E-01
: 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9 .4518E+0I 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9. 4518E+01 9.4518E+01
: 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2.9421E+00
: 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2.9421E+00
: 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 2. 9421E+00 Worst Two-Hour Doses Exclusion Time (hr)24 .0 Area Boundary Whole Body .Thyroid (rem) (rem)8.0076E-01 6.1995E+01 TEDE (rem)2.7090E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 140 I 28,000 cfm Case RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:57:53####4###########4#######################4##################4########
#44#################################################################
File information
##############4#######################4##4###
##### ################
Plant file = C:\Program Files\radtrad3.03\OC AST\FHA 2007\FHA source release modified flow rates fixed inp file diffuse source xq less conservative iodine fractions 28000 cfm increased time steps.psf Inventory file = c:\program files\radtrad3.03\defaults\ocfhaikr.nif Release file = c:\program files\radtrad3.03\oc ast\oc fha.rft Dose Conversion file = c:\program files\radtrad3.03\oc ast\oc6O.inp
#4444 4 4 4 4 44444 4444 #4444 4 4 4 4 4444 4444 44 44 4444 4# #4 4 4 4 #4##4 # #44444 4 4 4 4#4444 4 4 4 4 4 44444 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4#444 4 Radtrad 3.03 4/15/2001 28000 cfm Nuclide Inventory File: c:\program files\radtrad3.03\defaults\ocfhaikr.nif Plant Power Level: 1.1310E+01
, Compartments:
3 Compartment 1: Refuel Floor Airspace 3 1.0000E+02 0 0 0 0 0 Compartment 2: Environment 2 0.0000E+00 0 0 0 0 0 Compartment 3: Control Room 1 2.7500E+04 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 141 0 0 Pathways: 3 Pathway 1: Refuel Floor Airspace to Environment 1 2 2 Pathway 2: Environment to Control Room 2 3 2 Pathway 3: Control Room to Environment 3 2 2 End of Plant Model File Scenario Description Name: Plant Model Filename: Source Term: 1 1 1.OOOOE+00 c:\program files\radtrad3.03\oc ast\oc60.inp c:\program files\radtrad3.03\oc ast\oc fha.rft 2.4000E+01 1 0.0000E+00 5.7000E-01 4.3000E-01 1.OOOOE+00 Overlying Pool: 0 o.OOOE+00 0 0 0 0 Compartments:
3 Compartment 1: 0 1 0 0 0 0 0 0 0 Compartment 2: 0 1 0 0 0 0 0 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 142 10 Compartment 3: 0 1 0 0 0 0 0 0 0 Pathways:.3 Pathway 1: 0 0 0 0 0 1 2 2.4000E+01 7.4400E+02 0 0 0 0 0 0 Pathway 2: 0 0 0 0 0 1 2 2.4000E+01 7.4400E+02 0 0 0 0 0 0 Pathway 3: 0 0 0 0 0.i 7.6750E+00 0.0000E+00 2.8000E+04 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.OOOOE+00 0.0000E+00 2 2.4000E+01 2.8000E+04 7.4400E+02 0.0000E+00 0 0 0 0 0 0 Dose Locations:
3 0. OOOOE+00 0. 0000E+/-00 0. OOOOE+00 0. OOOOE+00 0. OOOOE+/-00 I CALCULATION NO. C-1302-822-E310-082 I N. No. 1 I PAGE NO. 143 I CACLTO O -3282-3002 RV o I PAENO 4 Location 1: Exclusion Area Boundary 2 1 2 2.4000E+01 1.41O0E-03 7.4400E+02 O.OOOOE+00 1 4 2.4000E+01 3.5000E-04 3.2000E+01 1.8000E-04 4.8000E+01 2.3000E-04 7.4400E+02 0.OOOE+00 0 Location 2: Low Population Zone 2 1 2 2.4000E+01 7.4400E+02 1 4, 2.4000E+01 3.2000E+01 4.8000E+01 7.4400E+02 0 Location 3: Control Room 3 0 1 2 2.4000E+01 7.4400E+02 1 1.3500E-04 0.OOOOE+00 3.50O0E-04 1.8000E-04 2.3000E-04 o.0000E+00 3.5000E-04 O.0000E+00 4 2.4000E+01 1.OOOE+00 4.8000E+01 6.OOOOE-01 1.2000E+02 4.OOOOE-01 7.4400E+02 0.0000E+00 Effective Volume Location: 1 2 2.4000E+01 2.1500E-03 7.4400E+02 0.0000E+06 Simulation Parameters:
2 2.4000E+01 2.OOO0E-03 7.4400E+/-02
.0.0000E+00 Output Filename: C:\Prcogram Files\radtrad3.o781 1 1 1 0 0 End of Scenario File CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 144#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:57:53############################################################.###########
4##4#####4######4########4##4#444#######4###4########4###4############4#
Plant Description
#######################################################################
Number of Nuclides = 60 Inventory Power = 1.0000E+00 MWth Plant Power Level = 1.1310E+01 MWth Number of compartments
= 3 Compartment information Compartment number 1 (Source term fraction = 1.OOOOE+00 Name: Refuel Floor Airspace Compartment volume = 1.OOOOE+02 (Cubic feet)Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Refuel Floor Airspace to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: Refuel Floor Airspace to Environment.
Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 2.7500E+04 (Cubic feet)Compartment type is Control Room Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Total number of pathways CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 145#######################################################################
RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:57:53#######################################################################
4#######################################################################
Scenario Description Time between shutdown and first release Radioactive Decay is enabled Calculation of Daughters is enabled 2.4000E+01 (Hours)Release Fractions and Timings NOBLES IODINE CESIUM TELLURIUM STRONTIUM BARIUM RUTHENIUM CERIUM LANTHANUM GAP 0.000001 hr 5.OOOOE-02 2.5000E-04 0.0000E+00 0.0000E+00 0.0000E+00 O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 EARLY IN-VESSEL 0.0000 hrs 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.O000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 LATE RELEASE 0.0000 hrs 0.OOOOE+00 0.OOOOE+00
: 0. OOOE+00 0.OOOOE+00 0.OOOOE+00 O.OOOOE+00 0.0000OE+00 0.OOOOE+00 0.OOOOE+00 RELEASE MASS (gm)1.329E+00 1. lOOE-03 0. OOOE+00 0. OOOE+00 0. 00OE+00 0.OOOE+00 0. OOOE+00 0. 00OE+00 0. OOE+00 Inventory Power 11. MWt Nuclide Namp Kr-83m Kr-85m Kr-85 Kr-87 Kr-88 Kr-89 1-131 1-132 1-133 1-134 1-135 Xe-133 Xe-133m Xe-135 Xe-135m Xe-137 Xe-138 Group Specific Inventory (Ci/MWt)1 4.150E+03 1 6. 940E+03 1 8.060E+02 1 1.290E+04 1 .830E+04 1 3 .980E+04 2 4. 016E+04 2 3. 660E+04 2 5.180E+04 2 5. 600E+04 2 4. 820E+04 1 5.230E+04 1 1.380E+03 1 1.810E+04 1 l.560E+04 1 5.100E+04 1 4.780E+04 half life (s)6. 696E+03 1 613E+04 3 386E+08 4. 578E+03 1 022E+04 1 896E+02 6 947E+05 8 280E+03 7 .488E+04 3. 156E+03 2. 380E+04 4 .532E+05 1. 927E+05 3. 272E+04 9. 180E+02 2. 304E+02 8. 520E+02 Whole Body DCF (Sv-m3/Bq-s) 7.480E-15.7.480E-15 1.190E-16 4. 120E-14 1.020E-13 1.020E-13 1.820E-14.1.120E-13 2.940E-14 1.300E-13 8.294E-14 1.560E-15.1.560E-15 1.190E-14 1.190E-14 1.190E-14 1.190E-14 Inhaled Thyroid (Sv/Bq)0. OOOE+00 0. OOOE+00 0.OOOE+00 0. OO0E+00 0. OOOE+00 0. OOOE+00 2. 920E-07 1. 740E-09 4.860E-08 2.880E-10 8.460E-09 0.OO0E+00 0. OOOE+00 0. OOOE+00 0. OOOE+00 0.OOOE+00 0. OOOE+00 Inhaled Effective (Sv/Bq)0 OOOE+00 0 OOOE+00 0 0O0E+00 0 000E+00 0 OOOE+00 0. 000E+0 8 890E-09 1. 030E-10 1.580E-09 3.550E-11 3.320E-10 0.OOOE+00 0. OOOE+00 0.OOOE+00 0. OOOE+00 0. OOOE+00 0. 0OOE+00 Fraction 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Nuclide Daughter *Fraction Kr-85m Kr-87 Kr-88 Kr-89 Sr-90 Sr-91 Sr-92 Y-93 Zr-95 Zr-97 Mo-99 Kr-85 Rb-87 Rb-88.Sr-89 Y-90 Y-91m Y-92 Zr-93 Nb-95m Nb-97m Tc-99m 0.21 1.00 1.00 1.00 1.00 0.58 1.00 1.00 0.01 0.95 0.88 Daughter Fraction Daughter none 0.00 none none 0.00 none none 0.00 none none 0.00 none none 0.00 none Y-91 0.42 none none 0.00 none none 0.00 none Nb-95 0.99 none Nb-97 0.05 none Tc-99 0.12 none I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 146 ]Tc-99m Ru-103 Ru-105 Ru-106 Sb-127 Sb-129 Te-127m Te-129 Te-129m Te-131m Te-132 1-131 1-133 1-135 Xe-133m Xe-135 Xe-135m Xe-137 Cs-137 Ba-140 La-141 Ce-143 Ce-144 Nd-147 Np-239 Pu-238 Pu-239 Tc-99 Rh-103m Rh-105 Rh-106 Te-127m Te-129m Te-127 1-129 Te-129 Te-131 1-132 Xe-131m Xe-133m Xe-135m Xe-133 Cs-135 Xe-135 Cs-137 Ba-137m La-140 Ce-141 Pr-143 Pr-144m Pm-147 Pu-239 U-234 U-235 1.00 1.00 1.00 1.00 0.18 0.22 0.98 1.00 0.65 0.22 1.00 0.01 0.03 0.15 1.00 1.00 0.99 1.00 0.95 1.00 1.00 1.00 0.02 1.00 1.00 1.00 1.00 none none none none Te-127 Te-129 none none 1-129 1-131 none none Xe-133 Xe-135 none none Cs-135 none none none none none Pr-144 none none none none 0.00 0.00 0.00 0.00 0.82 0.77 0.00 0.00 0.35 0.78 0.00 0.00 0.97 0.85 0. 00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.98 0.00 0.00 0.00 0.00 none none none none none none none none none none none none none none none none none none none none none none none none none none none 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Iodine fractions Aerosol -Elemental
=Organic =COMPARTMENT DATA Compartment number Compartment number Compartment number 0.00OOE+00 5.700CE-01
: 4. 3000E-01 1: Refuel Floor Airspace 2: Environment 3: Control Room PATHWAY DATA Pathway number 1: Refuel Floor Airspace to Environment Pathway Filter: Removal Data Time (hr).2. 4000E+01 7.4400E+02 Flow Rate (cfm)7.6750E+00 0.0000OE+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.OOOOE+00 O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02
.Flow Rate (cfm)2.8000E+04 0.0000E+00 Filter Efficiencies
(%).Aerosol Elemental Organic 0.0000E+00 0.0OCOE+00 0.O000E+00 0.OOOOE+00 0.0000E+00 0.0000E+00 Pathway number 3: Control Room to Environment I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 I PAGE NO. 147 1 ICLCLTO NOC-3282E102 I RV o IL PAEN.17 I Pathway Filter: Removal Data Time (hr)2.4000E+01 7.4400E+02 Flow Rate (cfm)2.8000E+04 0.0000E+00 Filter Efficiencies
(%)Aerosol Elemental Organic 0.0OO0E+00 0.OQ00E+00 0.OOOE+00 0.0000E+00 O.OOOOE+00 O.OOOOE+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1. 4100E-03 0.OOOE+00 Location Breathing Rate Data Time (hr) Breathing 2.4000E+01
: 3. 2000E+01 4.8000E+01 7.4400E+02 Location Low Population Zone Rate (mW3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 C.OO00E+00 is in compartment 2 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 X/Q (s
* m^-3)1.3500E-04 0.OOOOE+00 Location Breathing Rate De Time (hr) Breathi 2.4000E+01
: 3. 2000E+01 4. 8000E+01 7.4400E+02 Location Control Room ing Rate (mW3
* sec^-l)3.5000E-04 1.8000E-04 2.3000E-04 0.0000E+00 is in compartment 3 Location X/Q Data Time (hr)2.4000E+01 7.4400E+02 Location Breathing Time (hr)2.4000E+01 7.4400E+02 Location Occupancy Time (hr)2.4000E+01 4.8000E+01 1.2000E+02 7.4400E+02 X/Q (s
* m^-3)2.1500E-03 C.OOCE+00 Rate Data Breathing Rate (m^3 sec^-l)3.5000E-04
.0000OE+00 Factor Data Occupancy Factor 1.0000E+00 6.0000E-01
: 4. COOCE-01 C.O000E+00 USER SPECIFIED TIME STEP DATA -SUPPLEMENTAL TIME STEPS Time C.0000E+00 7.2000E+02 Time step 2.0000E-03 0.0000E+00 CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGE NO. 148 RADTRAD Version 3.03 (Spring 2001) run on 7/01/2008 at 11:57:53#############i##############################################i###########
itititit it it it#ititit it it it it it it it it it it it it it it it it A it it it it it # ..it it ititititit it it it it it itit it it it it it it it ititititit it it it it it it it it it it it it it it it itititit it####################################################################
Dose Output####################################################################
Exclusion Area Boundary Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.8911E-06 1.8911E-06 Low Population Zone Doses: Time (h) = 24.0000 Whole Body Delta dose (rem) 1.8107E-07 Accumulated dose (rem) 1.8107E-07 Control Room Doses: Time (h) = 24.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.3771E-12 2.3771E-12 Exclusion Area Boundary Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 8.0083E-01
: 8. 0083E-01 Thyroid 1.4300E-04 1.4300E-04 Thyroid 1.3692E-05 1.3692E-05 Thyroid 6.6603E-09 6.6603E-09 Thyroid 6. 2001E+01 6. 2001E+01 Thyroid 5.9363E+00 5.9363E+00 Thyroid 9. 4520E+01 9.4520E+01
*Thyroid 3.024 9E-15 6. 2001E+01 TEDE 6. 2941E-06 6. 2941E-06 TEDE 6.0262E-07 6.0262E-07 TEDE 2. 0745E-10 2. 0745E-10 TEDE 2.7093E+00 2.7093E+00 TEDE 2.5940E-01 2.5940E-01 TEDE 2.9422E+00 2.9422E+00 TEDE 1.4301E-16 2.7093E+00 Low Population Zone Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 32.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 7.6675E-02 7.6675E-02 Whole Body 3.2890E-02 3.2890E-02 Exclusion Area Boundary Doses: Time (h) = 48.0000 Whole Body Delta dose (rem) 5.0380E-17 Accumulated dose (rem) 8.0083E-01 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGENO. 149J Low Population Zone Doses: Time (h) = 48.0000 Whole Body Delta dose (rem) 4.8236E-18 Accumulated dose (rem) 7.6675E-02 Control Room Doses: Time (h) = 48.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.2423E-18 3.2890E-02 Exclusion Area Boundary Doses: Time (h) = 120.0000 Whole Body Delta dose (rem) 2.9673E-49 Accumulated dose (rem) 8.0083E-01 Low Population Zone Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 120.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 2.8411E-50 7.6675E-02 Whole Body 7. 9728E-51 3.2890E-02 Thyroid 2.8961E-16 5.9363E+00 Thyroid 9. 6997E-15 9.4520E+01 Thyroid 3.5423E-47
: 6. 2001E+01 Thyroid 3. 3916E-48 5.9363E+00 Thyroid 5. 3771E-47 9. 4520E+01 Thyroid 2.6550-191
: 6. 2001E+01 Thyroid 2.5420-192 5.9363E+00 Thyroid 2.6651-191 9.4520E+01 TEDE 1.3693E-17
: 2. 5940E-01 TEDE 2. 9928E-16 2.9422E+00 TEDE 1.3788E-48 2.7093E+00 TEDE 1. 3201E-49 2. 5940E-01 TEDE 1.6506E-48 2.9422E+00 TEDE 9.5828-193 2.7093E+00 TEDE 9.1750-194
: 2. 5940E-01 TEDE 8.1439-193 2.9422E#00 Exclusion Area Boundary Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.4965-193 8.0083E-01 Low Population Zone Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Control Room Doses: Time (h) = 744.0000 Delta dose (rem)Accumulated dose (rem)Whole Body 1.A328-194 7.6675E-02 Whole Body 2.6642-195 3.2890E-02 360003####################################################################
1-131 Summary####################################################################
Time (hr)24 .000 24.250 24.498 24 .746 24 .994 25.242 Refuel Floor Airspace 1-131 (Curies)1.0470E+02 3.3080E+01 1.0549E+01 3.3638E+00 1.0727E+00 3.4205E-01 Environment 1-131 (Curies)2.4107E-04 7.1562E+01 9.4076E+01 1.0125E+02 1.0354E+02 1.0427E+02 Control Room 1-131 (Curies)6.8489E-06 7.6621E-02 2.4433E-02 7.7913E-03 2.4845E-03 7.9227E-04 CALCULATION NO. C-1302-822-E310-082 REV. No. 1 PAGE NO. 150 25.490 25.738 25.986 26.234 26.482 26.730 26.978 27.226 27.474 27.722 27.970 28.218 28.466 28.714 28.962 29.210 29.458 29.706 29.954 30.202 30.450 30. 698 30.946 31.194 31.442 31.690 31.938 32.000 32.248 32.496 32.744 32 992 33.240 33.488 33.736 33. 984 34.232 48.000 120.000 744 .000 1. 0908E-01 3. 4782E-02 1. 1091E-02 3. 5369E-03 1. 1278E-03 3 5965E-04 1. 1469E-04 3.6572E-05
: 1. 1662E-05 3. 7188E-06 1. 1859E-06 3. 7816E-07 1.2059E-07 3.8453E-08
: 1. 2262E-08 3. 9102E-09 1.2469E-09
: 3. 9761E-10 1 .2679E-10 4 .0432E-11 1.2893E-11 4.1114E-12
: 1. 3110E-12 4. 1807E-13 1.3332E-13 4.2512E-14
: 1. 3556E-14 1. 0187E-14 3. 2485E-15 1. 0359E-15 3.3033E-16 1.0534E-16 3.3590E-17 1.0711E-17 3.4156E-18 1.0892E-18 3.4732E-19 9.6443E-47 7.5382-191 0.OOOOE+00
: 1. 0451E+02 1.0458E+02
: 1. 0461E+02 1. 04 61E+02 1. 0461E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02 1.0462E+02
: 2. 5264E-04 8. 0563E-05 2. 5690E-05 8. 1922E-06 2. 6123E-06 8 .3303E-07 2. 6564E-07 8. 4708E-08 2. 7012E-08 8. 6137E-09 2 .7468E-09 8 .7589E-10 2 .7931E-10 8. 9066E-11 2. 8402E-11 9. 0568E-12 2. 8881E-12.9. 2096E-13 2. 9368E-13 9.3649E-14
: 2. 9863E-14 9. 5228E-15 3. 0367E-15 9. 6834E-16 3. 0879E-16 9. 8467E-17 3. 1399E-17 2. 3596E-17 7.5242E-18 2.3993E-18
: 7. 6511E-19 2.4398E-19
: 7. 7801E-20 2.4810E-20 7.9113E-21 2.5228E-21 8.0448E-22 2.2338E-49 1.7460-193 0.0000E+00
####################################################################
Cumulative Dose Summary##4################################################################
Exclusion Area Bounda Time (hr)24.000 24.250 24. 498 24 .746 24. 994 25.242 25.490 25.738 25.986 26.234 26. 482.26.730 26. 978 27 .226 27.474 Thyroid (rem)0.OOOOE+00 4.2432E+01
: 5. 5767E+01 6.0015E+01
: 6. 1369E+01 6. 1800E+01 6. 1937E+01 6. 1981E+01 6.1995E+01
: 6. 1999E+01 6. 2001E+01 6.2001E+01
: 6. 2001E+01 6.2001E+01
: 6. 2001E+01 TEDE (rem)0 OOOOE+00 1.8604E+00
: 2. 4405E+00 2 ..6241E+00 2. 6823E+00 2. 7007E+00 2. 7065E+00 2. 7084E+00 22 7090E+00 2.7092E+00 2.7092E+00 2.7093E+00 2 .7093E+00 2 7093E+00 2.7093E+00 Low Population Zone Thyroid TEDE (rem) (rem)0.OOOOE+00 0.0000E+00 4.0626E+00 1.7813E-01 5.3394E+00 2.3366E-01 5.7461E+00 2.5124E-01 5.8757E+00 2.5681E-01 5.9170E+00 2.5858E-01 5.9301E+00 2.5914E-01 5.9343E+00 2.5932E-01 5.9357E+00 2.5937E-01 5.9361E+00 2.5939E-01 5.9362E+00 2.5940E-01 5.9363E+00 2.5940E-01 5.9363E+00 2.5940E-01 5.9363E+00 2.5940E-01 5.9363E+00 2.5940E-01 Control Thyroid (rem)0.OOOOE+00
: 6. 2248E+01 8.4240E+01
: 9. 1245E+01 9. 3477E+01 9 4188E+01 9. 4415E+01 9. 4487E+01 9. 4510E+01 9.4517E+01 9.4519E+01
: 9. 4520E+01 9.4520E+01
: 9. 4520E+01 9.4520E+01 Room TEDE (rem)0 0000E+00 1.9382E+00
: 2. 6226E+00 2. 8404E+00 2. 9098E+00 2 9319E+00 2. 9389E+00 2. 9412E+00 2. 9419E+00 2. 9421E+00 2. 9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 I CALCULATION NO. C-1302-822-E310-082 I REV. No. 1 1 PAGENO. 151 1 27.722 27.970 28.218 28..466 28.714 28.962 29.210 29.458 29.706 29.954 30.202 30.450 30.698 30.946 31.194 31.442 31.690 31.938 32.000 32.248 32.496 32.744 32.992 33.240 33.488 33.736 33.984 34.232 48.000 120.000 744.000 6 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6 .2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6 .2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6. 2001E+01 6 .2001E+01 6. 2001E+01 6. 2001E+01 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2.7093E+00 2 7093E+00 2.7093E+00 2.7093E+00
: 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 2 .7093E+00 2. 7093E+00 2. 7093E+00 2. 7093E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00 5.9363E+00
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2. 5940E-01 2.5940E-01 2.5940E-01
: 2. 5940E-01 2. 5940E-01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+0i 9 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 9. 4520E+01 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00 2.9422E+00
####################################################################
Worst Two-Hour Doses Exclusion Time (hr)24.0 Area Boundary Whole Body Thyroid (rem) (rem)8.0076E-01 6.1995E+01 TEDE (rem)2.7090E+00 Page 152 Mscisz, Thomas J From: NUCORE29@aol.com Sent: Tuesday, July 01, 2008 7:52 PM To: Rommel, John C.Cc: Mscisz, Thomas J; DeLaRosa, Jessica; NUCORE29@aol.com
 
==Subject:==
Third Party Idependent Review John: I thank you very much for giving NUCORE an opportunity to perform a third party independent review of the Oyster Creek FHA analysis documented in C-1302-822-E310-082, Rev 1. NUCORE performed the line-by-line technical review of the analysis to validate the design inputs and assumptions, and their compliance with the RG 1.183 requirements.
The technical information in the analysis is properly input into the RADTRAD code including the X/Q for the most limiting release point, the CR air intake flow rate determined based on a parametric study, and post-FHA reactor building release rate to remove 99.99% activity over two hours period. The following additional review was conducted to determine the technical consistencies between the analysis and License Amendment Request (LAR): 1. LAR Table 4-1 determines that all potential release points are considered.
: 2. Design Input Table 4-3 determines that the most limiting release point and X/Q are selected for the analysis to maximize the CR dose. The EAB & LPZ X/Qs are previously accepted by the NRC.3. The sensitivity study documented in Attachment E provides the basis for using the CR intake flow rate of 2,000 cfrm for the FHA analysis, which produces the maximum CR dose. It is to be noted here that it has been shown true for the LOCA (a long term accident) that the flow rate of 4,000 cfm produces the maximum dose in the CR, which is not the case for the FHA because it is a short term accident and CR dose is optimized at a lower intake flow rate as shown in the sensitivity study documented in Attachment E. The intake flow rate of 2,000 is used, which produces the maximum CR dose.4. The reactor building volume (100 ft3) and CR exhaust rate of 2,000 cfm are correctly used in the RADTRAD model.The review process is documented in Comment / Resolution Form attached with this e-mail, which captures the technical and editorial inconsistencies need to be resolved.
The EXELON individuals (Tom/Jessica) have incorporated/resolved the comments satisfactory and the information in the analysis was appropriately changes and revised. NUCORE concludes that the information in the analysis is technically correct and legally in compliance with the regulatory requirements.
Should you have any question regarding the subject matter, do not hesitate to contact me on (856)-577-4649 or send me an e-mail at nucore29@aQolcom.
Thanks.Gopal J. Patel (856)-577-4649 (cell)(856)-339-1355 (856)-469-4141 Gas prices getting you down? Search AOL Autos for fuel-efficient used car.s.7/2/2008 ATTACHMENT 2 Oyster Creek Nuclear Generating Station Technical Specifications Change Request 338 -Supplemental Response Secondary Containment Operability Requirements During Refueling Proposed Changes to License Amendment Request -Excerpts Change Summary* Section 4.4 was revised to change the number of significant figures in the radioactivity being exhausted in two hours.* Section 4.5 was changed to reflect the consideration of a bounding CR flow rate for the FHA (different from that for the LOCA).* Table 4-1 was updated to reflect release points that cannot be open during fuel movement." Table 4-3 was changed to reflect the values and descriptions from the calculation.
Values are now consistent with the calculation." Table 4-4 was changed to reflect the new dose values for the CR, EAB, and LPZ.* The Commitment Table was updated to reflect the additional openings that will not be allowed to be open during fuel movement.
Attachment 2 Page 1 of 10 Section 4.4 of the November 2, 2007, License Amendment Request (LAR) is revised to change the number of significant figures in the radioactivity being exhausted in two hours. The value 99.9999% was revised to 99.99% to be consistent with the FHA Calculation.
Section 4.5 of the November 2, 2007, License Amendment Request (LAR) is completely revised to read as follows: 4.5 Control Room Model The Oyster Creek Control Room HVAC system contains no HEPA, charcoal filters, or recirculation.
All intake air into the control room is unfiltered.
As a result, the radionuclide concentration inside the Control Room reaches equilibrium with the concentration of the plume at the Control Room HVAC System air intake within a short period of time after the postulated release. The dose to Control Room operators is calculated over a total duration of 720 hours. Oyster Creek LAR No. 315, "Application of Alternative Source Term," submitted to NRC on March 28, 2005, reanalyzed the design basis LOCA radiological dose consequences for Oyster Creek using Alternative Source Term methodology.
The Control Room operator dose consequences were conservatively analyzed for the LOCA analysis using the full Control Room HVAC system flow seen during the purge mode of operation.
It should be noted that the purge mode (14,000 cfm intake) is not expected to be in operation during a radiological event.Therefore, the assumption that the Control Room HVAC system is operating in the purge mode for the duration of the LOCA results in a conservative radiological dose to Control Room operators for the LOCA analysis.
However, the Control Room would be in the partial recirculation mode (2,000 cfm), which produces a slightly lower dose. In both modes of operation (purge and partial recirculation) the radiation exposure to personnel in the Control Room remains within the regulatory limits (less than 5 Rem TEDE). The LOCA analysis contains a sensitivity study that bounds the range of flow between the 2,000 cfm flow in the partial recirculation mode, and the maximum flow of 28,000 cfm for the unlikely event both fans are operating in the full purge mode. Therefore, since any increase in flow beyond 4,000 cfm does not cause an increase in dose, the amount of unfiltered inleakage does not affect the total calculated Control Room operator dose for the LOCA analysis (calculated at 14,000 cfm). Note that this has previously been approved in TS Amendment No. 262, dated April 26, 2007.A new sensitivity study was performed (Attachment E of Calculation C-1302-822-E310-082, Revision 1) to determine the most limiting control room HVAC system flow rate for the fuel handling accident.
The different release fractions and timing of the radiological source term for the fuel handling accident versus the LOCA results in a different dose profile for the Control Room than that for the LOCA. The sensitivity study developed for the FHA bounds the normal, full recirculation, partial recirculation, and purge modes of operation with a maximum flow of approximately 28,000 cfm for the unlikely event that both fans are operating in the full purge mode. The sensitivity study performed bounds the range of flows between the 2,000 cfm flow in the partial recirculation mode, and the maximum flow of 28,000 cfm for the unlikely event both fans are operating in the full purge mode. The sensitivity study shows that any increase in flow beyond 2,000 cfm does not cause an increase in total calculated Control Room operator dose for this Fuel Handling Accident analysis (calculated at 2,000 cfm).
Attachment 2 Page 2 of 10 Table 4.1 of the November 2, 2007, License Amendment Request (LAR) is revised as follows. The vertical bar in the margin shows the sections that were revised.Table 4-1 Potential Release Points Considered For Oyster Creek Fuel Handling Accident (With Respect To CR Intakes)Item Description Comments:7 X/Q Modeling Performed?......-, 1 RB Roof hatch It is feasible that the airlock could be defeated during an outage if YES NOTE: This hatch has an airlock associated with it so roof access is significant roof maintenance is required. (Values calculated) possible during plant operation.
2 Ventilation ductwork below siding structure on west side of RB (north end It is not expected that these penetrations will be opened during fuel NO of west wall): This is permanently installed ductwork from the refueling movement.
Must prevent from being opened during floor area. fuel movement.3 Ventilation ductwork below siding structure on west side of RB (south It is not expected that these penetrations will be opened during fuel NO end of west wall): This is permanently installed ductwork from the movement.
Must prevent from being opened during refueling floor area. fuel movement.4 RB grade-level access at south east corner of RB: This access is a It is possible that this access point could be open with appropriate NO security barrier and will not normally be opened. security measures in place during an outage with fuel movement.
X/Q bounded by RB commodities penetration on south RB wall (Item 10)'5 Main stack exhaust fans and ductwork at(base of main stack (also known This ductwork could be dismantled during an outage with fuel YES as the Stack tunnel Door) movement in progress.
Support for this work is the reason for this (Values calculated) evaluation.
6 RB entrance (D/W Access Facility)
There is an airlock associated with If the airlock is defeated, the actual point of release could be at the YES2 this access point, entrance to the D/W Access Facility (northeast of RB), which is (Values calculated) closer to the CR intake.6A RB personnel access airlock on east wall of 23' 6" elevation RB wall It may be beneficial if the airlock could be defeated during an outage YES (near columns RA and R5). with fuel movement.
The actual point of release is directly in front of (Values calculated) the airlock.7 RB Truck Airlock (at column RA, between columns R2 and R3): This airlock could be open during an outage with fuel movement.
NO X/Q bounded by RB commodities penetration on south RB wall (Item 10)and/or RB personnel airlock on east wall (Item 6A)'8 Isolation Condenser (IC) exhaust (east wall of RB) There is a potential that the IC would be opened during an outage. NO This release point is a release point for a LOCA. X/Q bounded by the Reactor Building Roof Hatch release. (Item 1)9 RB diffuse release This area source is from exposed RB walls "visible" to the CR YES intakes. (Values calculated) 10 RB commodities penetration on south RB wall 4 (23.5' elev.) This is a flanged connection through which, air, electric, and water YES connections are run. Existing procedures allow for use. (Values calculated)
Attachment 2 Page 3 of 10 11 RB commodities penetration on north RB wall (23.5' elev.) This is a flanged connection through which, air, electric, and water YES connections are run. Existing procedures will provide administrative (Values calculated) controls regarding opening during fuel movement.12 MAC Facility Personnel Airlock (exits out of tornado/missile protection Existing procedures will provide administrative controls regarding YES area located on the north RB wall (23.5' elev.) opening during fuel movement. (Values calculated) 13 MAC Facility Entrance (double doors) Existing procedures will provide administrative controls regarding YES opening during fuel movement. (Values calculated) 13A MAC Facility Entrance (single door) Existing procedures will provide administrative controls regarding NO opening during fuel movement.
X/Q bounded by the MAC Facility Personnel Airlock (Item 12)1 14 Trunion Room Door (at Column Lines R4 and RG) This room contains the Outboard MSIVs and opens into the Turbine NO Building and is serviced by Reactor Building HVAC systems. X/Q values for Turbine Building Existing procedures will provide administrative controls to prevent releases were previously calculated for opening during fuel movement.
MSIV leakage during a LOCA.Therefore, the same X/Q values will be used for this release location for the FHA.'Bounding modeled release point most proximate to subject release point.2 There are four (4) doors associated with the D/W Access Facility (Item 6). The X/Q for the door on the northern wall would be bounded by the door on the west wall, which is closer to Intakes A and B. Similarly, on the southern wall, the X/Q for the eastern-most door would be bounded by the western-most door, which is closer to Intakes A and B.There are two commodities penetrations located on the south RB wall (Item 10). The taut string length was calculated from each penetration to both Intakes A and B, and the penetration of shortest length to Intake A and to Intake B was selected to be modeled.
Attachment 2 Page 4 of 10 Table 4.3 of the November 2, 2007, License Amendment Request (LAR) is revised. The entire table is changed to read as follows: Table 4-3 Parameters Applicable to AST Fuel Handling Accident Dose Considerations for Oyster Creek Nuclear Generating Station Parameter or Method 'AST Value Comments Reactor Power 1969 MWth Includes 2 % margin for instrument uncertainty relative to the rated thermal power of 1930 MWt.Fuel Assembly Configuration 9 x 9 with 140 rods damaged Bounding assumptions for and properties current Oyster Creek licensing basis FHA. Movement of irradiated fuel will conservatively not occur less than 24 hours after the associated reactor shutdown.Radial Peaking Factor 1.7 Conservative bounding assumption.
Allowable Fuel Burnup and RG 1.183, Table 3. The GE 11 fuel burnup is 55.1 non-LOCA gap fractions Fuel bundle peak burnup will GWD/MTU. There is a not exceed 62 GWD/MTU. For procedural step to ensure that fuel exceeding 54 GWD/MTU, 1) peak rod-average burnup of the maximum linear heat the fuel is less than 62 generation rate will not exceed GWD/Mt. For Oyster Creek's 6.3 kW/ft. current operating cycle (Cycle 21), maximum rod average exposure at end-of-cycle is 55.1 GWd/Mt. The maximum linear heat generation rate for fuel rods projected to exceed 54 GWd/Mt is 5.1 kW/ft.FHA Radionuclide Inventory From the 60 isotopes forming Spent fuel source terms are the RADTRAD library used in based on the same bounding the LOCA analysis, with decay reactor core source terms as to 24 hours. Gap activities are was used for the LOCA per R.G. 1.183. analysis previously reviewed and approved by the NRC in TS Amendment No. 262 dated April 26, 2007.Underwater Decontamination Noble Gases: 1 For conservatism, the effective Factor minimum depth of 23 feet is Particulate (cesiums and assumed to be the water rubidiums):
infinity coverage over the reactor core. This is the worst-case Iodine: 200, corresponding to location for a fuel drop FHA to a 23-ft water depth for an take place (significantly more assembly drop into the reactor damage is produced than a vessel drop in the fuel pool).Iodine chemical distribution 95% Csl, instantaneously RG 1.183, Sections 1.3 & 2 dissociating in the pool water and re-evolving as elemental iodine. Since the pH of the Attachment 2 Page 5 of 10 Parameter or Method AST Value-,, ,.Comments pool water is not maintained above 7, iodine is assumed to be 57% elemental and 43%organic in the air space above the pool.Activity Transport to the Activity reaching the refuel RG 1.183, Section 5.3.Environment floor airspace will essentially be all exhausted within 2 hours by using an artificially high exhaust rate.Release Pathways The release pathways are No credit is taken for filtration described in this table. by the SGTS, or the elevated release resulting from exhaust through.the Oyster Creek Main Stack.Dose Conversion Factors EPA Federal Guidance EPA Federal Guidance Reports 11 and 12 Reports 11 and 12 Offsite Dose Limit 6.3 rem TEDE 1OCFR50.67 and RG 1.183 Control Room Dose Limit 5 rem TEDE for the duration of Per 1OCFR50 App. A, GDC 19 the accident and 10CFR50.67 CR Volume Volume 27,500 For the FHA, the expected mode of operation occurs at CR Intake Rate 2,000 cfm 2,000 cfm. For the FHA, the expected mode of operation occurs at 2,000 cfm. See Attachment E of Calculation C-1302-822-E310-082, Rev. 1 for sensitivity study.Refuel Floor Ventilation Rate For this analysis, an artificial This evacuates 99.99% of all and Volume volume of 100 ft 3 with an activity within two hours.artificially high exhaust rate (7.675 cfm) is assumed for I simplicity.
Attachment 2 Page 6 of 10 Parameter or Method .AST Value I Comments CR Potential Release Points Drywell Access Facility (West Wall)Drywell Access facility (South Wall)Commodities Penetration on the RB South Wall Commodities Penetration on the RB North Wall MAC Facility Personnel Airlock MAC Facility Entrance RB Roof Hatch Stack Tunnel Door East Airlock Door Trunion Room Doors to Turbine Bldg.Reactor Building Wall (Diffuse Area)Limiting X/Qs (0 -2 hr)1.61 E-03 sec/m 3 1.93E-03 sec/m3 1.77E-03 sec/m3 5.21 E-03 sec/m 3 6.75E-03 sec/m 3 6.62E-03 sec/m 3 1.82E-03 sec/m 3 8.55E-04 sec/m 3 1.40E-03 sec/m 3 3.73E-03 sec/m 3 2.15E-03 sec/m 3 From Calculation C-1302-822-E310-081, Revision 0. All releases considered as ground level releases.Permitted to be open during fuel movement Permitted to be open during fuel movement Permitted to be open during fuel movement No__t permitted to be open during fuel movement Not permitted to be open during fuel movement Not permitted to be open during fuel movement Permitted to be open during fuel movement Permitted to be open during fuel movement Permitted to be open during fuel movement No_[t permitted to be open during fuel movement.
X/Q values are from Calculation C-1302-826-E540-017, Revision 0, as pertains to MSIV leakage.The Reactor Building Wall Diffuse Source is the highest X/Q evaluated yielding acceptable dose consequence and is the bounding design basis potential release point.Other release locations with higher X/Q values will be maintained closed during fuel movement using administrative controls.
Attachment 2 Page 7 of 10 Parameter or, Method AST Value Comments EAB Release Point Basis and Normal RB exhaust stack and All releases considered as Distance to EAB 414 m (considered as ground level releases.applicable to all release locations)
Limiting Dispersion From calculation C-1302-826-Factors (0 -2 hr) 1.41 E-03 sec/i 3  E310-018 Rev. 0 LPZ Release Point Basis and Normal RB exhaust stack and All releases considered as Distance to LPZ 3218 m (considered as ground level releases.applicable to all release locations)
Limiting Dispersion From calculation C-1302-826-Factors (0 -2 hr) 1.35E-04 sec/i 3 E310-018 Rev. 0 Attachment 2 Page 8 of 10 Table 4.4 of the November 2, 2007, License Amendment Request (LAR) is revised as follows.The vertical bar in the margin shows the revised calculated doses.Table 4-4 Results (Rem TEDE)Dose Location" (Rem TEDE)LIMITS CR = 5.0; EAB & LPZ = 6.3 EAB 2.71 LPZ 0.26 CR 2.94 Attachment 2 Page 9 of 10 The Summary of AmerGen Commitments described in Enclosure 3 of the November 2, 2007, License Amendment Request (LAR) is revised as follows. The vertical bar in the margin depicts the commitment modifications.
 
==SUMMARY==
OF AMERGEN COMMITMENTS The following table identifies regulatory commitments made in this document by AmerGen. (Any other actions discussed in the submittal represent intended or planned actions by AmerGen. They are described to the NRC for the NRC's information and are not regulatory commitments.)
COMMITMENT TYPE COMMITMENT COMMITTED ONE-TIME DATE OR"OUTAGE" ACTION PROGRAMMATIC (Yes/No) (Yes/No)Oyster Creek will follow the guidelines in Upon No Yes Section 11.3.6.5 of NUMARC 93-01, Rev. 3 implementation of during refueling within containment.
Plant approved procedures will be revised, as appropriate, to amendment implement these guidelines.
The following guidelines are included in the assessment of systems removed from service during movement of irradiated fuel: During fuel handling/core alterations, ventilation system and radiation monitor availability (as defined in NUMARC 91-06) should be assessed, with respect to filtration and monitoring of releases from fuel.Following shutdown, radioactivity in the fuel decays away fairly rapidly.The basis of the Technical Specification operability amendment is the reduction in doses due to such decay. The goal of maintaining ventilation system and radiation monitor availability is to reduce doses even further below that provided by the natural decay.A single normal or contingency method to promptly (within 1 hour)close secondary containment penetrations should be developed.
Such prompt methods need not completely block the penetration or be canable of resistinci_
ressure.
Attachment 2 Page 10 of 10 COMMITMENT TYPE COMMITMENT COMMITTED ONE-TIME DATE OR"OUTAGE" ACTION PROGRAMMATIC (Yes/No) (Yes/No)The purpose of the "prompt methods" mentioned above are to enable ventilation systems to draw the release from a postulated fuel handling accident in the proper direction such that it can be treated and monitored.
The evaluated release points listed in Table 4-1 will be identified in the Oyster Creek Updated Final Safety Analysis Report (UFSAR) and in appropriate plant procedures governing secondary containment integrity and refueling activities.
Evaluation of other locations will be administratively controlled in accordance with the requirements of 10 CFR 50.59.These controls will ensure that future evaluations of any additional openings in secondary containment will remain bounded by this analysis.Plant procedures will continue to require that secondary containment integrity be maintained when handling heavy loads (greater than one fuel assembly), such as the reactor vessel head or dryer/separator assembly, over the reactor cavity with fuel in the reactor vessel.The following secondary containment potential openings will remain closed during refueling activities under administrative controls:* Ventilation ductwork below siding structure on west side of Reactor Building (north end of west wall)* Ventilation ductwork below siding structure on west side of Reactor Building (south end of west wall)" Trunion Room Doors to Turbine Building* Reactor Building Commodities (flanged) penetration on north RB wall* MAC Facility Doors Upon implementation of approved amendment Upon Implementation of approved amendment Upon Implementation of approved amendment No No No Yes Yes Yes}}

Revision as of 13:05, 10 November 2018

Redirect to:

Retrieved from "https://kanterella.com/w/index.php?title=ML081930802&oldid=1177874"